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Summary  
In living cells, aspartate is a central metabolite and the precursor for amino acids, cell wall components 
and the vitamin pantothenate. On the industrial scale, aspartate finds wide application in the artificial 
sweetener aspartame, but the chemical properties of aspartate and its derivatives allow further 
applications in the polymer, solvent, and the pharmaceutical market. Since decades, aspartate is 
synthesized by the enzymatic conversion of petrochemically synthesized fumarate, and is therefore 
directly dependent on limited fossil raw materials. Corynebacterium glutamicum is a well known as 
producer of amino acids and organic acids. It was engineered in this work for the overproduction of 
aspartate and its derivatives β-alanine and ectoine from renewable carbon sources. 
To enable the overproduction of aspartate, a growth decoupled process was developed, which was 
modified focusing on enhancing the precursor supply, improving the transamination of aspartate 
precursors, the reduction of by-products, and increasing the productivity. C. glutamicum is not able to 
proliferate under anaerobic conditions and excretes mainly succinate, lactate, and acetate as 
fermentation products. The deletion of the succinate dehydrogenase and the lactate dehydrogenase 
genes led to the strain ΔsdhCAB ΔldhA, which produces aspartate with a yield of 0.55 mol/mol glucose. 
The addition of sodium bicarbonate to the medium enhanced the precursor supply and increased the 
aspartate titer to 0.83 mol/mol glucose. Furthermore, the overproduction was enhanced by the 
expression of the aspartate aminotransferase AspB, which transaminates oxaloacetate to aspartate. 
The alanine-valine transaminase gene was deleted to reduce the by-product alanine, which improved 
the aspartate yield to 1.02 mol/mol glucose. The velocity of the process was increased 1.5-fold by the 
overexpression of the glycolytic glyceraldehyde dehydrogenase GapA. With the substrate maltose, the 
highest aspartate yield of 0.80 g/g and productivity of 0.176 mM/h*gCDW were achieved. 
The non-proteinogenic amino acid β-alanine is derived from aspartate by decarboxylation by the 
aspartate-α-decarboxylase PanD. The decarboxylases of Bacillus subtilis, Escherichia coli, and the 
endogenous enzyme were tested in the aspartate producing strain C. glutamicum ΔsdhCAB ΔldhA and 
enabled the overproduction of β-alanine with a final titer of 0.24 g/g glucose. 
In contrast to the anaerobic production of aspartate and β-alanine, the biosynthesis of ectoine was 
achieved aerobically by the heterologous expression of the ectABC gene cluster of 
Chromohalobacter salexigens. Efficient overproduction of ectoine was already achieved with the wild 
type, and was further enhanced by introducing the ectoine biosynthetic genes into the lysine 
producing C. glutamicum DM1729. This strain produces ectoine with a yield of 0.146 g/g glucose, and 
was further modified to synthesize ectoine from the non-food carbon sources xylose, arabinose, and 
glycerol. 
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Zusammenfassung 
Die Aminosäure Aspartat nimmt im Stoffwechsel von Organismen eine zentrale Rolle ein und dient 
unter anderem als Vorläufermolekül für Aminosäuren, Zellwandbausteine und dem Vitamin 
Pantothensäure. Im industriellen Maßstab wird Aspartat hauptsächlich zur Synthese des Süßstoffs 
Aspartam genutzt, allerdings erlauben die strukturellen Eigenschaften der Aminosäure und ihrer 
Derivate auch Anwendungen  in der Polymersynthese und im kosmetischen Bereich. Heutzutage wird 
Aspartat durch die enzymatische Umsetzung von Fumarat erzeugt, das wiederum durch chemische 
Synthese aus fossilen Rohstoffen erzeugt wird. In dieser Arbeit wurde die Produktion von Aspartat und 
dessen Derivate β-Alanin und Ectoin auf Basis von nachwachsenden Rohstoffen mit dem 
Amniosäureproduzenten Corynebacterium glutamicum untersucht.   
Um die Produktion von Aspartat zu ermöglichen, wurde ein vom Wachstum entkoppelter Prozess 
entwickelt, der mit Hinblick auf die Bereitstellung von Vorläufermolekülen, deren verbesserte  
Aminierung, der Reduktion von Nebenprodukten und der Erhöhung der Produktivität modifiziert 
wurde. Unter anaeroben Bedingungen findet in C. glutamicum keine Zellteilung statt und der 
Organismus wechselt zu einem fermentativen Metabolismus, der durch die Exkretion von Succinat, 
Laktat und Acetat gekennzeichnet ist. Die Deletion der Gene der Succinatdehydrogenase (sdhCAB) und 
die Laktatdehydrogenase (ldhA) führte zum Stamm ΔsdhCAB ΔldhA, der Aspartat mit einem Ertrag von 
0.55 mol/mol Glukose exkretiert. Durch die Zugabe von Natriumhydrogencarbonat konnte die 
Anaplerose verbessert, und der Ertrag auf 0.83 mol/mol gesteigert werden. Des Weiteren wirkte sich 
die Expression des Gens der Aspartat Aminotransferase AspB positiv auf die Ausbeute aus. Um die 
Bildung des Nebenprodukts Alanin zu verringern, wurde das Alanin-Valin Aminotransferase Gen 
deletiert, was den Ertrag auf 1.02 mol/mol Glukose erhöhte. Die Produktivität der 
Aspartatfermentation konnte durch die Expression der glykolytischen Glycerin-3-Phosphat-
dehydrogenase um das 1,5-fache gesteigert werden. Zudem führte die Verwendung des Disaccharids 
Maltose zur höchsten Ausbeute von 0.80 g/g und höchsten Produktivität von 0.176 mM/h*gCDW.  
Die nicht-proteinogene Aminosäure β-Alanin wird durch Decarboxylierung von Aspartat durch die 
Aspartat-α-Decarboxylase PanD gewonnen. Die Decarboxylasen aus Bacillus subtilis, Escherichia coli 
und das endogene Enzym wurden in den Aspartat-produzierenden Stamm ΔsdhCAB ΔldhA 
eingebracht, und ermöglichten die Produktion von β-Alanin mit einem Ertrag von 0.24 g/g Glukose. 
Durch die heterologe Expression der ectABC Gene aus Chromohalobacter salexigens konnte bereits im 
Wildtypstamm eine signifikante Menge des kompatiblen Soluts unter aeroben Bedingungen erzeugt 
werden. Dieser Ertrag konnte im Lysin-prozierenden Stamm C. glutamicum DM1729 auf 0,146 g/g 
gesteigert werden, der im weiteren Verlauf für die Verstoffwechslung der non-food Kohlenstoffquellen 
Xylose, Arabinose und Glycerin modifiziert wurde.  
13 
 
1 Introduction 
1.1  Characteristics of Corynebacterium glutamicum and its application in 
biotechnology 
Corynebacterium glutamicum was isolated in 1957 from soil samples during a screening for a natural 
glutamate excreting organism. The Gram-positive, immobile, non-sporulating bacterium is named after 
the typical club-shaped form and undergoes snapping division. It is facultative anaerobic, has a high 
G + C content and is generally regarded as safe (GRAS). 
Together with Streptomycetales, Micrococcales and Actinomycetales, the order Corynebacteriales 
belongs to the class Actinobacteria which contains more than 200 genera (Gao and Gupta, 2012; Zhi et 
al., 2009). The order Corynebacteriales comprises six families which are characterized by the presence 
of mycolic acids in the cell wall. Only a few exceptions like Corynebacterium amycolatum, C. atypicum 
and C. kroppenstedtii lack this characteristic (Bernard and Goodfellow, 2012). Several organisms of the 
Corynebacteriales have been sequenced due to their importance as human pathogens like 
Corynebacterium diptheriae and Mycobacterium tuberculosis or their role in the biotechnological 
industry like C. glutamicum or C. efficiens (Cerdeno-Tarraga et al., 2003; Cole et al., 1998; Kalinowski et 
al., 2003; Nishio et al., 2003). 
C. glutamicum is widely used in white biotechnology and synthesizes 2.2 million tons of glutamate and 
1.7 million tons of lysine per year (Ajinomoto, 2010, 2011). Next to these, also pathways for the 
synthesis of branched chain, aromatic and other amino acids are developed (Becker and Wittmann, 
2012; Blombach et al., 2008; Hasegawa et al., 2012; Ikeda et al., 2009; Kelle et al., 1996; Peters-
Wendisch et al., 2005; Schneider et al., 2011). The portfolio of biotechnological produced compounds 
by C. glutamicum is steadily increasing and not limited to amino acids (Zahoor et al., 2012). Pathways 
were also optimized for the biofuels ethanol and isobutanol (Blombach et al., 2011; Inui et al., 2004a; 
Sakai et al., 2007; Smith et al., 2010), and the diamines putrescine and cadaverine (Buschke et al., 
2011; Mimitsuka et al., 2007; Schneider et al., 2012; Schneider and Wendisch, 2010). The organism 
naturally excretes succinic and lactic acid under anoxic conditions. This scaffolding was used to 
engineer C. glutamicum for production of succinate, both under aerobic and anaerobic conditions 
(Litsanov et al., 2012a; Litsanov et al., 2012c; Okino et al., 2008a). Under oxygen deprivation 
conditions both stereoisomers of lactic acid can be synthesized (Okino et al., 2005; Okino et al., 
2008b). Recently, efficient production of the central precursor pyruvate was shown and also 
carotenoids can be overproduced (Heider et al., 2012; Wieschalka et al., 2012). Furthermore, the 
global demand for these products increases annually. The amino acid glutamate is used as a flavor 
14 
 
enhancer in Asian food, while lysine, threonine, and valine are fed to livestock to enhance growth. 
Increasing prices of oil favor the synthesis of biofuels from renewable and sustainable resources. In 
addition, the aforementioned diamines are used in polyamide synthesis, while lactic acid is 
polymerized and used as packing material. Succinic acid is mentioned as a top value added chemical 
from carbohydrates and serves as building block for commodity and specialty chemicals (Werpy et al., 
2004). This wide range of producible molecules substantiates the importance of the organism for 
industrial biotechnology.  
The value of the organism is based on a variety of benefits. Cultivation of C. glutamicum is performed 
at moderate temperatures and high cell densities are obtained even in shake flasks. Furthermore, the 
biomass and metabolic activity remains stable, if the organism is arrested in growth due to nutrient 
limitation of the medium or a switch to anoxic conditions (Blombach et al., 2007; Inui et al., 2004b). In 
fed-batch cultivations, this feature enables the utilization of carbon source for product synthesis, and 
minimizes investments in retaining biomass. The organism is able to grow on a variety of carbon 
sources and shows with a few exceptions no catabolite repression (Arndt and Eikmanns, 2007). The 
mixture of glucose with gluconeogenetic carbon sources like pyruvate, lactate, and acetate, as well as 
the mixture with other six carbon sugars like fructose leads to a monophasic growth with simultaneous 
consumption of the carbon sources (Cocaign et al., 1993; Dominguez et al., 1997; Wendisch et al., 
2000).  
C. glutamicum is accessible to genetic manipulations by a large tool box, with vectors for heterologous 
expression, promoter probe vectors, and suicide plasmids that enable gene deletions or single base 
exchanges as well as stable introduction of new genetic material (Nesvera and Patek, 2011). The 
sequencing of the 3.28 Mb genome was performed independently by two research groups, and paved 
the way for further improvements of the strain (Ikeda and Nakagawa, 2003; Kalinowski et al., 2003). 
Transcriptomic and proteomic data is used to describe the physiology of the organism, and the 
knowledge about regulation and genetic organization allows fine tuning of specific pathways. 
 
1.2 The central metabolism of C. glutamicum 
The central metabolism of C. glutamicum consists of glycolysis, the tricarboxylic acid cycle (TCA) and 
the pentose phosphate pathway (PPP) (Figure 1). This network generates energy and delivers 
precursors for several anabolic reactions. Energy in the form of the reduction equivalents NADH or 
menaquinone is used to establish a proton motif force at the cytoplasmatic membrane, while NADPH 
is used for assimilatory purposes, e. g. the reductive amination of 2-oxoglutarate to glutamate by the 
glutamate dehydrogenase Gdh (gdh, cg2280). 
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Figure 1: The central metabolism of C. glutamicum. 
White boxes: native proteins of C. glutamicum; grey boxes: heterologous proteins to broaden substrate 
spectrum. Carbon source uptake and utilization: PtsG: PTS transporter glucose; Hpr, PtsI: unspecifc PTS 
components; MusEFGK2I: ABC-transporter for maltose uptake; MalQ: 4-α-glucanotransferase; MalP: 
maltodextrin phosphorylase; Pgm: α-phosphoglucomutase; Glk: glucokinase; AraA: L-arabinose isomerase; AraB: 
L-ribulokinase; AraD: L-ribulose-5-phosphate-4-epimerase; XylAXc: xylose isomerase; XylB: xylulose kinase; GlpF: 
glycerol facilitator; GlpK: glycerol kinase; GlpD: glycerol-3-phosphate dehydrogenase; Pentose phosphate 
pathway: Zwf, opcA: glucose-6-phosphate dehydrogenase; Gnd: 6-phosphogluconate dehydrogenase; Rpe: 
ribulose-5-phosphate epimerase; Glycolysis and subsequent reactions: Pgi: phosphoglucose isomerase; Pfk: 
phosphofructokinase; Fda: fructose-1,6-bisphosphate aldolase; GapA: glyceraldehyde-3-phosphate 
dehydrogenase;  Pyk: pyruvate kinase; LdhA: lactate dehydrogenase (NAD-dependent); LldD: lactate 
dehydrogenase (quinone-dependent); Pqo: pyruvate-quinone oxidoreductase; AckA: acetate kinase; Pta: 
phosphotransacetylase; AlaT: alanine transaminase; AvtA: alanine valine transaminase; Anaplerosis: Ppc: PEP-
carboxylase; PckA: PEP-carboxykinase; Pyc: pyruvate carboxylase; Odx: oxaloacetate decarboxylase; MalE: malic 
enzyme; TCA-cycle and subsequent reactions: PDHC: pyruvate dehydrogenase complex; GltA: citrate synthase; 
Acn: aconitase; Icd: isocitrate dehydrogenase; AceA: isocitrate lyase; AceB: malate synthase; ODHC: 2-
oxoglutarate dehydrogenase complex; Cat: Succinyl-CoA:Acetate CoA transferase; SucCD: succinyl-CoA 
synthetase; SdhCAB: succinate dehydrogenase; AspA: aspartase; Fum: fumarase; Mqo: malate quinone 
oxidoreductase; Mdh: malate dehydrogenase; AspB: aspartate aminotransferase. 
 
 
1.2.1 Carbon source uptake 
C. glutamicum is able to utilize several carbon sources, ranging from C2-sources like ethanol to 
disaccharides like sucrose (Cocaign et al., 1993; Dominguez et al., 1997; Yokota and Lindley, 2005). 
Gluconeogenetic carbon sources are activated to actetyl-CoA and are metabolized in the TCA cycle. For 
example, D- and L-lactate are oxidized to pyruvate by the quinone dependent lactate dehydrogenases 
(DlD and LldD, respectively) and activated at the pyruvate dehydrogenase complex (PDHC). The 
general uptake system for carbohydrates is the phosphotransferase system, transferring the 
phosphate group of phosphoenol pyruvate (PEP) to the sugar, synthesizing sugar-6-phosphates (Figure 
1). It consists of the general uptake proteins E1 and HPr, encoded by ptsI and ptsH, respectively, and 
substrate specific transporters for glucose (ptsG), fructose (ptsF) and sucrose (ptsS). PTS independent 
uptake of glucose was shown in PTS-deficient mutants, with the inositol transporters IolT1 and IolT2 
(Lindner et al., 2011). These permeases import glucose, fructose, and inositol and subsequent 
phosphorylation is performed by the glucokinases Glk or PpgK. The utilization of the disaccharide 
maltose in C. glutamicum was uncovered recently. It is initiated with the import of maltose by the 
ABC-transport system MusEFGK2I (Henrich et al., 2013). The 4-α-glucanotransferase MalQ catalyzes 
the addition of maltose to maltodextrin, thereby liberating one glucose molecule which is 
phosphorylated to glucose-6-phosphate by the glucokinase Glk. Maltodextrin is a chain of α-1,4-linked 
glucose molecules and serves as storage polymer. Its degradation involves the maltodextrin 
phosphorylase MalP and the α-phosphoglucomutase Pgm. MalP synthesizes glucose-1-phosphate that 
is converted by Pgm to glucose-6-phosphate, which can be metabolized in glycolysis (Seibold et al., 
2009).  
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Next to these food carbon sources, the substrate spectrum of C. glutamicum was enlarged to non-food 
carbon sources by the integration of heterologous pathways. Lignocellulosic plant material contains 
25-30 % hemicelluloses, consisting mainly of arabinose and xylose. Recently, utilization of arabinose 
was enabled by expression of the E. coli araBAD operon, encoding the L-arabinose isomerase AraA, the 
L-ribulokinase AraB and the L-ribulose-5-phosphate-4-epimerase AraD (Kawaguchi et al., 2008). 
Furthermore, the type strain C. glutamicum ATCC 31831 is able to utilize arabinose and additionally 
carries an arabinose transporter encoded by araE (Kawaguchi et al., 2009). Xylose utilization was first 
shown in C. glutamicum by the expression of the E. coli genes for the xylose isomerase xylA and for the 
xylulose kinase xylB (Kawaguchi et al., 2006). C. glutamicum possesses an endogenous kinase encoded 
by cg0147, while no functional isomerase was discovered so far. In a screening for xylose isomerases, 
accelerated xylose consumption was found with XylA of Xanthomonas campestris (Meiswinkel et al., 
2013). Both arabinose and xylose are converted to D-xylulose-5-phosphate and enter the pentose 
phosphate pathway.  
Glycerol is a stoichiometric waste product in biodiesel (fatty-acid-methyl-ester, FAME) synthesis, and 
expression of the genes of E. coli encoding the glycerol facilitator (glpF), the glycerol kinase (glpK) and 
the glycerol-3-phosphate dehydrogenase (glpD) enables growth and amino acid production in 
C. glutamicum based on this carbon source (Rittmann et al., 2008). Glycerol is phosphorilated to 
glycerol-3-phosphate and oxidized to dihydroxyacetone phosphate, which feeds glycolysis. 
 
1.2.2 Glycolysis  
The monosaccharides glucose and fructose are utilized in their phosphorilated forms via the glycolysis 
and supply the organism with precursors for amino acid synthesis or energy generation. 
Phosphorylation of the sugars is mediated during the uptake by the PTS and subsequent activation and 
substrate level phosphorylation is performed according to the Embden Meyerhoff Parnas pathway. 
Glycolytic genes are scattered across the genome, only one transcriptional unit was detected, 
containing the genes for the glyceraldehyde-3-phosphate dehydrogenase (gapA), the 
3-phosphoglycerate kinase (pgk), the triosephosphate isomerase (tpi) and the phosphoenol pyruvate 
carboxylase (ppc), which catalyzes anaplerotic reactions (Eikmanns, 1992; Schwinde et al., 1993). 
Several genes of the glycolysis are controlled by the master regulators SugR and RamA (Engels et al., 
2008; Toyoda et al., 2009). The transcriptional regulation was studied in detail on GapA, a key enzymes 
of glycolysis which catalyzes the NAD-dependent phosphorylation of glyceraldehyde-3-phosphate to 
1,3-bisphosphoglycerate. SugR was shown to bind to the promoter region of gapA and to repress 
expression in the absence of sugars, while RamA serves as activator of the gene, being able to bind to 
three different sites in the promoter region (Toyoda et al., 2008, 2009). Moreover, the activity of many 
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glycolytic enzymes is regulated by feedback inhibition. GapA and its gluconeogenetic counterpart GapB 
are regulated inversely by the level of ATP and ADP and GapA is additionally inhibited by NADH, 
thereby controlling the glycolytic flux (Danshina et al., 2001; Dominguez et al., 1998; Omumasaba et 
al., 2004). Feedback inhibition is also found for the key enzyme pyruvate kinase (pyk). In this case, high 
ATP concentrations inhibit its activity, while AMP activates the enzyme (Ozaki and Shiio, 1969). 
 
1.2.3 Pentose phosphate pathway  
The main functions of the PPP are the supply of reduction equivalents and the synthesis of precursors 
for histidine, aromatic amino acids, and nucleotide synthesis. The PPP is connected to the glycolysis by 
fructose-6-phosphate and glyceraldehyde-3-phosphat. In the oxidative part of the PPP, two moles of 
NADPH per mol glucose are generated by the glucose-6-phosphate dehydrogenase encoded by zwf 
and opcA and the 6-phosphogluconate dehydrogenase encoded by gnd. This feature is exploited in the 
industrial synthesis of lysine, as four moles of the reduction equivalent are needed to synthesize one 
mol of the amino acid (Marx et al., 1997; Schrumpf et al., 1991; Sonntag et al., 1993). Therefore flux is 
redirected from glycolysis to the PPP by disruption of the gene for the glycolytic phosphoglucose 
isomerase (pgi) or by the expression of the gluconeogenetic fructose-1,6-bisphosphatase (fbp) (Becker 
et al., 2005; Georgi et al., 2005; Marx et al., 2003). In a more direct approach, the flux was redirected 
by the expression of zwf (Becker et al., 2007). The Gnd irreversibly decarboxylates 6-phosphogluconate 
to ribulose-5-phosphate (Ru-5P) and marks the end of the oxidative part (Moritz et al., 2000). The non-
oxidative part is performed by four enzymes and leads to ribose-5-phosphate as precursor for 
nucleotide and histidine synthesis and to erythrose-4-phosphate as precursor for the synthesis of 
phenylalanine, tyrosine and tryptophan. Another important intermediate of the PPP is xylulose-5-
phosphate, as it serves as the entry point of the lignocellulosic carbon sources arabinose and xylose 
(Kawaguchi et al., 2008; Kawaguchi et al., 2006).  
 
1.2.4 Anaplerosis 
The anaplerotic node links glycolysis and the TCA cycle by the molecules pyruvate, phosphoenol 
pyruvate (PEP), oxaloacetate and malate to each other. The synthesis of amino acids of the aspartate 
family is draining off oxaloacetate from the TCA, which is replenished by the carboxylation of the 
glycolytic molecules by the PEP carboxylase Ppc (ppc) and the pyruvate carboxylase Pyc (pyc) 
(Eikmanns et al., 1989; Peters-Wendisch et al., 1997) (Figure 1). To enable gluconeogenesis, 
oxaloacetate can be decarboxylated to PEP by PEP carboxykinase PckA (pckA) or to pyruvate by 
oxaloacetate decarboxylase Odx (odx), while the malic enzyme MalE (malE) decarboxylates malate to 
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pyruvate (Gourdon et al., 2000; Jetten and Sinskey, 1993; Klaffl and Eikmanns, 2010; Riedel et al., 
2001). Pyc and Pck are dependent on ATP or GTP, while Ppc uses the energy of ester-bond phosphate. 
Odx is strictly dependent on divalent magnesium ions and MalE on NADP
+
. The carboxylation of 
pyruvate by Pyc was found to be the predominant reaction of the anaplerotic node under aerobic 
conditions. This feature is exploited in the synthesis of lysine by expression of the pyc
P458S
 gene, 
encoding a deregulated carboxylase with higher activity (Georgi et al., 2005; Peters-Wendisch et al., 
1993). Under anaerobic condition, Pyc is of subordinate importance as Ppc is the primary enzyme for 
the synthesis of oxaloacetate (Inui et al., 2004b).  
 
1.2.5 Tricarboxylic acid cycle 
The TCA cycle serves energy generation and supplies cells with precursors for amino acids (Figure 1). 
2-oxoglutarate is the precursor for amino acids of the glutamate family (glutamate, glutamine, arginine 
and proline) and it is irreversibly synthesized by the isocitrate dehydrogenase Icd (icd, cg0766). 
Fumarate is synthesized by the succinate dehydrogenase SdhCAB (sdhCAB, cg0445-0447) and 
oxaloacetate by the malate-quinone oxidoreductase Mqo (mqo, cg2192) and both compounds can 
serve as precursors for amino acids of the aspartate family (Eikmanns et al., 1995). Succinyl-CoA can be 
drained off from the TCA cycle for the synthesis of lysine, or the CoA-group is transferred by the 
succinyl-CoA:acetate CoA-transferase Cat (cat, cg2840) to acetate, for the synthesis of acetyl-CoA (Veit 
et al., 2009). 
NADPH for anabolic purposes is only generated at the Icd, while energy for the respiratory chain is 
generated by four enzymes or protein complexes. Of these, the SdhCAB and the Mqo are 
membrane-bound and quinone-dependent. The SdhCAB is a trimeric flavoprotein containing a 
transmembrane cytochrom b, and oxidizes succinate to fumarate (Kurokawa and Sakamoto, 2005). 
The Mqo has a cytoplasmatic NAD-dependent counterpart, the malate dehydrogenase Mdh (mdh). 
During growth, Mdh and Mqo are simultaneously active and catalyze opposite reactions; Mqo oxidizes 
malate to oxaloacetate in a quinone-dependent manner and Mdh oxidizes NADH for the reduction of 
oxaloacetate to malate. Nevertheless, under aerobic conditions Mdh is dispensable for growth, 
whereas Mqo is essential (Molenaar et al., 2000; Molenaar et al., 1998).  
 
1.3 Anaerobic conditions 
The change from oxic to anoxic conditions requires several adjustments in the metabolism of 
C. glutamicum. When oxygen is limiting, the organism switches from respiration to fermentation of 
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succinic, lactic and acetic acid and loses its ability to grow. Therefore, C. glutamicum was regarded as 
strict aerobe until growth was detected in the presence of nitrate, which can be used as terminal 
electron acceptor (Nishimura et al., 2007; Takeno et al., 2007). The growth arrest is a major advantage 
for biotechnological applications, as carbon sources are not steadily invested into biomass but in the 
synthesis of the product of interest. The organism can be packed to high optical densities and retains 
stable metabolic activities for at least 360 hours (Inui et al., 2004b). These features were exploited to 
develop processes for the anaerobic production of organic acids with C. glutamicum (Litsanov et al., 
2012a; Okino et al., 2005).  
Genetic profiling under anaerobic conditions revealed an up-regulation of glycolytic genes especially 
the gapA-pgk-tpi-ppc operon in addition with the genes encoding the lactate and the malate 
dehydrogenase (Inui et al., 2007; Molenaar et al., 2000). Furthermore, the genes for the oxidative arm 
of the TCA cycle, aceA, gltA, icd, odhA, and sucCD show a significant down-regulation under these 
conditions. Therefore, the fermentative metabolism based on the glycolysis and the reductive arm of 
the TCA cycle, which leads from oxaloacetate via malate and fumarate to succinate. The up-regulation 
of gapA, ldhA, mdh and ppc is crucial for carbon source consumption. The glycolytic GapA is inhibited 
by NADH, which is regenerated to NAD
+
 either by LdhA for the synthesis of lactate, or by the Mdh 
during the synthesis of succinate. Furthermore, the reductive branch of the TCA cycle is fueled by Ppc. 
It was shown that fermentative synthesized succinate is exclusively derived from the carbon fixing 
reactions of Ppc and not Pyc, which is the predominant enzyme to replenish the TCA cycle under 
aerobic conditions (Inui et al., 2004b).  
 
1.4 The amino acid aspartate  
L-Aspartate was first identified as hydrolysis product from asparagine in juice of Asparagus officinalis. 
Next to glutamate, it is the only acidic amino acid and has a negatively charged, polar side chain. 
L-Aspartate is non-essential in mammals and can be synthesized from oxaloacetate by transamination 
or from fumarate by reductive amination. The L-form of aspartate is proteinogenic but D-aspartate is 
found in archaeal as well as Gram-positive bacteria as part of the peptidoglycan. These organisms, like 
Pyrococcus horikoshi or Enterococcus faecium, possess the aspartate racemase that synthesizes the 
D- from the L-form (Bellais et al., 2006; Liu et al., 2002). In mammals, D-aspartate is a neurotransmitter 
and found in the nervous and endocrine system. Here, only the proteinogenic form of the amino acid 
is discussed, and whenever aspartate is written, the L-form is addressed. 
Aspartate is a central precursor in the cell, involved in several pathways ranging from amino acid to 
vitamin synthesis, and it is the basis for the cell wall component diaminopimelic acid in C. glutamicum. 
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Next to these physiological functions, aspartate finds application in chemical industry. Besides the well 
known utilization in the low calorie sweetener aspartame, a dipeptide of aspartate and phenylalanine, 
new applications in the solvent and polymer market evolve. Aminated derivatives of dicarboxylic acids 
like amine butanediol, amine tetrahydrofuran and amine butyrolactone hold potential to replace the 
acids derived from petrochemical resources. Additionally, polymerized aspartate can replace polacrylic 
acid or polycarboxylates which find wide application as packaging material or as superabsorber in 
diapers. Due to the possibility of fermentative generation, aspartate was identified as a top-value 
added chemical from biomass (Werpy et al., 2004). Industrial synthesis of aspartate is performed by 
enzymatic conversion of fumarate and ammonia with aspartases (or aspartate ammonia lyases) since 
the 1970s. For this purpose, E. coli cells are entrapped in matrices consisting of polyacrylamid, 
polyurethane foam or carrageen. In the latter a production stability of nearly two years was 
established, with a productivity of 200 mM aspartate per gram cells per hour. Annually, approximately 
30.000 tons are synthesized (Eggeling and Sahm, 2009). A recent drawback of this enzymatic 
conversion is the high price for the substrate fumarate. It is synthesized chemically from maleic 
anhydride in a scale of 90.000 tons per year. Nevertheless, product costs are high, and fermentative 
routes exploiting the ability of the fungi Rhizopus nigricans or related species to excrete fumarate are 
currently in the focus of research (Roa Engel et al., 2008; Roa Engel et al., 2011).  
 
1.4.1 Synthesis of aspartate under physiological conditions 
Under physiological conditions, aspartate is a derivative of the TCA cycle and can be synthesized by 
amination of fumarate or by transamination from oxaloacetate (Figure 2). The aspartase (AspA) 
catalyzes the reversible amination of fumarate to aspartate and belongs to the aspartase/fumarase 
superfamily. The reaction of fumarase and aspartase follows the same scheme, differing only in the 
functional group that is leaving the molecule (Veetil et al., 2012).  
Several aspartases have been purified from Gram-positive and Gram-negative organisms including 
Pseudomonas fluorescens, Bacillus subtilis and Bacillus sp. YM55-1, possessing a thermostable enzyme, 
but the best studied is the E. coli aspartase AspA (aspA, b4139) (Cardenas-Fernandez et al., 2012; 
Kawata et al., 1999; Shi et al., 1997; Sun and Setlow, 1991; Takagi et al., 1986). It is a homotetramer 
with 478 amino acid residues each, containing three functional domains. The central domain contains 
the catalytic side, but due to the lack of aspartate bound crystals, not all catalytic residues were 
identified (Kawata et al., 1999; Shi et al., 1997; Weiner et al., 2008). Nevertheless, engineered versions 
of AspA with increased catalytic properties are available (Wang et al., 2000). The aspartase is 
characterized by a high substrate specificity, next to aspartate only aspartate semialdehyde can be 
deaminated resulting in an inactivation of the enzyme (Yumoto et al., 1982). Activity of AspA is 
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depending on magnesium ions and it is allosterically activated by aspartate (Karsten et al., 1986). 
Molecules mimicking the structure of aspartate, like malate, succinate and N-acetylaspartate were 
found to inhibit the aspartase (Falzone et al., 1988).  
Aminotransferases are categorized according to their substrates into four groups and catalyze the 
reversible transfer of amino groups from amino to organic acids. Although many aminotransferases 
show overlapping substrate specificity, glutamate is one of the most important amino group donors. In 
C. glutamicum, glutamate is synthesized in a NADP-dependent manner either from 2-oxoglutarate by 
the glutamate dehydrogenase Gdh (gdh, cg2280), or from glutamine by the glutamine synthetase 
GltBD (gltBD, cg0229-0230). However, the alanine aminotransferases AlaT and AvtA have different 
amino group donors. AlaT (alaT, cg3149) utilizes additionally to glutamate also aspartate as amino 
donor, while the alanine-valine aminotransferase AvtA (avtA, cg2877) uses valine to transaminate 
pyruvate to alanine (Marienhagen et al., 2005). The E. coli aspartate aminotransferase AspC is one of 
the best studied pyridoxal phosphate (PLP) dependent enzymes, and its structure and reaction 
mechanism was studied in detail. It is homodimeric, and each monomer chain consists of a large and a 
small domain, with the active site located on the interface. PLP lies at the bottom of the active center 
and serves as acceptor molecule for the amino group (Jäger et al., 1994; Okamoto et al., 1994). AspC 
belongs to subgroup Iα of aminotransferases, where the binding of the substrate induces a 
conformational change that affects the large and the small domain and brings the enzyme into the 
closed form. Next to the biosynthesis of aspartate, E. coli AspC has overlapping substrate specificity 
and catalyzes the synthesis of tyrosine and phenylalanine (Hammes et al., 2011). The aspartate 
aminotransferase AspB (aspB, cg0294) of C. glutamicum and shows only a weak aminotransferase 
motif, but the function was determined by measuring the specific activity for aspartate and 
α-ketoglutarate. In contrast to E. coli, AspB is not involved in the synthesis of other amino acids 
(Marienhagen et al., 2005; McHardy et al., 2003). 
  
Figure 2: Synthesis of aspartate and its function as precursor m
Aspartate is synthesized from the TCA cycle intermediates oxaloacetate and fumarate and serves as precursor 
β-alanine, the amino acids of the aspartate family, the cell wall component diaminopimelate
solute ectoine. AspB: aspartate aminotransferase; Gdh: glutamate dehydrogenase; AspA: aspartase; PanD: 
aspartate-α-decarboxylase; LysC: aspartate kinase; Asd: aspartate semialdehyde dehydrogenase; Hom: 
homoserine dehydrogenase; DapA: dihydropicolinate synthase; LysA diaminopimel
 
1.4.2 Synthesis of amino acids of the aspartate family
The amino acids of the aspartate family comprise asparagine, lysine, threonine, methionine
isoleucine. With the exception of asparagine, t
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the synthesis of threonine, 
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For the biotechnological synthesis of these amino acids, regulations at the level of aspartate and 
aspartate semialdehyde are applied to reach the desired fluxes. Basis for every pathway are feedback 
resistant variants of the aspartokinase (Kelle et al., 2005). At the next branching point, reduced activity 
of Hom leads to lysine excretion, while increased activity of the dehydrogenase promotes synthesis of 
isoleucine (Cremer et al., 1988; Morbach et al., 1996). For example, the strain DM1729 contains only 
three point mutations that lead to efficient synthesis of lysine: increased activity of anaplerotic 
pyruvate carboxylase (pyc
P458S
), feedback resistant aspartokinase (lysC
T311I
) and homoserine 
dehydrogenase (hom
V59A
) with reduced activity (Georgi et al., 2005).  
 
1.4.3 Export of amino acids 
In C. glutamicum three transporters are known to excrete amino acids. Arginine and lysine are 
exported by the lysine efflux permease LysE (lysE, cg1424), which is characterized by a low KM for 
lysine to ensure export only under excess of the amino acid (Vrljic et al., 1999; Vrljic et al., 1995; Vrljic 
et al., 1996). The threonine exporter (thrE, cg2905) also contributes the transport of serine, while the 
branched chain amino acid transporter BrnFE (brnFE, cg0314-0315) shows the broadest substrate 
spectrum and facilitates the excretion of isoleucine, leucine, valine, and methionine (Kennerknecht et 
al., 2002; Simic et al., 2001). No specific transport system was identified for aspartate so far. Excretion 
of glutamate is still not fully understood. Several methods that induce glutamate excretion are known 
like the limitation of biotin or the addition of the antibiotics penicillin and ethambutol (Radmacher et 
al., 2005; Shiio et al., 1962). These methods are thought to affect membrane tension by changing the 
composition of the cytoplasmatic membrane or weakening the integrity of the cell wall. In turn, these 
changes in membrane tension activate mechanosensitive channels and lead to efflux of molecules. 
Mutational studies of the channel protein YggB showed that C-terminal alterations lead to constant 
efflux of glutamate, without the need of induction. Therefore the involvement of YggB in glutamate 
export is very likely (Nakamura et al., 2007).  
 
1.5 The non proteinogenic amino acid β-alanine 
In C. glutamicum, this β-amino acid is derived by decarboxylation of aspartate by the aspartate-α-
decarboxylase PanD (panD, cg0172) ( 
Figure 2). The physiological role of β-alanine in C. glutamicum is the synthesis of the B-vitamin 
pantothenate (vitamin B5). The vitamin is a part of coenzyme A and the acyl carrier protein, and 
therefore, essential for enzymes in the TCA cycle and in fatty acid synthesis. Biosynthesis of 
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pantothenate is a split pathway involving the synthesis of D-pantoate by the α-ketopantoate 
hydroxymethyl transferase PanB (panB, cg0149) and the α-ketopantoate reductase IlvC (ilvC, cg1437). 
The D-pantothenate synthetase PanC (panC, cg0148) ligates β-alanine to D-pantoate and generates D-
pantothenate.  
Chemical synthesis of β-alanine is well known and patented since more than 70 years, but it is 
dependent on petrochemical resources, high pressure and rather high temperatures (Paden, 1943). In 
mammals, β-alanine can only be synthesized by degradation of uracil, and furthermore, it is the 
limiting factor for the synthesis of the dipeptide carnosine (Traut and Jones, 1996). Carnosine is mainly 
found in muscles and serves as physicochemical buffer. It is thought to enhance muscle performance, 
which explains why β-alanine is often used by athletes as food supplement (Derave et al., 2007). 
Additionally, β-alanine can be used for the synthesis of hydroxypropionic acid, which serves as a 
precursor for acrylic acid (Liao et al., 2010; Marx et al., 2007; Straathof et al., 2005). Polyacrylic acid 
absorbs multiple times the own weight of water and this super-absorbing property is applied, e. g. in 
diapers. 
The decarboxylase PanD is an interesting enzyme as it undergoes a self-induced posttranslational 
modification. The 136 aa long protein is synthesized as an inactive pro-enzyme, and performs 
self-proteolysis between the amino acids Gly24 and Ser25, which leads to the formation of an α-and β-
chain. Other decarboxylases like the diaminopimelate decarboxylase LysA are dependent on pyridoxal 
phosphate, but the self-proteolysis of PanD forms a pyruvoyl-residue located in the α-chain, which 
serves as the prosthetic group of the enzyme (Cui et al., 2013; Schmitzberger et al., 2003). The 
complete decarboxylase is multimeric, containing three α-and three β-chains, as well as an inactive 
pro-enzyme. C. glutamicum panD was identified by functional complementation of an E. coli mutant 
strain and was used for production of pantothenate in this organism (Dusch et al., 1999a; Sahm and 
Eggeling, 1999). An active transport system was detected in E. coli, where the amino acid carrier CycA 
was shown to import β-alanine (Schneider et al., 2004). Potential candidates from C. glutamicum were 
tested in deletion studies, but no transporter was identified so far (Radmacher et al., 2002).  
 
1.6 Ectoine 
Ectoine is a compatible solute that was first discovered in Halorhodospira halochloris, and is 
widespread in γ-proteobacteria like Halomonas and Chromohalobacter, actinobacteria like 
Brevibacterium and Streptomyces, and firmicutes like Bacillus and Marinococcus (Galinski et al., 1985; 
Kuhlmann and Bremer, 2002; Louis and Galinski, 1997; Onraedt et al., 2005; Roberts, 2005). It is a 
derivative of aspartate and synthesized by five enzymatic steps. The initial synthesis of aspartate 
semialdehyde is similar to the synthesis of lysine and threonine and catalyzed by the aspartokinase 
 and the aspartate semialdehyde dehydrogenase. 
transamination of aspartate semialdehyde 
diaminobutyrate, which is further acetylated 
step, acetyl diaminobutyrate is condense
hydroxylation by ectoine hydroxylase (EctD)
heat stress protection (Garcia-
macromolecules, cells or tissues. It was shown to improve protein folding and activity, and to decrease 
the melting temperature of DNA. It is used in sun blockers to quench singlet oxygen derived from 
ultraviolet light, and was shown to moisturize human skin 
2004; Heinrich et al., 2007; Pastor
performed by a process called “bacterial milking”. T
cultivated under high salt conditions to induce ectoine synthesis. After reaching an appropriate cell 
density, a hypoosmotic shock (15
addition of distilled water. This shock induces the release of ectoine to the culture medium. Product 
and cells are separated and cells are recycled in fresh medium under high salt conditions
Galinski, 1998). Next to this a two reactor system was evolved for 
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hypoosmotic shock is applied (Fallet
drawbacks arising from the high salt media. 
Figure 3: Biosynthesis of ectoine.  
Aspartate is converted in five enzymatic steps to ectoine. 
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The biosynthesis of ectoine was studied in detail in H. halochloris, Halomonas elongata and 
Chromohalobacter salexigens (Canovas et al., 1997; Ono et al., 1999; Peters et al., 1990). With a few 
exceptions, all genes for the synthesis of ectoine are organized as an operon. A gene encoding an 
ectoine hydroxylase is found usually in this operon, too, or it is separately encoded as in the case of 
C. salexigens (Pastor et al., 2010). Transcriptional regulation of ectABC operon was investigated in the 
Gram-negative organism C. salexigens, and depends on several factors. Different promoters are used 
for induction in the stationary phase and under salt or heat stress conditions. Additionally, 
transcription is blocked, if ectoine or other compatible solutes can be taken up from the environment 
(Calderon et al., 2004; Garcia-Estepa et al., 2006; Rodriguez-Moya et al., 2013).  
The hydrostatic pressure of H. elongata is maintained by unspecific mechanosensitive channels, which 
release ectoine under hypoosmotic conditions, while no active export was discovered so far (Sauer and 
Galinski, 1998). Active importers belong to the betaine-carnithine-choline transporter (BCCT) 
superfamily like Marinococcus halophilus EctM and Virgibacillus pantotheticus EctT or to the 
tripartite-ATP-dependent periplasmatic transporter TRAP-T family like H. elongata TeaABC. The 
function of the BCCT-like transporters is the uptake of the compatible solute in response to increased 
osmolarity, while TeaABC re-imports ectoine leaking through the cell membrane (Grammann et al., 
2002; Kuhlmann et al., 2011; Vermeulen and Kunte, 2004). C. glutamicum encodes members of the 
BCCT family, EctP and LcoP, as well as the permease ProP belonging to the major facilitator 
superfamily (MFS), which are known to import ectoine under hyperosmotic conditions (Peter et al., 
1998; Steger et al., 2004). Under hypoosmotic conditions, the mechanosensitive channels MscL and 
YggB as well as a third yet unknown transporter are known to release compatible solutes to the 
environment (Nottebrock et al., 2003).  
 
1.7 Aims of this work 
The aim of this work is to enable C. glutamicum for the bio-based production of the amino acid 
L-aspartate and the derivatives β-alanine and ectoine. Aspartate is valuable chemical with well-
established and also new potential applications, but its large-scale production is based on 
petrochemical resources. To establish a glucose-based production scheme with C. glutamicum is one 
major goal of this work. The fundamental strategy is to provide cells with the precursor molecules 
fumarate and oxaloacetate and to produce either the aspartase or the aspartate aminotransferase 
which are able to convert these precursors into the product of interest. Apart from this, the drain off 
of aspartate must be prevented to avoid that the amino acid is metabolized intracellulary. This is either 
accomplished by an inactivation or deregulation of the aspartokinase, or by growth deprived 
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conditions, i.e. by anaerobic cultivation. After constructing a basic aspartate excreting mutant, further 
genetic modifications of the basic production strain target to reduce potential by-products and to 
optimize the supply with the aforementioned precursors, to enhance the productivity of the process. 
The production of the non-proteinogenic amino acid β-alanine is dependent on a sufficient supply with 
the substrate aspartate. Therefore, the production of an aspartate-α-decarboxylase in an aspartate 
producing mutant is the basis for the overproduction of β-alanine. Improvements of the process aim at 
by-product reduction and reduced metabolization of the β-amino acid, i.e. by blocking the 
pantothenate pathway. The introduction of the ectoine biosynthetic genes into C. glutamicum targets 
at the salt-independent production of the compatible solute. Furthermore, improvements in the 
supply with aspartate and especially aspartate semialdehyde benefit the production of ectoine. To 
prove the sustainability of the process, also the production from non-food carbon sources is 
investigated. Existing industrial processes for the production of aspartate, β-alanine, and ectoine are 
based on petrochemical resources or cost intensive, cyclic fermentations. This work targets to develop 
alternative, bio-based processes, exploiting the particular features of the host organism 
C. glutamicum. 
 
 
 
  
29 
 
2 Material and Methods 
2.1 Chemicals  
All chemicals used in this work were provided by the companies Sigma-Aldrich GmbH (Taufkirchen), 
Merk AG (Darmstadt), Roche Deutschland Holding GmbH (Grenzach-Wyhlen), or Carl Roth AG 
(Arlesheim), if not indicated otherwise. 
2.2 Bacterial strains 
Table 1: Strains used in this work 
 
Strain Genetic characteristics Abbre- 
viation 
Reference 
E. coli    
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1 
 Invitrogen 
S17 recA pro hsdR RP4-2-Tc::Mu-Km::Tn7  (Simon et al., 
1983) 
    
C. glutamicum    
Wild type C. glutamicum ATCC13032 wt (Abe et al., 
1967) 
DM1729 pyc
P458S
,hom
V59A
, lysC
T311I
  (Georgi et al., 
2005) 
ΔaspB Δcg0294  This work 
ΔpanD Δcg0172  This work 
Δfum Δcg1145  Dr. M. Persicke, 
unpublished 
ΔldhA Δcg3219 L This work 
ΔsdhCAB Δcg0445-0447 S Dr. J.-W. Youn, 
unpublished 
ΔsdhCAB ΔldhA Δcg0445-0447 Δcg3219  SL Dr. J.-W. Youn, 
unpublished 
ΔsdhCAB ΔldhA ΔaspB Δcg0445-0447 Δcg3219 Δcg0294 SLB This work 
ΔsdhCAB ΔldhA Δcat Δcg0445-0447 Δcg3219 Δcg2840 SLC This work 
ΔsdhCAB ΔldhA ΔpanD Δcg0445-0447 Δcg3219 Δcg0172 SLD This work 
ΔsdhCAB ΔldhA ΔpanBC Δcg0445-0447 Δcg3219 Δcg0148-0149 SLBC This work 
ΔsdhCAB ΔldhA Δmdh  Δcg0445-0447 Δcg3219 Δcg2613 SLM This work 
ΔsdhCAB ΔldhA ΔalaT Δcg0445-0447 Δcg3219 Δcg3149 SLT This work 
ΔsdhCAB ΔldhA ΔavtA Δcg0445-0447 Δcg3219 Δcg2877 SLV This work 
ΔsdhCAB ΔldhA ΔalaT ΔavtA Δcg0445-0447 Δcg3219  
Δcg3149 Δcg2877 
SLTV This work 
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2.3 Plasmids and Oligonucleotides  
Table 2: Plasmids used in this work 
 
Plasmid Characteristics Reference 
Expression plasmids  
pEKEx3 Spec
R
; C. glutamicum/E. coli shuttle vector for regulated 
gene expression (Ptac lacI
Q
 pBL1 oriVCg pUC18 oriVEc) 
(Stansen et al., 
2005) 
pEKEx3-aspA Expression of C. glutamicum cg1697 This work 
pEKEx3-aspABs Expression of B. subtilis 168 aspA BSU23570 This work 
pEKEx3-aspAEc Expression of E. coli MG1655 aspA b4139 This work 
pEKEx3-aspB Expression of C. glutamicum cg0294 This work 
pEKEx3-aspBBs Expression of B. subtilis 168 aspB BSU22370 This work 
pEKEx3-aspBEc Expression of E. coli MG1655 aspC b0928 This work 
pEKEx3-aspDHPa Expression of Pseudomonas aeruginosa PAO1 aspDH 
PA3505 
This work 
pEKEx3-aspDHRe Expression of Ralstonia eutropha H16 aspDH H16_0736 This work 
pEKEx3-ectABCCs Expression of C. salexigens ectoine biosynthetic genes 
ectABC Csal_1876-1878 
This work 
pEKEx3-gapA  Expression of C. glutamicum cg1791 (Siedler et al., 
2013) 
pEKEx3- gdhPs Expression of Peptostreptococcus asaccharolyticus gdhPs  J. Schneider 
unpublished, 
according to 
(Marx et al., 
1999) 
pEKEx3-ldhA Expression of C. glutamicum cg3219 This work 
pEKEx3-lldD Expression of C. glutamicum cg3227 (Stansen et al., 
2005) 
pEKEx3-mdh Expression of C. glutamicum cg2613 This work 
pEKEx3-mdh-gapA  Expression of C. glutamicum cg2613 and cg1791  This work 
pEKEx3-panD Expression of C. glutamicum cg0172 This work 
pEKEx3-panDBs Expression of B. subtilis 168 panD BSU22410 This work 
pEKEx3-panDEc Expression of E. coli MG1655 panD b0131 This work 
pEKEx3-ppc Expression of C. glutamicum cg1787 This work 
pEKEx3-ppc-mdh-
gapA  
Expression of C. glutamicum cg1787, cg2613 and cg1791 This work 
pEKEx3-pyc
P458S
 Expression of deregulated C. glutamicum cg0791  This work 
pEKEx3-udhAEc Expression of E. coli MG1655 udhA b3962 (Lindner et al., 
2013) 
pEKEx3-xylAXc-xylB Expression of Xanthomonas campestris ATCC33913 xylA 
XCC1758 and C. glutamicum xylB cg0147 
(Meiswinkel et 
al., 2013) 
pVWEx1 Kan
R
; C. glutamicum/E. coli shuttle vector for regulated 
gene expression (Ptac, lacI
Q
, pHM1519 
oriVCg, pACYC177 oriVEc) 
(Peters-Wendisch 
et al., 2001) 
pVWEx1-araBADEc Expression of E. coli MG1655 arabinose utilization genes 
b0061-b0063  
(Schneider et al., 
2010) 
pVWEx1-aspA Expression of C. glutamicum cg1697 This work 
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Table 2 continued   
pVWEx1-aspB Expression of C. glutamicum cg0294 This work 
pVWEx1-ectABCCs Expression of C. salexigens ectoine biosynthetic genes 
ectABC Csal_1876-1878 
This work 
pVWEx1-glpFKDEc Expression of E. coli MG1655 glycerol utilization genes 
b3926-b3927 and b3426 
(Rittmann et al., 
2008) 
pVWEx1-pntABEc Expression of E. coli MG1655 pntAB b1602-1603 Dr. J.-W. Youn, 
unpublished 
   
Promoter probe plasmids  
pET2   (Vasicova et al., 
1998) 
pET2-lysC Carrying the intergenic region of cg0305-0306 This work 
pET2-lysCB6 Carrying the intergenic region of cg0305-0306 with the B6 
dapA promoter (Vasicova et al., 1999) 
This work 
pET2-lysCB27 Carrying the intergenic region of cg0305-0306 with the B27 
dapA promoter (Vasicova et al., 1999) 
This work 
pET2-lysCJ3 Carrying the intergenic region of cg0305-0306 with the J3 
dapA promoter (Vasicova et al., 1999) 
This work 
pET2-lysCT1C Carrying the intergenic region of cg0305-0306 with   
transition of TC position +49 upstream the start codon 
This work 
   
Deletion plasmids   
pK19mobsacB-alaT For the deletion of cg3149 (Marienhagen et 
al., 2005) 
pK19mobsacB-
aspB 
For the deletion of cg0294 This work 
pK19mobsacB-
avtA 
For the deletion of cg2877 (Marienhagen et 
al., 2005) 
pK19mobsacB-ldhA For the deletion of cg3219 (Blombach et al., 
2011) 
pK19mobsacB-lldD For the deletion of cg3227 (Krause, 2012) 
pK19mobsacB-lysC  For the deletion of cg0306 This work 
pK19mobsacB-mdh For the deletion of cg2613 (Blombach et al., 
2011) 
pK19mobsacB-
panBC 
For the deletion of cg0148-0149 (Krause, 2012) 
pK19mobsacB-
panD 
For the deletion of cg0172 This work 
pK19mobsacB-pqo For the deletion of cg2891 (Litsanov et al., 
2012b) 
pK19mobsacB-pta-
ackA 
For the deletion of cg3047-3048 (Litsanov et al., 
2012c) 
pK19mobsacB-
ramA 
For the deletion of cg2831 (Cramer et al., 
2006) 
pK19mobsacB-
sugR 
For the deletion of cg2115 (Engels and 
Wendisch, 2007) 
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Table 3: List of oligonucleotides used in this work 
Name Sequence 
Restriction  
site Function 
Primers for deletions 
M13 24for CGCCAGGGTTTTCCCAGTCACGAC Vector primer pK19mobsacB 
M13 24rev AGCGGATAACAATTTCACACAGGA Vector primer pK19mobsacB 
aspB Del A CTCGTCGACTCAGTTTGCGGAGGATAGGG SalI Deletion of cg0294 
aspB Del B  
CCCATCCACTAAACTTAAACACAGCGAAACTGAA 
CTCAT Deletion of cg0294 
aspB Del C 
TGTTTAAGTTTAGTGGATGGGGCGGAGCATTACG 
CTAACTAA Deletion of cg0294 
aspB Del D CTCGTCGACTGTCCCGGTTGGGCATGC SalI Deletion of cg0294 
aspB Del E TGCAGGGACTCACCAGAG Verfication of deletion of cg0294 
aspB Del F AGGCACGGACACGT Verfication of deletion of cg0294 
ldhA Del A CGCCCGGGTTCGGCAACAATGACGGCGAGA SmaI Deletion of cg3219 
ldhA Del B 
CCCATCCACTAAACTTAAACAGACGGTTTCTTTC 
ATTTTCGATCC Deletion of cg3219 
ldhA Del C 
TGTTTAAGTTTAGTGGATGGGAAGCAGTTCTTCT 
AAATCTTTGGCG Deletion of cg3219 
ldhA Del D CGCCCGGGGGCATCGACGACATCTGAG SmaI Deletion of cg3219 
ldhA Del E CGCCCGGGGGCATCGACGACATCTGAG Verfication of deletion of cg3219 
ldhA DelF TGATGGCACCAGTTGCGATGT Verfication of deletion of cg3219 
LysC DelA  CGAAAGCTTACATCGGTGTCATCAGAG HinDIII Deletion of cg0306 
LysC Del B 
CCCATCCACTAAACTTAAACACTGTACGACCAG 
GGCCAC Deletion of cg0306 
LysC Del C 
TGTTTAAGTTTAGTGGATGGGTATGCAGGCAC 
CGGACGCTAA Deletion of cg0306 
LysC Del D TCGGTCGACCAATAATGCCCTTGACCAGGG SalI Deletion of cg0306 
lysC Del E TGCCGAAACCAAGTGCTACTGT Verfication of deletion of cg0306 
LysC Del F TACAAGACCAGCGGCATCGTGA Verfication of deletion of cg0306 
panD Del A  ATCGTCGACCGCGGTCAACGTCATC SalI Deletion of cg0172 
panD Del B 
CCCATCCACTAAACTTAAACAGGCCGGTGAAT 
CTTACTTCC Deletion of cg0172 
panD Del C 
TGTTTAAGTTTAGTGGATGGGCCTGGATCCG 
GGCTT Deletion of cg0172 
panD Del D ATCGTCGACTCGCGCCGGTGAATC SalI Deletion of cg0172 
panD Del E GGATGGTCTGGACTGGG Verfication of deletion of cg0172 
panD Del F ACCAGGTAATTCTGGGTA Verfication of deletion of cg0172 
sdhCAB Del E CATGGCGCAACTATAGCGTGA Verfication of deletion of cg0445-0447 
sdhCAB DelF TGAAGGCTCCAGGGAACTC Verfication of deletion of cg0445-0447 
alaT Del E CGAGGAACGGCAATAATC Verfication of deletion of cg3149 
alaT Del F AGCAAGACCTGACATACC Verfication of deletion of cg3149 
avtA Del E GTCTGCGTTCCTGTTGCT Verfication of deletion of cg2877 
avtA Del F TAGCGGTTGAGCAGTTCG Verfication of deletion of cg2877 
cat actA Del E GGAGGCAAGGTCAAAG Verfication of deletion of cg2840 
cat actA Del F TAGGCAGGTCGATCG Verfication of deletion of cg2840 
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Table 3 continued 
Primers for determination of TSS and promoter strength 
pET2 FOR CTCCCTATCACTGCATGAG Vector primer pET2 
pET2 rev ACGGTGGTATATCCAGTG Vector primer pET2 
cg0305/0306 For  CTGCAGTTCAGGGTAGTTGACTAAAGAG PstI 
Amplification of intergenic region of  
cg0305 and cg0306 
cg0305 0306 Rev GGATCCCTTTGTGCACCTTTCG BamHI 
Amplification of intergenic region of 
cg0305 and cg0306 
lysC B6 Pro 2 CGCTCACATGGTTGCCTTCCCTTTATAAACTGTG Introduction of dapA promoter hexamer B6 
lysC B6 Pro 3 TAAAGGGAAGGCAACCATGTGAGCGGGTAAC Introduction of dapA promoter hexamer B6 
lysC B27 3 TAAAGGAAACCATGAGCGGGTAACTGTC 
Introduction of dapA promoter hexamer 
B27 
lysC B27 2 GACAGTTACCCGCTCATGGTTTCCTTTA 
Introduction of dapA promoter hexamer 
B27 
lysC J3 nr 3 TAAAGGAAACCTTGAGCGGGTAACTGTC Introduction of dapA promoter hexamer J3 
lysC J3 Nr.2 GACAGTTACCCGCTCAAGGTTTCCTTTA Introduction of dapA promoter hexamer J3 
lysC T1C Nr 2 GACAGTTACCCGCTCAACTCTGCCTTTA 
Introduction of dapA promoter hexamer 
T1C 
lysC T1C Nr3 TAAAGGCAGAGTTGAGCGGGTAACTGTC 
Introduction of dapA promoter hexamer 
T1C 
lysC RACE 400 TGTCAGAACCACCACG Determination of TSS lysC 
lysC RACE 300 GGTGGTGAGCACACC Determination of TSS lysC 
lysC RACE 200 CTCACCAGCAGTCAG Determination of TSS lysC 
 
Primers for expression 
pVWEx1 for CATCATAACGGTTCTGGC Vector primer pVWEx1/pEKEx3 
pVWEx rev ATCTTCTCTCATCCGCCA Vector primer pVWEx1/pEKEx3 
aspA Cgl 
GGAGGATCCGAAAGGAGGCCCTTCAGATGTCT
AAGACGAGCAAC BamHI Amplification of cg1697 
aspA Cgl rev GGAGAGCTCTTAGTTCTCCAAGTAGAGCC SacI Amplification of cg1697 
aspA Bs For  
GGAGGATCCGAAAGGAGGCCCTTCAGATGTTA
AACGGCCAAAAAGA BamHI Amplification of aspA B. subtilis 
aspA Bs Rev 
GGAGAGCTCTTATTTTTCTAATAGTTCTTTCCCT
G SacI Amplification of aspA B. subtilis 
aspA Ec For  
GGAGGATCCGAAAGGAGGCCCTTCA 
GATGTCAAACAACATTCGTATCG BamHI Amplification of aspA E. coli 
aspA Ec rev  
GGAGAGCTCTTACTGTTCGCTTTCAT 
CAG SacI Amplification of aspA E. coli 
aspB For  
CAGGTCGACGAAAGGAGGCCCTTCA 
GATGAGTTCAGTTTCGCTGCAG SalI Amplification of cg0294 
aspB Rev 
GTCCAGCTGTTAGTTAGCGTAATGCT 
CCGC PvuII Amplification of cg0294 
aspB BSU fw 
GGGTCGACGAAAGGAGGCCCTTCAG 
ATGAAACTGGCAAAAAGAGTATCCG SalI Amplification of aspB B. subtilis 
aspB BSU rv  
GAGGTCGACTTAGCTATGTTTTTCTA 
CAAAACGC SalI Amplification of aspB B. subtilis 
aspC EC fw 
GAGGGATCCGAAAGGAGGCCCTTCA 
GATGTTTGAGAACATTACCGCC BamHI Amplification of aspB E. coli 
aspC EC rv  GAGGGATCCTTACAGCACTGCCACAATC BamHI Amplification of aspB E. coli 
AsDH Ral fw 
GAGGGATCCGAAAGGAGGCCCTTCA 
GATGCTGCATGTGTCCATG BamHI Amplification of aspDH R. eutropha 
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2.4 Cultivation and conservation of strains 
2.4.1 E. coli strains 
For the cultivation of E. coli DH5α and S17, lysogeny broth medium (LB) was used (Sambrook and 
Russell, 2001). Strains were incubated at 37 °C in baffled shaking flasks at 120 rpm or on solid agar 
plates (LB with 1.8 % agar). Plasmid-carrying strains were selectively incubated with appropriate 
antibiotics (50 µg/ml kanamycin, 100 µg/ml spectinomycin, and 100 µg/ml ampicillin) 
 
2.4.2 C. glutamicum strains  
C. glutamicum strains were grown aerobically at 30 °C in baffled flasks at a shaking speed of 120 rpm 
or on solid agar plates (BHI with 1.8 % agar). Precultivation of the C. glutamicum ATCC 13032 wild type 
strain and all deletion strains was performed in brain heart infusion (BHI). All strains harboring a 
deletion of the succinate dehydrogenase operon sdhCAB (cg0445 - cg0447) were precultured in BHI 
supplemented with 50 mM glucose and 100 mM 3-(N-morpholino)-propane sulfonic acid (MOPS). The 
pH value was adjusted to 7 with a 10 M potassium hydroxide solution (KOH). Precultures were washed 
 
Table 3 continued 
 
AsDH Ral rev GAGGGATCCCTAGATCGATACCGCGTG BamHI Amplification of aspDH R. eutropha 
AsDH Pseu fw  
GAGGGATCCGAAAGGAGGCCCTTCAG 
ATGCTGAATATCGTCATGATCG BamHI Amplification of aspDH P. aeruginosa PAO1 
AsDH Pseu rev GAGGGATCCCTAGATCGAAATCGCGTGG BamHI Amplification of aspDH P. aeruginosa PAO1 
ectA fw 
CAGGGATCCGAAAGGAGGCCCTTCAGAT 
GACGCCTACAACCGAG BamHI Amplification of ectABC C. salexigens 
ectC rev  CAGGGATCCTCAATCGACCGGTGCG BamHI Amplification of ectABC C. salexigens 
ldhA for 
GAGGGATCCGAAAGGAGGCCCTTCAGAT 
GAAAGAAACCGTCGG BamHI Amplification of cg3219 
ldhA rev  GAGGAGCTCTTAGAAGAACTGCTTCTG SacI Amplification of cg3219 
mdh fw 
GAGGGATCCGAAAGGAGGCCCTTCAGAT 
GAATTCCCCGCAGAAC BamHI Amplification of cg0763 
mdh rev  GAGGGATCCTTAGAGCAAGTCGCGC BamHI Amplification of cg0763 
panD Fw 
GAGGTCGACGAAAGGAGGCCCTTCAGAT 
GCTGCGCACCATCCT SalI Amplification of cg0172 
panD rev  GAGGTCGACCGCTAAATGCTTCTCGACG SalI Amplification of cg0172 
panD Bsu fw 
CAGGGATCCGAAAGGAGGCCCTTCAGAT 
GTATCGAACAATGATGAGCG BamHI Amplification of panD B. subtilis 
panD Bsu rev CAGGGATCCCTACAAAATTGTACGGGCTGG BamHI Amplification of panD B. subtilis 
panD Eco fw  
CAGGGATCCGAAAGGAGGCCCTTCAGAT 
GATTCGCACGATGCTG BamHI Amplification of panD E. coli 
panD Eco rev  CAGGGATCCTCAAGCAACCTGTACCGG BamHI Amplification of panD E. coli 
ppc FOR  
GAGGTCGACGAAAGGAGGCCCTTCAGAT 
GACTGATTTTTTACGCG SalI Amplification of cg1787 
ppc REV  GAGGTCGACGAGCTAGCCGGAGTTGCGC SalI Amplification of cg1787 
pyc FOR  
GAGCCTGCAGGGAAAGGAGGCCCTTCAG 
GTGTCGACTCACACATC SbfI Amplification of cg0791 
pyc REV  GAGCCTGCAGGTTAGGAAACGACGACG SbfI Amplification of cg0791 
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once with minimal medium and diluted to an initial optical density (OD600) of 1 for the main 
cultivations. 
Cultivation of main cultures was performed in modified CGXII minimal medium (mCGXII) developed for 
the ERA-IB project BioChemProBB. The medium contains 21 g/l MOPS, 5 g/l (NH4)2SO4, 5 g/l urea, 1 g/l 
KH2PO4, 1 g/l K2HPO4, 0.25 g/l MgSO4 x 7 H2O, 10 mg/l CaCl2 x 2 H2O, and 0.2 mg/l biotin. The trace 
element solution contains 10 mg/l FeSO4 x 7 H2O, 0.1 mg/l MnSO4 x H2O, 1 mg/l ZnSO4 x 7 H2O mg, 0.2 
mg/l CuSO4, 0.02 mg/l NiCl2 x 6 H2O and was prepared as a stock solution (1000x). The pH value was 
adjusted to 7 with a 10 M KOH. Furthermore, CGXII minimal medium was used as described by 
Keilhauer et al. (Keilhauer et al., 1993). In addition to the standard carbon source (c-source) glucose, 
other c-sources like maltose, arabinose, glycerol and xylose were used. Stock solutions were added to 
yield final concentrations of 100 - 200 mM. During media testings the concentration of ammonium 
sulfate and urea was modified in a range from 0 - 40 g/l. For the selection of recombinant strains, the 
medium was supplemented with appropiate antibiotics (100 µg/ml ampicillin, 100 µg/ml 
spectinomycin, and 25 µg/ml kanamycin). Induction of expression plasmids was performed by the 
addition of 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG).  
 
2.4.2.1 Anaerobic cultivation of C. glutamicum strains 
For anaerobic cultivations, Hungate culture tubes (Dunn Labortechnik, Asbach) with screw caps and 
butyl rubber septum were used. Strains were precultivated in BHI-MOPS to reach the mid-exponential 
growth phase, harvested, and washed once with minimal medium. In a volume of 10 ml, main cultures 
were routinely incubated at 30 °C in a roller system with an OD600 of 30. Minimal medium was 
supplemented with different c-source- concentrations ranging from 25 to 100 mM. No selective 
pressure was applied with antibiotics, as anaerobic conditions prevent cell division, and therefore, a 
loss of recombinant plasmids. Furthermore, different bicarbonates (NaHCO3, Ca(HCO3)2, and NH4HCO3) 
were added solid in concentrations ranging from 0 to 200 mM. An additional supplement to the 
cultures was potassium nitrate (0 - 60 mM). Samples of 1 ml were taken with syringes via the rubber 
septum. All figures in the results section show data of two independently grown cultures. 
 
2.4.2.2 Cultivation of C. glutamicum in the Biolector 
Cultivation of C. glutamicum in the Biolector was performed in 48 well flowerplates. Overnight cultures 
were washed once in minimal medium and used to inoculate the main cultures to an OD600 of 1. Cells 
were cultivated in 1 ml CGXII minimal medium supplemented with appropriate c-source (100-200 mM) 
at 30 °C and a shaking speed of 1100 rpm. The scattered light was detected with optodes with a 
filterset appropriate to measure high cell densities (gain of 20), which implies that low optical densities 
(below OD600=1) are measured with decreased accuracy. The biomass (OD600) was calculated 
automatically based on a calibration experiment for the flowerplates with a slope of 0.0525 and offset 
of -1.9481. The specific growth rate was determined in the logarithmic growth phase from the 
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calculated OD600 (gain 20) with an average of 10 data points. All graphs depicted in the results section 
show data from three independently grown cultures. 
 
2.4.3 Conservation of strains 
Strains were grown over night in 5 ml BHI. 700 µl of culture were mixed with 300 µl of sterile 87 % 
glycerol and stored at –80 °C.  
 
2.4.4 Determination of cell dry weight 
A 100 ml culture was inoculated in minimal medium supplemented with 50 mM glucose and 100 mM 
sodium bicarbonate to OD600 of 30. The experiment was performed in 100 ml Schott flask with screw 
cap. After 0, 24, 48 and 72 h the optical density was measured, and 20 ml of culture were sampled in 
50 ml Falcon tubes, washed twice with 0.9 % sodium chloride solution and resuspended in 5 ml. As a 
blank, Falcon tubes were loaded with 5 ml of the solution. All samples were dried at 60 °C for three 
days and weight twice. All used Falcons tubes were kept at 60 °C for two days and weighed prior to 
use. 
 
2.5 Generation of competent cells 
2.5.1 E. coli DH5α and S-17 cells 
1 ml overnight culture was used to inoculate 50 ml LB medium. The culture was grown as described 
above to an OD600 of 0.6. After centrifugation (7 min, 4000 rpm, 4 °C) the cells were washed three 
times with 25 ml RF1-solution and resuspended in fresh RF1-solution. In between every washing step 
cells were and stored on ice for 10 min. The final pellet was resuspended in 2 ml RF2 buffer and 500 µl 
aliquots were stored at −80 °C. The RF1 buffer contains 12 g/l rubidium chloride, 9.9 g/l MgCl2 x 4 H2O, 
2.9 g/l potassium acetate, 1.5 g/l CaCl2 x2 H2O, and 150 g/l glycerol (87 %). The pH-value was adjusted 
to 5.8 with 0.2 N acetic acid. The RF2 solution contains 2.1 g/l MOPS, 1.2 g/l rubidium chloride, 11 g/l 
CaCl2 x2 H2O, and 15 g/l glycerol (87 %). The pH-value was adjusted to 6.8 with 0.4 M NaOH. Both 
buffers were sterile filtered and stored at 4 °C.   
 
2.5.2 C. glutamicum cells 
1 ml overnight culture was used to inoculate 50 ml BHIS medium. The culture was grown as described 
above. At an OD600 of 0.6, 15 µl ampicillin (5 mg/ml) was added and cells were incubated for another 
1.5 h. Cells were harvested (4000 rpm, 7 min, 4 °C) and washed three times in 30 ml EPB1 buffer. The 
final pellet was resuspended in 1.5 ml EPB2 buffer and 150 µl aliquots were stored at −80 °C.  
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The EPB1 buffer contains of 40 ml/l 0.5 M HEPES, and 50 ml/l glycerol (100 %) ad 1 l dH2O. Buffer EPB2 
contains 2 ml 0.5 M HEPES, 30 ml glycerol (100 %), in a final volume of 200 ml dH2O. The 0.5 M HEPES 
solution was adjusted to pH=7.2. All buffers were autoclaved and stored at 4 °C. 
 
2.6 Transformation of bacterial cells 
2.6.1 E. coli DH5α and S-17 cells 
For the transformation of E. coli cells, 150 µl of competent cells were thawed on ice and mixed with 
50-250 ng of plasmid DNA or 2-5 µl of ligation mix. After incubation on ice for 15 min, a heat shock at 
42 °C was applied for 90 sec. Cells were mixed with 1 ml of LB medium and incubated for 45-60 min at 
37 °C and 500 rpm in a Thermomixer (Eppendorf, Hamburg). Afterwards, cells were pelleted, 
resuspended in 100 µl LB medium and plated selectively on appropriate agar plates. 
 
2.6.2 C. glutamicum cells 
For the electroporation of C. glutamicum cells, an aliquot of competent cells was thawed on ice and 
mixed in a sterile electroporation cuvette with 100-300 ng of plasmid DNA. For transformation of 
suicide vectors like pK19mobsacB, a higher amount of DNA was used (1 − 20 µg). The electroporation 
was performed with a BioRad Gene Pulser Xcell (Hercules, USA) at 2.5 kV, a parallel resistance of 200 
Ω, and a capacitance of 25 µF. The cell suspension was transferred in a sterile Eppendorf cup filled with 
1 ml preheated BHI medium, and incubated for 6 min at 46 °C. The heat shock was applied to increase 
transformation efficiency, by inhibiting the restriction system of C. glutamicum (30). Afterwards 4 ml 
BHI was added, cells were incubated in a roller system at 30 °C for 1 h and finally plated on selective 
agar plates. 
 
2.6.3 Conjugation (E. coli S-17/C. glutamicum) 
For the conjugation of plasmid DNA a two-organism system was used including E. coli S17 as donor 
organism and C. glutamicum as the recipient of the plasmid. First, a 50 ml culture of C. glutamicum is 
inoculated. A 50 ml LB culture with 50 µg/ml kanamycin of the E. coli S17 donor strain is inoculated 
two hours later, so that both strains reach the desired OD600 of 1-1.5 at the same time. Of the recipient 
culture 30 ml were harvested (4000 rpm, 7min, RT) and resuspended in 3 ml LB medium. Aliquots of 
800 µl were treated for 9 min at 50 °C, and afterwards, kept on ice for 5 min. Of the donor culture 10 
ml were harvested (4000 rpm, 10 min, RT) and resuspended in 1 ml LB medium. 200 µl of donor cells 
were mixed with 800 µl of heat treated recipient cells and centrifuged for 10 min at 3000 rpm and RT. 
Subsequently, the pellet was resuspended in 100 µl BHI medium and transferred to a sterile 
nitrocellulose membrane, placed on a BHI plate without selection marker. After incubation for 20 h at 
30 °C, the membrane is transferred to a test tube. Cells are removed from the membrane by adding 
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2 ml BHI medium and vortexing. Dilutions of the cells were plated on BHI containing kanamycin (25 
µg/ml) and nalidixin (50 µg/ml). Nalidixin is used as a marker against Gram-negative species, and is 
therefore inhibiting growth the E. coli donor strain. Growing recipient cells are streaked out on fresh 
BHI kanamycin 25 (µg/ml)/nalidixin 50 (µg/ml) plates. 
 
2.7 Generation of deletion strains 
All deletions in this work were performed in-frame by a two step homologous recombination 
procedure (Eggeling and Bott, 2005). In this method, the non-replicative vector pK19mobsacB was 
used, which contains two selection markers. A kanamycin resistance cassette is used for the first step 
of homologous recombination, and serves thereby as a control for the integration of the vector into 
the chromosome. The second marker is the sacB gene, originated from B. subtilis, encoding a levan 
sucrase, which inhibits growth on sucrose (Jäger et al., 1992). Both flanking regions of the gene of 
interest, each spanning at least 400 bp, were amplified and combined in a second PCR to one fragment 
with the help of a linker sequence. This fragment was cloned in the vector pK19mobsacB and the 
construct was transformed into C. glutamicum. To initiate the second step of recombination, the 
sensitivity to sucrose was utilized. Cells growing on sucrose lack the levan sucrase, either by 
disintegration of the vector from the chromosome, or due to the low stability of the sacB gene. 
Two different strategies were used for the disintegration. First, positive clones were streaked on BHI 
Suc10 plates containing 10 % sucrose. If this method failed to obtain the deletion, 5 ml of an overnight 
culture were washed three times with CgXII medium, lacking all nitrogen- and phosphorus-sources. 
The culture (5 ml) was incubated at 30 °C with 25 mM glucose in the same medium for 6 h, and three 
dilutions (10
-2
, 10
-3
, 10
-4
) were plated on BHI Suc10 agar.  
Growing cells were replica-plated on BHI and BHIKan25 plates. In kanamycin sensitive cells the second 
step of recombination, the disintegration of the vector occurred. These positive clones were tested by 
colony PCR for the chromosomal deletion of the gene of interest.   
 
2.8 Isolation and purification of nucleic acids 
2.8.1 Isolation of genomic DNA 
Genomic DNA was isolated according to Eikmanns et al. (Eikmanns et al., 1994). Cells were disrupted 
with SDS (10 %) and lysozyme (10 mg/ml). Proteins were denatured by Proteinase K treatment and 
residual RNA was degraded with RNaseA (Fermentas, Sankt Leon Roth). Residual cell debris was salted 
out with 6 M sodium chloride and removed by centrifugation (30 min, 5000 rpm). DNA was 
precipitated with ethanol and resuspended in TE-buffer (10 mM Tris/HCl, pH 8; 0,5 mM EDTA). 
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2.8.2 Isolation of plasmid DNA 
Plasmid DNA was isolated from E. coli with the Qiaprep Spin MiniPrep kit from Qiagen (Hilden) 
according to the manufacturer’s protocol. In case of C. glutamicum, cell walls were disrupted by 
incubation with lysozyme (10 mg/ml lysozyme) for 2 hs prior to kit use. 
 
2.8.3 Isolation of total RNA 
Cells were cultivated under the desired conditions and grown to exponential phase (ODMAX=5) and 20 
ml of culture where centrifuged in 50 ml falcon tubes filled with 25 g of ice. The cells were 
resuspended in 350 µl RLT buffer from the RNeasy Mini Kit (Qiagen), mixed with 250 mg silica beads 
(d= 0.5 mm) and disrupted for 2 x 30 sec with the Silamat S6 (Vivadent, Ellwangen). After 
centrifugation (3 min, 16000 rpm, 4 °C) RNA was purified from the supernatant with RNeasy Mini Kit 
according to the manufacturer’s protocol. 
 
2.8.4 Purification of DNA 
PCR products were purified with the Qiaquick PCR purification kit (Qiagen) according to the 
manufacturer’s recommendations. For ligations, restricted DNA (vector and insert) was purified with 
the “Qiaquick MinElute purification kit” (Qiagen). 
 
2.8.5 Determination of nucleic acid concentrations  
The extinction was measured spectrophotometrically at 260 nm with the Nanodrop 
Spectrophotometer ND-1000 from Peqlab (Erlangen) to determine the concentration of DNA.  
Impurities caused by proteins were determined by the factor of E260/E280 (1.8 − 2.0) , while 
contaminations of carbohydrates were determined with the factor of E260/E230 (> 2.0) (Sambrook 
and Russell, 2001). 
 
2.9 Polymerase chain reaction (PCR) methods 
2.9.1 PCR  
Amplification of DNA fragments was performed as described by Saiki and Tyndall (Saiki et al., 1988; 
Tindall and Kunkel, 1988). Taq-DNA polymerase (NEB, Frankfurt/Main) was used in analytical PCRs, for 
the verification of ligations or deletions. For preparative PCRs, the proofreading KOD Hot Start DNA 
polymerase (Novagen; San Diego, USA) was used. PCR protocols were carried out as recommended by 
the manufacturer. Primers were provided by Eurofins MWG operon (Ebersberg) and Metabion 
(Martinsried/München). The annealing temperature of the used primers was calculated with 
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CloneManager Suite9. Genomic DNA, plasmid DNA or lysed bacteria served as template for the PCR 
reactions. 
2.9.2 Rapid amplification of cDNA ends with PCR (RACE-PCR) 
The 5’ RACE-PCR was performed to determine the transcriptional start point of the gene lysC. 2 µg (ad 
dH2O 12 µl) of total RNA were mixed with 1 µl random primer (10 pmol/µl), and incubated at 65 °C for 
5 min. After a short incubation on ice (1 min), 1 µl of a 10 mM dNTP mix, 4 µl of 5x SuperScriptII buffer, 
and 2 µl 100 mM DTT were added and the mix was incubated for 2 min at room temperature (RT). 
After the addition of 1 µl SuperScriptII (200 U), the mixture was kept for 10 min at RT, and was 
incubated for 50 min at 42 °C. The enzyme was inactivated for 10 min at 70 °C. For removal of residual 
RNA, 2.3 µl of RNAseH buffer and 1 µl RNAseH were added and incubated for 10 min at 37 °C. The 
cDNA was purified with the Qiagen PCR purification kit and eluted in 50 µl. For poly (cA) or poly (cT) 
tailing, 15 µl of cDNA were mixed with 14 µl dH2O, 8 µl of 5x tdT buffer, and 1 µl of dATP or dCTP 
(10 mM), respectively. The solution was heated for 3 min at 94 °C and cooled on ice. 2 µl of terminal 
deoxynucleotide transferase (tdT, 20 U/µl, Thermo scientific, Waltham, USA) were added and 
incubated for 25 min at 37 °C. The enzyme was heat inactivated for 10 min at 70 °C. Afterwards, PCRs 
were performed with oligo(dT) or oligo (dG) promers and the primer lysC RACE 400; the product 
purified, splitted, and used in another PCR with oligo(dT) or oligo(dG) and lysC RACE 300. The two 
products, one with polyC tail, one with polyA tail, were sequenced with lysC RACE 200. The first base 
after each tail resembles the transcriptional start point of lysC. 
 
2.9.3 Agarose gel electrophoresis 
Separation of DNA fragments was performed in agarose gels with TAE-buffer (40 mM Tris, 1 mM EDTA, 
0.35 % (v/v) acetic acid, pH=8) (Sambrook and Russell, 2001). According to the size of the DNA 
fragments, the concentration of agarose varied between 0.8 and 2 %. DNA fragments were mixed with 
6x loading buffer (0.25 % bromophenol blue (Sigma), 40 % (v/v) glycerol) and separated in an electric 
field (80 − 140 V). Staining of DNA fragments was performed with ethidium bromide (1 mg/l H20) for 5 
− 15 min. As DNA standards served the 1 kb DNA ladder (New England Biolabs) or the 100 bp marker 
(Invitrogen).  
 
2.10 Restriction, modification and ligation of DNA 
2.10.1 Restriction 
Restriction of nucleic acids was performed with restriction endonucleases from Fermentas (Sankt 
Leon-Roth). DNA was mixed with nuclease-free water, buffer and enzyme according to the 
manufacturer’s protocol and incubated for at least 2 h at the given temperatures. 
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2.10.2 Dephosphorylation of vector DNA 
To prevent religation of restricted vector DNA, blunt or sticky 5’ends of DNA were dephosphorylated 
with the help of rapid alkaline phosphatase (Rapid DNA Dephos and Ligation Kit, Roche). The enzyme 
was used according to the manufacturer’s protocol. However, incubation time of the 
dephosphorylation was exceeded to 2 h. 
 
2.10.3 Phosphorylation of nucleic acids 
Prior to blunt-end ligation, all PCR products were phosphorylated with the T4-Polynucleotide kinase 
from Thermo Scientific (Schwerte) according to the manufacturer’s protocol. 
 
2.10.4 Ligation  
Restricted and dephosphorylated vector DNA (50-100 ng) was mixed with insert DNA in a molar ratio 
between 1:3 and 1:20. Ligation was accomplished by the T4-ligase of the Rapid DNA Dephos and 
Ligation kit from Roche (Mannheim). 
 
2.11 Protein-biochemical methods 
2.11.1 Preparation of crude protein extracts 
For enzymatic assays, cells were cultivated in complex media (LB or, if necessary, BHI) to an OD600=4. 
The cultures were harvested (10 min, 4000 rpm, 4 °C) and stored at -20 °C. Pelleted cells were washed 
once in the appropriate assay buffer (4 °C) and resuspended in 1 ml. The disruption of the cell wall and 
membrane was either achieved by sonication or bead milling. The resuspended cells were sonicated 
for 9 min with Hielscher (Teltow) UP200S, 24 kHz (amplitude: 50 %, pulse: 50%) in an ice bath. Bead 
milling was performed with Silamat S6 (ivoclar vivadent, Ellwangen), with 0.5 mm silica beads three 
times for 30 sec. Cell debris was removed by centrifugation (1 h, 16000 rpm, 4 °C). For discontinuous 
assays based on quantification by HPLC, crude protein extracts were purified with PD-10 columns (GE 
Healthcare, Munich), to remove residual salts and amino acids.  
 
2.11.2 Determination of protein concentration according to Bradford 
Protein concentration was determined spectrophotometrically at 595 nm (Shimadzu 
Spectrophotometer UV1800) using Bradford reagent (Sigma, Seelze) (Bradford, 1976). 50 µl of sample 
were mixed with 1.5 ml Bradford reagent and incubated for 20 to 60 min at RT. A standard curve was 
prepared accordingly in a range of 0.1 – 0.8 mg/ml with bovine serum albumin. All standards were 
prepared at least in duplicates; the protein samples were measured in at least two different dilutions. 
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2.12 Enzymatic assays 
2.12.1 Aspartate aminotransferase (AspB) activity assay 
The activity of the aminotransferase was determined by quantifying the amount of formed aspartate 
during the conversion of glutamate and the amino-acceptor oxaloacetate (modified from Marienhagen 
(Marienhagen et al., 2005)). The assay was performed in 200 mM Tris-HCl buffer (pH 8) at 30 °C in a 
final volume of 2 ml. The assay mixture contained 50 mM L-glutamate, 0.2 mM pyridoxal-phosphate 
and crude protein extract (50, 100 and 200 µl purified with PD-10 columns). The reaction was started 
with the addition of 10 mM oxaloacetate. 350 µl samples were taken at 0, 0.5, 1, 2, and 24 h and 
mixed immediately with 350 µl 3 % perchloric acid to stop the reaction. After centrifugation (6 min, 
14680 rpm, RT), 600 µl of the solution were mixed with 300 µl 1.5 M Tris-HCl buffer (pH 8). The 
produced amount of aspartate was quantified by HPLC with 200 µM asparagine as internal standard. 
The samples at 0 h were used to calculate the basal amount of glutamate in the crude extracts. 
 
2.12.2 Aspartate ammonium lyase (AspA) activity assay 
The aspartase catalyzes the amination of fumarate to aspartate. In a discontinuous assay, the 
amination of fumarate to aspartate was quantified by HPLC analysis (modified from Karsten et al. 
(Karsten et al., 1986)). The assay was performed at 30 °C in 0.1 M Tris-HCl buffer (pH 8.4) with a final 
volume of 2 ml  and contained 50 mM fumarate, 2 mM MgCl2, 100 mM NH4Cl, 1 mM DTT and purified 
crude protein extract. 150 µl samples were taken at 0, 0.5, 1, 2, and 24 h and mixed immediately with 
150 µl of 3 % perchloric acid to stop the reaction. After centrifugation (6 min, 14680 rpm, RT), 200 µl of 
the solution were mixed with 100 µl 1.5 M 1.5 M Tris-HCl buffer (pH 8). Aspartate concentrations were 
calculated according to the internal standard (200 µM asparagines).  For the basal amount of 
aspartate, the samples at 0 h were taken in account. The deamination of aspartate was followed 
spectrophotometrically by the liberation of fumarate at 240 nm (ε= 2,255 mM
-1
*cm
-1
) (Kawata et al., 
1999). The assay was performed in 50 mM TAPS-NaOH (N-Tris(hydroxymethyl)methyl-3-
aminopropanesulfonic acid) buffer, pH=8.5 and contained crude protein extract, 1 mM DTT, and 2 mM 
MgCl2. The basal absorption was measured for 3 min and the reaction was started by addition of 100 
mM aspartate. 
 
2.12.3 Aspartate decarboxylase (PanD) activity assay 
The activity of the aspartate decarboxylases of C. glutamicum, E. coli MG1655 and B. subtilis 168 were 
determined by measuring the conversion of aspartate to β-alanine  via HPLC-analysis, modified from 
Dusch (Dusch et al., 1999a). The reaction was kept at 30 °C, containing 5 mM aspartate, extraction 
buffer (0.1 M potassium phosphate, 0.5 mM dithiothreitol, pH 6.8) and dilutions of the crude extract in 
a final volume of 2 ml. All crude protein extracts were purified with PD-10 columns (GE Healthcare, 
Munich). 350 µl samples were taken at 0, 1, 2, and 24 h and mixed immediately with 350 µl of a 3 % 
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perchloric acid solution to stop the reaction. After centrifugation of precipitated proteins (6 min, 
14680 rpm, RT), 600 µl of the supernatant were mixed with 300 µl of 1.5 M Tris-HCl buffer (pH 8) to 
neutralize the solution. Adequate dilutions of the mixture were measured by HPLC with 200 µM of 
asparagine as an internal standard. The samples at 0 h were taken as t0 for the calculation of the 
specific activity.  
 
2.12.4 Aspartate dehydrogenase (AspDH) activity assay 
The assay was performed as described by Li (Li et al., 2011) with crude protein extracts from a malate 
dehydrogenase deficient strain (ΔsdhCABΔldhAΔmdh). The amination of oxaloacetate was measured 
indirectly by detection of the oxidation of NADH at 340 nm (ε= 6.22 mM
-1
*cm
-1
) and at 30 °C. The assay 
mixture had a final volume of 1 ml and contained 50 µl 2 M NH4Cl, 50 µl 4 mM NADH and 100 mM Tris-
HCl buffer (pH 8). The basal absorption was measured for 3 min and the reaction was started with 50 
µl of 80 mM oxaloacetate. The deamination of aspartate was monitored by measuring the reduction of 
NAD+. The reaction was performed in a final volume of 1 ml and contained crude protein extract, 50 µl 
2.5 mM NAD
+
, and 100 mM glycine NaOH buffer (pH 9.8). The reaction was started by adding 50 µl of a 
1 M aspartate solution. 
 
2.12.5 Chloramphenicol acetyl-CoA (CAT) transferase assay 
The chloramphenicol acetyl-CoA transferase assay was used to determine the promoter strength of 
the lysC gene and variants thereof. The promoter probe vector pET2 carries a promoterless reporter 
gene for the chloramphenicol acetyl-CoA transferase. The enzyme catalyses the transfer of the acetyl 
group from acetyl-CoA to chloramphenicol. The free CoA-group converts the reagent 5,5-dithiobis (2-
nitrobenzoic acid) (DTNB) to yellowish 2-nitro-5-thiobenzoeic acid (TNB) which can be quantified at 
412 nm (ε=13.6 mM
-1
*cm
-1
). The amount of hydrolyzed acetyl-CoA is proportional to the generated 
TNB. The assay contained 50 µl 0.9 M Tris-HCl (pH 7.8), 50 µl 0.9 mM acetyl-CoA, 50 µl DTNB [3.6 
mg/ml dissolved in 100 mM Tris-HCl (pH=7.6)], water, and crude extract in a final volume of 500 µl. 
Basal absorption was measured spectrophotometrically at 412 nm for 3 min at 37 °C after addition of 
50 µl 2.5 mM chloramphenicol. 
 
2.12.6 Diaminobutyrate acetylase (EctA) assay 
The acylation of diaminobutyrate with acetyl-CoA was performed at 30 °C as described by Schubert 
(Schubert et al., 2007). The hydrolysis of acetyl-CoA was measured indirectly by the formation of 2-
nitro-5-thiobenzoeic acid, which can be detected spectrophotometrically at 412 nm (ε=13.6 mM
-1
*cm
-
1
). The assay mixture contains 60 mM Tris-HCl buffer (pH 8.5), 0.3 mM DTNB, 0.4 mM NaCl, and 1 mM 
acetyl-CoA. The basal absorption was measured for 3 min, and the reaction was induced with the 
addition of 30 mM diaminobutyrate. 
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2.12.7 Diaminobutyrate transaminase (EctB) assay 
For the determination of the activity of the diaminobutyrate transaminase, the formation of glutamate 
was measured by HPLC analysis (Ikai and Yamamoto, 1997). In this reaction L-2, 4-diaminobutyrate and 
α-ketoglutarate are converted to L-aspartate-semialdehyde and glutamate. The assay mixture was 
kept at 30 °C and containing 100 mM Tris-HCL (pH 8.5), 10 mM L-2, 4-diaminobutyrate, 10 mM α-
ketoglutarate and 0.2 mM pyridoxal phosphate in a final volume of 2 ml. The crude extracts were 
purified with PD-10 columns. 150 µl samples were taken at 0, 0.5, 1, 2, and 24 h and mixed 
immediately with 150 µl of 3 % perchloric acid to stop the reaction. After centrifugation (6 min, 14680 
rpm, RT), 200 µl of the solution were mixed with 100 µl 1.5 M Tris-HCl buffer (pH 8). The generated 
glutamate was quantified by HPLC with 200 µM asparagine as internal standard. The samples at 0 h 
were used to quantify the basal amount of glutamate in the crude extracts. 
 
2.12.8 Glyceraldehyde-3-phosphate dehydrogenase (GapA) assay 
The assay was performed using a modified version from Omumasaba (Omumasaba et al., 2004). 
Phosphorylation of glyceraldehyde-3-phosphate (GAP) to 1, 3-bisphosphoglycerate is measured 
spectrophotometrically by formation of NADH at 340 nm (ε= 6.22 mM
-1
*cm
-1
). The assay contained 25 
µl 1 M sodium hydrogen phosphate, 25 µl 4 mM EDTA, 25 µl 1 mM NAD
+
, and 50 µl  0.5 M 
triethanolamine hydrochloride (pH 8.5), and water in a total volume of 500 µl. The basal absorption 
was followed for 3 min; the reaction was started with the addition of 2.5 mM GAP.  
 
2.12.9 Malate dehydrogenase (Mdh) activity assay 
The activity of the malate dehydrogenase was performed with crude protein extracts from a malate 
dehydrogenase deficient strain (ΔsdhCABΔldhAΔmdh). The reduction of oxaloacetate to malate was 
measured indirectly by the oxidation of NADH at 340 nm (ε= 6.22 mM
-1
*cm
-1
) and 30 °C. The assay was 
performed in 100 mM Tris-HCl buffer (pH 8.2) and contained 0.2 mM NADH. The basal absorption was 
measured for 3 min and the formation of NADH was induced by the addition of 4 mM oxaloacetate.  
 
2.13 Quantification of amino acids and other organic acids 
2.13.1 Determination of pyruvate in culture supernatants 
Due to low stability in cell free culture supernatants, pyruvate was quantified enzymatically directly 
after sampling. The conversion of pyruvate to lactate by the L-lactate dehydrogenase was followed 
photometrically by measuring the decrease of absorption of NADH at 340 nm. The standard curve 
covered pyruvate concentrations ranging from 1 − 100 µM. 100 µl of sample was mixed with 500 µl 
100 mM Tris-HCl buffer (pH 7.4), 290 µl dH20, and 100 µl 1.5 mM NADH. After incubation for 5 min at 
37 °C, the absorption at t0 at 340 nm was determined. The enzymatic reaction was started by addition 
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of 1.2 U L-lactate dehydrogenase and incubated for another 60 min at 37 °C. The amount of converted 
NADH is proportional to the amount of pyruvate in the supernatants and was calculated by 
determining the final absorption at 340 nm.  
 
2.13.2 High performance liquid chromatography (HPLC) 
For the determination of acids, sugars and amino acid quantities, an “Agilent 1200 series”-system was 
used. It was equipped with a diode array detector (DAD), a refractive index detector and a 
fluorescence detector. Columns were provided by CS-Chromatographie Service (Langerwehe). Cell free 
culture samples were obtained by centrifugation (6.5 min, 146800 rpm, RT). 
Sugars and organic acids were isocratically detected with the RID, separated on an organic acid resin 
(300x8 mm) column in 5 mM sulfuric acid with a flow rate of 1 ml/min at 70 °C for 14.5 min. Standards 
were obtained from Sigma (Seelze), and were measured in a range from 1 to 200 mM.  
The detection of ectoine was performed isocratically in 80 % acetonitrile with a flow rate of 1 ml/min 
with the DAD detector at 210 nm on a Multospher APS-HP 5 µ Hilic (125x4 mm) column for 16 min 
(Kuhlmann and Bremer, 2002). 200 µl of sample or standard was mixed with 800 µl of 100 % 
acetonitrile. The standards were solved in CGXII medium and covered a concentration range of 1 to 25 
mM ectoine. 
Amino acids were detected by the FLD (excitation at 230 nm; emission at 450 nm) by automated 
precolumn derivatization with ortho-phthaldialdehyde (OPA) and reversed-phase high performance 
liquid chromatography (RP-HPLC) on a LiChrosphere 100RP 18 EC 5 µ (125x4 mm) at 40 °C. For the 
detection of aspartate, glutamate, α- and β-alanine the program OPA1G8quick (15.5 min) was used, 
for lysine the program OPA1G8 (22.5 min). The programs differ in their concentration gradients, but 
are based on the same solvents; methanol and 0.1 M trisodium acetate buffer (pH 7.2) supplemented 
with 0.03 % sodium azide. For the quantification of amino acids, the quality of the derivatization was 
taken into account by normalizing the peak areas with the quotient of external and internal asparagine 
standard. Standards were obtained from Sigma (Seelze), and were measured in a range of 10 to 300 
µM, depending on the respective amino acid. 
Table 4: RP-HPLC program OPA1G8 
 
Time (min) Buffer (%) Methanol (%) Flow rate (ml/min) 
1.0 75 25 0.35 
3.0 55 45 0.60 
7.0 35 65 0.60 
13.0 30 70 0.60 
13.2 20 80 0.60 
13.4 15 85 0.60 
14.0 80 20 0.60 
17.0 80 20 0.60 
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Table 5: RP-HPLC program OPA1G8quick 
 
Time (min) Buffer (%) Methanol (%) Flow rate (ml/min) 
0.0 75 25 0.35 
0.5 55 45 0.60 
4.0 35 65 0.60 
7.0 30 70 0.60 
7.2 20 80 0.60 
7.4 15 85 0.60 
8.0 80 20 0.60 
10.6 80 20 0.60 
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3 Results 
3.1 Production of aspartate under aerobic conditions 
A major aim of this study was the rational development of C. glutamicum strains that overproduce 
aspartate. Aspartate is synthesized either by direct amination of fumarate by aspartase (AspA) or by 
transamination of oxaloacetate by aspartate aminotransferase (AspB). As aspartate is not only used for 
protein synthesis, but at the same time serves as precursor of the other amino acids of the aspartate 
family, i.e. asparagine, lysine, threonine, methionine, and isoleucine, and of the cell wall precursor 
diaminopimelate. Therefore, it occupies an important role in metabolism as both an end product and 
an intermediate. As a consequence, metabolic engineering of aspartate producers has to consider not 
only the enhancement of its biosynthesis, but also the consequences for the metabolites derived from 
it.  
3.1.1 Aspartate does not serve as a carbon or nitrogen source in C. glutamicum 
Prior to constructing a strain producing aspartate, it was essential to investigate the ability of 
C. glutamicum to utilize aspartate as sole carbon and nitrogen source. Therefore, the C. glutamicum 
wild type was cultivated either in CGXII medium supplemented with glucose and 200 mM aspartate as 
sole nitrogen source or in standard CGXII medium containing 200 mM aspartate as sole carbon source. 
 
Figure 4: Growth of C. glutamicum pEKEx3 in CGXII containing different carbon and nitrogen sources.  
Dots: Standard CGXII supplemented with 200 mM glucose; triangles: CGXII without standard nitrogen sources 
supplemented with 200 mM aspartate and 200 mM glucose; squares: CGXII medium supplemented with 200 mM 
aspartate as carbon source. All cultures were induced with IPTG. The cells were cultivated in the BioLector 
microfermenter at 30 °C in microflower plates at 1100 rpm in a total volume of 1 ml. 
48 
 
 
The C. glutamicum wild type shows exponential growth in standard medium supplemented with 
glucose. In contrast, only poor growth was detected with aspartate as sole nitrogen source (Figure 4). 
In comparison to the standard sources urea and ammonium sulfate, utilization of aspartate as nitrogen 
source is possible, but inefficient. Negligible growth was detected when aspartate served as a carbon 
source. Therefore, C. glutamicum fulfills basic requirements as a host organism for the synthesis of 
aspartate. 
 
3.1.2 Expression of aspartase or aspartate aminotransferase is not sufficient for aspartate 
production 
The aspartase from E. coli was shown to promote lysine formation in C. glutamicum, when cells are fed 
with additional fumarate (Menkel et al., 1989), and engineered versions of this enzyme are used in 
industrial synthesis of aspartate since decades (Chibata et al., 1974; Jayasekera et al., 1997). To 
investigate whether the overexpression of the genes encoding the aspartase AspA (aspA, b4139) from 
E. coli or the aspartate aminotransferase AspB (aspB, cg0294) from C. glutamicum leads to the 
overproduction of aspartate in the wild type, both genes were cloned in the inducible expression 
vector pEKEx3. Strains carrying either pEKEx3-aspAEc or pEKEx3-aspB were cultivated in CGXII medium 
supplemented with 200 mM glucose. In comparison to the wild type carrying pEKEx3, both strains 
showed comparable growth behavior with rates of 0.36 ± 0.00 h
-1 
(AspA) and 0.38 ± 0.03 h
-1
 (AspB) and 
similar biomass formation. Analysis of the supernatants after 48 hours by HPLC analysis revealed 
neither aspartate nor any other amino acids or organic acids. 
 
3.1.3 Deletion of the fumarase gene fum and expression of aspAEc is not sufficient for aspartate 
production  
The fumarase Fum (fum, cg1145) catalyzes the hydration of fumarate to malate. A deletion of fum 
interrupts the TCA cycle and presumably leads to an accumulation of fumarate, which serves as 
precursor for the amination reaction by AspA to aspartate. Therefore, a wild type derivative with a 
deleted fum gene was transformed with the plasmid pEKEx3-aspAEc and cultivated in CGXII medium 
supplemented with 200 mM glucose.  
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Figure 5: Growth of Δfum in CGXII medium supplemented with 200 mM glucose.  
Open dots: Δfum pEKEx3; filled dots: Δfum pEKEx3-aspAEc. All cultures were induced with IPTG. The cells were 
cultivated in the BioLector microfermenter at 30 °C in microflower plates at 1100 rpm in a total volume of 1 ml. 
 
Interestingly, the Δfum strain expressing aspAEc showed an increased growth rate compared to the 
control strain (0.38 ± 0.00 h
-1
 and 0.25 ± 0.00 h
-1
, respectively) and reaches a 28 % increased biomass 
of 14.6 ± 0.3 gCDW*l
-1
 (Figure 5). However, the supernatants did not contain significant amounts of 
aspartate. Instead 3.4 ± 0.1 mM of alanine and 30.0 ± 1.9 mM of acetate were detected by HPLC 
analysis after 48 hours. 
 
3.1.4 Aspartate aminotransferase versus aspartase: a futile cycle? 
In C. glutamicum, the endogenous aspartate aminotransferase AspB (aspB, cg0294) transfers the 
amino group from glutamate to oxaloacetate. To prevent a futile cycle between the amination of 
fumarate by the plasmid encoded aspartase and the deamination of aspartate by the aspartate 
aminotransferase, a deletion of the aspB gene was generated. The deletion was introduced with the 
plasmid pK19mobsacB-aspB in the wild type as well as into a strain with deleted succinate 
dehydrogenase and lactate dehydrogenase (ΔsdhCAB, cg0445-cg0447 and ΔldhA, cg3219). The strains 
were transformed with the inducible expression vectors pEKEx3-aspAEc and pEKEx3-aspBCg, and 
cultivated in CGXII medium supplemented with 200 mM glucose.  
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Figure 6: Growth of strains with deleted aspartate aminotransferase in CGXII supplemented with 200 mM 
glucose.  
A: ΔaspB; B: ΔsdhCAB ΔldhA ΔaspB. Open symbols: pEKEx3; semi-filled symbols: pEKEx3-aspAEc; filled symbols: 
pEKEx3-aspBCg. All cultures were induced with IPTG. The cells were cultivated in the BioLector microfermenter at 
30 °C in microflower plates at 1100 rpm in a total volume of 1 ml. 
 
Both mutants could be cultivated in complex medium without any detectable aspB-dependent growth 
defect (data not shown). In contrast, the ΔaspB strain is characterized by a severe growth defect in 
glucose minimal medium, which could be rescued by the expression of a plasmid encoded aspB gene 
(Figure 6A, open and closed squares). Furthermore, the addition of 100 mM aspartate to a culture of 
ΔaspB pEKEx3 did not enable growth, indicating the lack of an aspartate specific uptake system (data 
not shown). When transformed with the plasmid pEKEx3-aspAEc (Figure 6A, semi-filled symbols), the 
ΔaspB strain showed a prolonged lag-phase of six hours and then resumed growth with a rate 
(0.41 h
-1
) comparable to that of strain ΔaspB pEKEx3-aspBCg (0.42 h
-1
). To differentiate if this growth 
behavior is due to a mutation or an adaptation, the cultures of strain ΔaspB pEKEx3-aspAEc were 
inoculated a second time under the same growth conditions, including a precultivation in complex 
medium. Cultures immediately started growing without a lag-phase, implying that one or more 
mutations had occurred that rescue the observed phenotype (data not shown). Growth of this strain 
was strictly dependent on the expression of the aspartase gene. 
The ΔsdhCABΔldhA background is characterized by an interruption of the oxidative branch of the TCA 
cycle at the level of succinate, and a deletion of the aspB gene leads to a different growth behavior 
(Figure 6B). In this case, the severe growth defect caused by the deletion of aspB could only be 
complemented by plasmid-encoded AspB whereas plasmid-encoded AspAEc only allowed very slow 
growth. Taken together, this suggests that the mutation allowing growth of strain 
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ΔaspB pEKEx3-aspAEc could be in the fumarase gene, causing a reduced activity and thus improved 
conversion to aspartate by the aspartase. 
A futile cycle between the synthesis of aspartate by AspA and its deamination by AspB can therefore 
be excluded. E. coli AspA cannot rescue the deletion of the aspB gene without further mutations, 
which implies that the enzyme is not able to synthesize aspartate under the tested conditions. 
Interestingly, the endogenous aspartase AspA of C. glutamicum (aspA, cg1697) is either not activated 
as a back-up system or not able to rescue the aspB deletion in the control strains. 
 
3.1.5 Deletion of panD does not improve the anaplerotic flux towards oxaloacetate 
The aspartate-α-decarboxylase PanD (panD, cg0172) generates the precursor β-alanine for the 
synthesis of pantothenate, which is a crucial part of coenzyme A. A deletion of the panD gene impairs 
the synthesis of acetyl-CoA in the pyruvate dehydrogenase complex thereby blocking the oxidative 
branch of the TCA cycle. This leads to an accumulation of pyruvate, which can be carboxylated to 
oxaloacetate by the anaplerotic enzyme pyruvate carboxylase Pyc (pyc, cg0791). Furthermore, PanD 
uses aspartate as substrate and irreversibly decarboxylates it to β-alanine.  
A deletion of the panD gene was obtained in the wild type with the vector pK19mobsacB-panD, which 
deletes 339 bp of 411 bp. The ΔpanD strain was transformed with the expression vector pEKEx3-aspB, 
and cultivated in CGXII medium (Figure 7). In contrast to previous results from Dusch et al., all strains 
were able to grow in glucose minimal medium without supplementation of pantothenate (Dusch et al., 
1999b). Cells overexpressing the aspB gene showed improved growth compared to the control strain 
with rates of 0.37 ± 0.00 h
-1
 (ΔpanD pEKEx3-aspB) and 0.27 ± 0.01 (ΔpanD pEKEx3), respectively. The 
ΔpanD pEKEx3-aspB cultures excreted alanine (20.6 ± 3.1 mM) and valine (14.1 ± 3.2 mM) as main 
fermentation products, but no aspartate was detected in the supernatants.  
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Figure 7: Growth of C. glutamicum ΔpanD in CGXII medium supplemented with 200 mM glucose.  
Open squares: ΔpanD pEKEx3; filled squares: ΔpanD pEKEx3-aspB. All cultures were induced with IPTG. The cells 
were cultivated in the BioLector microfermenter at 30 °C in microflower plates at 1100 rpm in a total volume of 
1 ml. 
 
 
3.1.6 The aspartokinase LysC 
The aspartokinase LysC (lysC, cg0306) catalyzes the first step in the synthesis of amino acids derived 
from aspartate. It transfers the terminal phosphate from ATP to aspartate and activates the molecule 
for subsequent reactions. In the C. glutamicum wild type, LysC is feedback inhibited by lysine and 
threonine, for which reason feedback-resistant variants of the enzyme are used in industrial amino 
acid synthesis (Shiio and Miyajima, 1969). 
 
3.1.6.1 The aspartokinase is an essential enzyme of C. glutamicum 
The aspartokinase constitutes one of the main targets for constructing a strain overproducing 
aspartate, as it marks the entry point for biosynthetic pathways based on this amino acid. An inhibition 
of this reaction reduces the conversion of aspartate to other amino acids and diaminopimelate and 
should lead to an accumulation of the compound. In order to inactivate the aspartokinase, the 
deletion vector pK19mobsacB-lysC was constructed. In case of a successful deletion, a LysC´-peptide of 
20 amino acids is synthesized. The plasmid was transformed into C. glutamicum and the kanamycin-
resistant integration mutants obtained by the first homologous recombination event were exposed to 
sucrose to induce a second homologous recombination event. In total, twelve integration mutants 
were obtained, 2000 clones were replica plated, and approximately 300 colony-PCRs were performed. 
However, none of the tested clones showed the desired lysC deletion. All kanamycin-sensitive and 
 sucrose-resistant clones showed the wild
gene in C. glutamicum and cannot be deleted.
 
3.1.6.2 Analysis of promoter variants for the downregulation of 
To gain insight into the expression of the 
was mapped by 5´RACE-PCR. The TSS 
TSS, a common σA binding motif 
promoter regions and matches the 
(Barreiro et al., 2004; Follettie et al.
To identify appropriate substitutes that reduce the expression of the aspartokinase, the strength of 
the native promoter was determined. 
promoter, where the exchange of all bases of the 
strength of dapA expression. Th
are the most important bases for functional expression 
dapA study, which lead to a weak 
of lysC. Additionally, a fourth promoter sequence was used, in which the first base was changed from 
thymine to cytosine (T1C) (Figure 
 
Figure 8: Promoter region of lysC and variants thereof.
The -10 region, transcriptional start point
are -10 variants of the dapA promoter. In the T1C hexamer, the first base 
(TC). 
 
The promoter variants depicted in 
and the complete intergenic region was 
promoterless chloramphenicol 
transferred into C. glutamicum 
photometric assay.  
 
-type genotype, strongly indicating that 
 
lysC 
lysC-asd operon, the transcriptional start 
is located 36 bp upstream of the start codon GTG.
with the sequence TAGAGT was found, which is also present in other 
-10 consensus sequence TANANT for C. glutamicum
, 1993; Jungwirth et al., 2008).  
The best studied promoter of C. glutamicum
-10 hexamer showed a clear influence on the 
e first and the last thymine corresponding to the positions 
(Vasicova et al., 1999). Three
expression of the gene, were chosen to replace the 
8). 
  
 (TSS), and the start codon are indicated. The hexamers B6, J
of the lysC promoter 
Figure 8 were introduced in the intergenic region of cg0305 and 
cloned in the promoter probe vector pET2, which contains
acetyl transferase gene. The corresponding pET2 derivatives were 
wild type and expression of the reporter gene was measured in a 
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Figure 9: Specific chloramphenicol acetyltransferase (CAT) activity of C. glutamicum wild type carrying the 
indicated pET-plasmids.  
The CAT activity correlates with the strength of the promoter. N. d.: not detected. 
 
For the wild type promoter an activity of 203.7 ± 26.5 mU*mg
-1
 was detected (Figure 9). For the 
hexamers B27, J3 and B6 specific activities between 20 to 40 mU*mg
-1
 were reported by Vasicova 
(Vasicova et al., 1999). In contrast, no activity of the reporter enzyme was detected in the experiment 
described here. The exchange of the first base of the σA core hexamer TANANT from T to C leads to an 
inactivation of the promoter, as no activity was detected in the CAT-assay (Figure 9). As the complete 
exchange of the promoter and the single nucleotide exchange hamper the expression of the cat gene, 
no attempt was performed to use these fragments in vivo for a down regulation of the lysC-asd 
operon. A reduction of the activity by controlling the expression level of the lysC gene was not possible 
with the tested promoters. 
 
3.2 Production of aspartate under anaerobic conditions 
As an alternative approach for aspartate overproduction, anaerobic instead of aerobic conditions were 
chosen. C. glutamicum does not grow under these conditions, but glucose is metabolized to lactate, 
acetate and succinate. Succinate is formed in the reductive branch of the TCA cycle via oxaloacetate, 
malate and fumarate. As the cells do not grow, aspartate formed under anaerobic conditions from 
oxaloacetate or fumarate is presumably not used as precursor for other amino acids and 
diaminopimelate. In this way, anaerobic conditions may mimic a lysC deletion. For anaerobic aspartate 
production, C. glutamicum ΔsdhCAB ΔldhA (SL) is used, which harbors in-frame deletions of genes for 
the succinate dehydrogenase (sdhCAB, cg0445-0447) and the L-lactate dehydrogenase (ldhA, cg3219). 
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These deletions ensure reduction of the by-products lactate and succinate and interrupt the reductive 
branch of the TCA cycle at the level of fumarate. However, C. glutamicum is unable to proliferate 
under anaerobic conditions without a terminal electron acceptor. Therefore, the cells for anaerobic 
aspartate production have to be precultured aerobically and then packed at high optical densities for 
the anaerobic process.  
 
3.2.1 Aspartate is produced under anaerobic conditions 
A culture of SL pEKEx3 was inoculated in anaerobic test tubes to an OD600=30 and incubated at 30 °C 
on a rolling shaker. The CGXII minimal medium was supplemented with 50 mM glucose and contains 
ammonium sulfate ((NH4)2SO4) and urea (CH4N2O) as nitrogen sources. After 72 hours, the 
supernatants of the cultures were analyzed by HPLC for the presence of amino acids and organic acids, 
as well as residual glucose (Figure 10).   In contrast to aerobic cultivations, the production of aspartate 
is possible when cells are cultivated under anaerobic conditions. Within 72 hours, 25.5 mM aspartate 
were detected in the supernatants, corresponding a molar yield of 0.55 mol/mol glucose. During the 
fermentation, glutamate, alanine, succinate, lactate, and acetate accumulate as by-products. The 
amino acid alanine (20.5 mM) is the main by-product, while the excretion of succinate and lactate is 
not completely prevented by the deletion of the succinate dehydrogenase and the lactate 
dehydrogenase genes.  
 
 
Figure 10: Production of aspartate by SL pEKEx3 under anaerobic conditions.  
The strain was inoculated in CGXII medium supplemented with 50 mM glucose. Accumulation of amino acids, 
organic acids and residual glucose in supernatants is depicted after 72 h. Red: aspartate; white: glutamate; black: 
alanine; blue: glucose; striped: succinate; grey: lactate. 
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3.2.2 Optimization of cultivation conditions 
3.2.2.1 Optimization of precultivation conditions promotes growth of SL 
The precultivation conditions need to be adapted to the special needs of the strain SL. The deletion of 
the succinate dehydrogenase led to decreased growth in lysogeny broth (LB) medium so that 
precultivation is best performed in BHI medium, which contains 2 % glucose. In this medium, the strain 
is able to grow to an optical density of OD600~5 while the wild type is able to grow to OD600~12. The 
ΔsdhCAB strain synthesizes 40 mM succinate from 200 mM glucose in CGXII, which causes acidification 
of the medium (Litsanov et al., 2012b). Hence, the BHI medium was buffered with 100 mM MOPS and 
the pH was adjusted to pH 7. Still the growth of SL ceases at OD600~5 (Figure 11). To further increase 
cell density of the preculture, 50 mM glucose was added to the BHI-MOPS medium. This enables 
growth to an optical density of OD600~20 and delivers a reasonable amount of cells for inoculation of 
the main cultures and prevents acidification of the medium.  
 
 
Figure 11: Growth of SL in complex medium.  
Open triangles: growth in BHI; open dots: growth in BHIMOPS; filled dots: growth in BHIMOPS supplemented 
50 mM glucose. 
 
3.2.2.2 Addition of sodium hydrogen carbonate improves the production of aspartate under 
anaerobic conditions 
The standard CGXII medium is optimized for the aerobic synthesis of amino acids and requires 
adaptations for anaerobic cultivations of SL. Under these conditions, the reductive branch of the TCA 
cycle is active and fueled by the carbon dioxide fixing reactions of phosphoenol pyruvate carboxylase 
and pyruvate carboxylase. To promote these anaplerotic reactions, the strain SL pEKEx3-aspB is 
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incubated with 50 mM glucose and increasing concentrations of sodium hydrogen carbonate 
(NaHCO3). Samples were taken after 72 hours and supernatants were analyzed by HPLC for formation 
of amino and organic acids.  
With increasing concentrations of NaHCO3, the aspartate titer elevates from 26.7 mM to 41.7 mM 
(Figure 12). This is an improvement of 56 % compared with the standard medium. A positive side 
effect of NaHCO3 utilization is the reduction of alanine in the supernatants. It still constitutes the most 
prominent by-product, but the amount is lowered by 40 % to 16.7 mM. A further increase of NaHCO3 
above 2mol/mol glucose had no beneficial effect on aspartate concentration. However, the amount of 
alanine was further reduced to 12.1 mM when 200 mM was added. Consequently, the concentration 
of two mol bicarbonate per mol glucose was used for all further experiments. 
Organic acids where quantified by HPLC, but the amounts of succinic and lactic acid are not influenced 
by the addition of NaHCO3. An accumulation of fumarate was not detected. Due to the instability of 
pyruvate in supernatants it was tested enzymatically directly after the sampling of the probes, but the 
precursor for alanine synthesis was not detected.  
 
 
Figure 12: Aspartate synthesis positively correlates with increasing NaHCO3 concentrations.  
The strain SL pEKEx3-aspB was incubated for 72 h with 50 mM glucose and NaHCO3 (0-200 mM). Red: aspartate; 
white: glutamate; black: alanine; dark blue: glucose. 
 
Besides NaHCO3, also potassium (KHCO3) and ammonium (NH4HCO3) hydrogen carbonate were tested 
as supplements with concentrations of 2 mol/mol glucose. The latter is of special interest, because it 
may also increase the input of ammonium to the medium. Compared to NaHCO3, both tested 
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carbonates had no beneficial effects. The use of KHCO3 reduced aspartate formation by 22 %, while 
NH4HCO3 shows results similar to NaHCO3 (data not shown). 
 
3.2.2.3 Addition of nitrate promotes glucose consumption and inhibits aspartate production  
To substitute oxygen during the cultivation, potassium nitrate was used in the standard medium as 
terminal electron acceptor. The strain SL is impaired in the fermentation of lactic and succinic acid and 
shows a slow glucose consumption which is presumably improved by the addition of nitrate. 
Cultures of SL pEKEx3 were supplemented with concentrations of 0, 30, or 60 mM nitrate, and the 
influence on glucose consumption was determined. After 0, 2.5, 6, 8, 10 and 24 hours supernatants 
were sampled and tested for the presence of glucose as well as amino and organic acids. 
 
 
Figure 13: Anaerobic glucose consumption of SL depending on the nitrate concentration.  
Cultures were inoculated to OD600=30 in CGXII minimal medium supplemented with 50 mM glucose and with the 
indicated concentrations of potassium nitrate. A: 0 mM nitrate; B: 30 mM nitrate; C: 60 mM nitrate. Dots: 
glucose concentration; bars: alanine.  
 
Addition of nitrate leads to a bi-phasic consumption of glucose (Figure 13). Depending on the 
concentration, the first phase is visible in the first four hours of incubation. The second phase shows a 
linear decrease of glucose. During this phase, consumption of glucose is 0.19 mM*h
-1
 without nitrate, 
0.28 mM*h
-1 
with 30 mM nitrate, and 0.53 mM*h
-1
 with 60 mM nitrate. The main fermentation 
product is the amino acid alanine.  
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To enable complete glucose consumption by the control strain without nitrate, the incubation time 
was prolonged. Samples were taken after 24, 48 and 72 hours and amino acid composition was 
determined (Figure 14). Without nitrate, the concentrations of aspartate and alanine increase over 
time reaching 16.9 mM and 15.1 mM within 72 hours, respectively. In contrast, the low amount of 
glutamate in the supernatants is not influenced by nitrate concentrations. However, the synthesis of 
aspartate is diminished by nitrate and alanine formation is promoted up to a concentration of 
32.6 mM. Furthermore, alanine synthesis is accelerated by increasing the nitrate concentration to 
60 mM. 
 
 
Figure 14: Anaerobic amino acid synthesis of SL pEKEx3 depending on nitrate concentration.  
Depicted is the amino acid composition of supernatants at the indicated time points. Cultures inoculated to 
OD600=30 in minimal supplemented with 50 mM glucose and 0, 30, or 60 mM potassium nitrate. Red: aspartate; 
white: glutamate; black: alanine. 
 
3.2.2.4 Biomass is stable under anaerobic conditions 
In production experiments, all tested cultures are packed to an OD600 of 30, but showed a significant 
decrease to OD600 of about 20 within the first 24 hours of cultivation. To test whether this decline was 
caused by cell death, the cell dry weight (CDW) of cultures was determined and compared to the 
optical density (Figure 15). After 24 hours, a drop in the OD600 from 30.8 to 19.1 was observed. Over 
time, the OD stabilizes at this level and did not decrease any further. Even though the CDW of the 
cultures decreased as well, this decline did not correlate with the drop in OD. The CDW is reduced 
from 7.43 to 6.27 g/l which resembles a change of OD600 of approximately 4. Biomass is therefore lost 
to a small extent (~13 %) in the beginning of anaerobic cultivation, but is generally stable over time. 
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Figure 15: Comparison of optical density and cell dry weight in the strain SL pEKEx3.  
Circles: OD600; bars: gram cell dry weight (gCDW*l-1).  
 
3.2.3 Synthesis of aspartate from the TCA intermediates fumarate and oxaloacetate 
3.2.3.1 Aspartases favor degradation of aspartate over amination of fumarate 
The deletion of the sdhCAB genes interrupts the reductive branch of the TCA cycle at the level of 
fumarate, which can then be aminated to aspartate by aspartase (EC 4.3.1.1). To find the best suited 
enzyme for production, the endogenous AspA (cg1697, aspA) as well as homologous enzymes from 
B. subtilis (BSU23570, aspA) and E. coli (b0928, aspC) were tested. The activity of the enzymes was 
tested in both directions, i.e. for the amination and the deamination reaction. The corresponding 
genes were expressed with 1 mM IPTG with the expression vector pEKEx3 and crude extracts obtained 
from cultures cultivated in complex medium were used for measurement of the aspartase activity.  
 
Table 6: Specific activities for aspartate synthesis and degradation of aspartases of C. glutamicum, B. subtilis, 
and E. coli.  
The corresponding genes were overexpressed in C. glutamicum wild type using the IPTG-inducible vector pEKEx3. 
Cell-free extracts were obtained from cells cultured aerobically in BHI medium with 1 mM IPTG to OD600 of 4, and 
used for the enzymatic assay. Abbreviations: Bs: B. subtilis; Cg: C. glutamicum; Ec: E. coli. 
 
 Amination [mU/mg] Deamination [mU/mg] 
C. glutamicum pEKEx3 7.9 ± 1.7 34.9 ± 20.0 
C. glutamicum pEKEx3-aspABs 120.2 ± 19.6 1273.0 ± 283.9 
C. glutamicum pEKEx3-aspACg 55.7 ± 7.9 72.5 ± 16.6 
C. glutamicum pEKEx3-aspAEc 105.4 ± 18.6 693.9 ± 122.5 
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The specific activities for the amination reaction of AspA from B. subtilis and E. coli are in a similar 
range, although the highest activity was measured for AspABs (Table 6). Interestingly, the native 
enzyme of C. glutamicum has a more than 50 % reduced activity.  
In comparison to the amination reaction, much higher activities were measured for the deamination of 
aspartate. AspABs showed a tenfold increase in activity (1273 mU/mg). The activity of AspAEc is also 
increased, but is approximately 46 % lower than the latter (694 mU/mg). Lowest activity was detected 
for the native AspA, which is comparable to the activity of the amination reaction.  
In conclusion, the preference for the degradation of aspartate is prominent in all tested enzymes. 
Although the native enzyme showed the lowest activity for the deaminating reaction, it was not 
chosen for the production of aspartate, caused by the low activity in the aminating direction. Overall, 
the enzymes of B. subtilis and E. coli were much more active. The difference in activity between 
amination and degradation is lower for AspAEc than for AspABs, leaving it as the most suitable enzyme 
for aspartate synthesis.  
 
3.2.3.2 Expression of aspAEc reduces aspartate formation 
In order to produce aspartate directly from fumarate under anaerobic conditions, the strain SL was 
transformed with the expression vector pEKEx3-aspAEc and used in production experiments. 
Supernatants were taken after 144 hours of anaerobic incubation in glucose-bicarbonate medium and 
analyzed by HPLC (Figure 16). In both strains a significant formation of aspartate was detected, but the 
expression of the aspartase gene from E. coli decreased aspartate synthesis by 26 % to 0.53 mol/mol 
glucose. Moreover, the strain SL pEKEx3-aspAEc excreted 40 % more alanine than the control strain. 
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Figure 16: Production of aspartate with strains SL pEKEx3 and SL pEKEx3-aspAEc.  
Strains were inoculated in CgXII medium supplemented with 100 mM glucose and 200 mM sodium bicarbonate. 
Accumulation of amino acids and residual glucose is shown in supernatants of cultures after 144 h. Red: 
aspartate; white: glutamate; black: alanine; blue: glucose. 
 
3.2.3.3 Expression of aspA cannot rescue the phenotype of aspB deletion 
Aspartate is connected to the TCA cycle by the intermediates fumarate and oxaloacetate. A disruption 
of the TCA at the level of ΔsdhCAB is thought to lead to an accumulation of fumarate, which can be 
aminated to aspartate by the aspartase. The aspartate aminotransferase can deaminate aspartate to 
oxaloacetate, and hence reverse the amination of aspartase. To test this hypothesis, a deletion of the 
aspB gene was introduced into SL. The strain ΔsdhCAB ΔldhA ΔaspB (SLB) was transformed with 
expression vectors for the genes of the aspartases from B. subtilis, E. coli and C. glutamicum, and used 
in anaerobic production experiments.  
In agreement with the results of the aerobic cultivations, the deletion of the aspB gene had a severe 
effect on aspartate overproduction (Figure 17). The control strain with intact AspB amino transferase 
showed significant excretion of aspartate, while the deletion strains utilized only a small proportion of 
the glucose within 72 hours and did not excrete aspartate. Expression of the different aspartase genes 
was not sufficient to compensate this phenotype. Therefore, the aspartate produced under anaerobic 
conditions is most likely synthesized from the transamination of oxaloacetate via AspB.  
The decreased aspartate content observed in the supernatants of SL pEKEx3-aspAEc showed that 
AspAEc deaminates aspartate to fumarate under the tested conditions (Figure 16). This is in agreement 
with the results for the specific activities of the aspartases (Table 6). A sufficient supply with fumarate 
for the aspartase-based overproduction of aspartate is not created by deletion of the succinate 
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dehydrogenase. Whether this deletion leads to an accumulation of fumarate is not known, as 
measurements of the intracellular metabolite pool were not performed.  
 
 
Figure 17: Aspartate formation and glucose consumption of SLB expressing AspA.  
Strains were transformed with AspABs, AspACg, and AspAEc and cultivated in optimized medium with 50 mM 
glucose. Accumulation of amino acids and residual glucose is shown in supernatants of cultures after 72 h. 
Abbreviations: SL: ΔsdhCAB ΔldhA; SLB: ΔsdhCAB ΔldhA ΔaspB; Bs: B. subtilis; Cg: C. glutamicum; Ec: E. coli. Red: 
aspartate; white: glutamate; black: alanine; dark blue: glucose. 
 
3.2.3.4 Overexpression of aspB improves aspartate formation 
The endogenous aspartate aminotransferase (aspB, cg0294) was identified in a bioinformatic approach 
by screening for aminotransferases in C. glutamicum and was found to be specific for aspartate and 
2-oxoglutarate (Marienhagen et al., 2005; McHardy et al., 2003). Under production conditions, 
plasmid-borne expression of the aspB gene in the strain SL increases aspartate formation by 18 % to 
40.9 mM (Figure 18), resembling a molar yield for aspartate of 0.83 mol/mol glucose. Altogether, the 
molar amounts of the product aspartate and the by-products glutamate, alanine, succinate, lactate, 
and acetate correspond 89.9 % of the invested molar carbon of glucose, while 10.1 % is lost to 
unknown by-products. 
Additionally, the heterologous aspartate aminotransferases of B. subtilis (aspB, BSU22370) and E. coli 
(aspC, b0928) were tested for aspartate production. Both genes were cloned into the expression 
vector pEKEx3 and compared to the native enzyme. All strains expressing the aminotransferase 
showed increased aspartate formation compared to the control strain carrying the empty vector, but 
do not exceed the aspartate levels obtained with the endogenous enzyme (data not shown). 
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Figure 18: Production of aspartate with plasmid-borne expression of the endogenous aspB.  
SL was transformed with the expression vector pEKEx3-aspB and cultivated in CGXII medium supplemented with 
50 mM glucose and 100 mM NaHCO3. Accumulation of amino and organic acids as well as residual glucose is 
shown in supernatants of cultures after 72 h. Red: aspartate; white: glutamate; black: alanine; dark blue: glucose; 
striped: succinate; grey: lactate; checked: acetate. 
 
3.2.3.5 Reductive amination by aspartate dehydrogenases  
The synthesis of aspartate from fumarate leads to NADH formation of up to two mol/mol glucose. 
These can be regenerated by the malate dehydrogenase Mdh (mdh, cg2613) to NAD
+
 when all PEP or 
pyruvate is carboxylated at the anaplerotic node. If oxaloacetate is directly converted to aspartate and 
not reduced to malate, a surplus of NADH is generated inhibiting several enzymes of the glycolysis. 
Aspartate dehydrogenases (AspDH) synthesizing aspartate from oxaloacetate in a NAD-dependent 
manner can circumvent this problem. AspDH are a newly discovered group of amino acid 
dehydrogenases with high substrate specificity. They are clustered into three different groups 
according to their origin, the hyperthermophilic, the archeal and the protobacterial cluster (Li et al., 
2012).  
Due to their mesophilic origin the AspDH of Pseudomonas aeruginosa PAO1 (aspDHPa, PA3505) and 
Ralstonia eutropha H16 (aspDHRe, H16_B0736) were selected and cloned into the expression vector 
pEKEx3. To determine the specific activities of the AspDH, the ΔsdhCAB ΔldhA Δmdh (SLM) background 
was used, as the NAD-dependent malate dehydrogenase is competitive for the substrate oxaloacetate 
and NADH in the assay. However, for none of the recombinant strains carrying an aspDH expression 
plasmid, aspartate dehydrogenase activity was detected, neither for the amination nor for the 
deamination reaction. According to these results, the expression of the aspartate dehydrogenases in 
SL had no beneficial effect under production conditions. Strains expressing the aspDH genes excrete 
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aspartate on the level of the control strains, and glucose consumption was unchanged (data not 
shown). 
 
3.2.4 Overexpression of ppc and feedback resistant pyc does not improve aspartate 
overproduction 
Addition of NaHCO3 to the medium was shown to enhance aspartate synthesis by improving 
anaplerosis (Figure 12). To further improve the supply with oxaloacetate for the transamination by 
AspB, the genes coding for phosphoenolpyruvate carboxylase Ppc (ppc) and a feedback resistant 
version of the pyruvate carboxylase Pyc
P458S
 (pyc
P458S
) were introduced into C. glutamicum SL pVWEx1-
aspB (Figure 19). Cultures were inoculated anaerobically, but the simultaneous overexpression of ppc 
or pyc
P458S
 plus aspB did not improve production of aspartate. Instead the accumulation of the amino 
acid in supernatants was in both cases decreased by around 13 % compared to the control strains.  
 
 
Figure 19: Aspartate production in SL pVWEx1-aspB expressing ppc and pyc
P458S
.  
Strains were inoculated in CGXII medium and supplemented with 50 mM glucose and 100 mM NaHCO3. 
Accumulation of amino acids and residual glucose is shown in supernatants of cultures after 72 h. Red: aspartate, 
white: glutamate; black: alanine; blue: glucose. 
 
3.2.5 Deletion of the aspartate-α-decarboxylase gene panD does not improve aspartate excretion 
Another approach to increase flux through the anaplerotic node is the deletion of the gene encoding 
the aspartate-α-decarboxylase PanD (cg0172, panD). PanD is a part of the pantothenate synthesis 
pathway and a deletion of the gene should inhibit the activity of the pyruvate dehydrogenase complex 
by depletion of coenzyme A. Thereby, pyruvate should accumulate and is available for carboxylation at 
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the anaplerotic node. The plasmid pK19mobsacB-panD was used to introduce the deletion of panD in 
the SL strain and led to ΔsdhCAB ΔldhA ΔpanD (SLD). The influence of the deletion on aspartate 
synthesis was tested under anaerobic conditions with and without aspB overexpression. Compared to 
the control strains, the supernatants of SLD displayed no variations in the amount or the composition 
of the excreted compounds (data not shown). 
 
3.2.6 Reducing by-product formation during aspartate production 
3.2.6.1 Deletion of cat decreases succinate concentration but negatively affects aspartate 
formation 
In the wild type expressing aspB, the organic acids succinate, lactate, and acetate are the main 
fermentation products and a reduction of these by-products is needed to enable the production of 
aspartate. Both single deletions of ldhA and sdhCAB reduce the content of lactate (grey) and succinate 
(striped), and promote the formation of the other; e.g. the deletion of ldhA promotes excretion of 
succinate (Figure 20). Still, residual amounts of succinate can be found in ΔsdhCAB as well as lactate in 
ΔldhA. Acetate is found in all supernatants, but its accumulation is reduced with the deletion of the 
sdhCAB genes. Interestingly, the deletion of sdhCAB led to the formation of a small amount of 
aspartate (9 mM). The additional deletion of the ldhA gene in ΔsdhCAB further decreased the 
excretion of organic acids and promotes amino acid production. SL pEKEx3-aspB excretes mainly 
aspartate, alanine, and succinate, and small proportions of lactate and acetate. However, compared to 
the strain ΔsdhCAB, the content of succinate is again increased in the strain SL. For a further reduction 
of succinate, the succinyl-CoA:acetate CoA transferase Cat (cat, cg2840) was deleted in SL to yield 
ΔsdhCAB ΔldhA Δcat (SLC). Cat transfers the prosthetic group from succinyl-CoA to acetate and 
releases succinate and acetyl-CoA. In fact, the deletion of the cat gene reduces succinate in the 
supernatants but simultaneously caused a decrease of aspartate and an increase of alanine synthesis. 
The aspartate concentration was reduced by 32 % to 22.5 mM and the alanine content was almost 
doubled (20.9 mM) compared to the strain SL.  
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Figure 20: Reduction of the by-product succinate by deletion of succinate dehydrogenase and butyryl-
CoA:acetate CoA transferase.  
Strains were inoculated in CGXII medium and supplemented with 50 mM glucose and 100 mM NaHCO3. 
Accumulation of amino acids, organic acids, and residual glucose is shown in supernatants of cultures after 72 h. 
Red: aspartate; black: alanine; dark blue: glucose; striped: succinate; grey: lactate; checked: acetate. 
Abbreviations: WT: wild type; L: ΔldhA; S: ΔsdhCAB; SL:  ΔsdhCAB ΔldhA; SLC: ΔsdhCAB ΔldhA Δcat. 
 
3.2.6.2 Deletion of alanine-valine aminotransferase gene avtA improves the synthesis of aspartate 
The aminotransferases AlaT and AvtA were identified to provide cells with alanine in minimal medium 
and are therefore the main targets for a reduction of this by-product (Marienhagen and Eggeling, 
2008). Both single and a double deletion in the strain SL were obtained and named according to their 
deletions; SLT for ΔsdhCAB ΔldhA ΔalaT, SLV for ΔsdhCAB ΔldhA ΔavtA and SLTV for the double 
deletion. To determine the influence of the deletions on alanine formation, the strains were cultivated 
anaerobically. Furthermore, the effect of the expression of the aspB gene was determined. 
Supernatants were analyzed by HPLC after 72 hours and the concentrations of the amino acids and 
residual glucose are depicted in Figure 21. 
The control strain SL pEKEx3 shows significant accumulation of aspartate and alanine (Figure 21 A). In 
contrast to their proposed functions, the single deletions of alaT and avtA resulted in an increased 
concentration of alanine in the supernatants. Excretion of aspartate was also affected negatively. The 
double deletion of these genes did not eliminate alanine excretion completely, but reduced it to 
5.2 mM. In contrast, the aspartate concentration stays on the same level of the control strain SL.  
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Figure 21: Deletions of alanine transaminases alaT and avtA.  
The single and double deletions were compared to the initial SL strain with and without expression of the 
aspartate transaminase. Strains were inoculated in CGXII medium and supplemented with 50 mM glucose and 
100 mM NaHCO3. Accumulation of amino acids and residual glucose is shown in supernatants of cultures after 
72 h. Red: aspartate; black: alanine; dark blue: glucose; Abbreviations: SL: ΔsdhCAB ΔldhA; SLT: ΔsdhCAB ΔldhA 
ΔalaT; SLV: ΔsdhCAB ΔldhA ΔavtA; SLTV: ΔsdhCAB ΔldhA ΔalaT ΔavtA. 
 
In general, the overexpression of aspB improves aspartate synthesis and reduces alanine formation 
(Figure 21 B). The highest concentration of aspartate was found in supernatants of SLV pEKEx3-aspB 
corresponding to an increase of 24 % compared to SL pEKEx3-aspB. The overexpression of aspB in the 
SLT background results in lower amounts of aspartate, which were at the level of the alanine 
concentration. Aspartate synthesis in the double deletion is also increased, but did not exceed the 
amount formed by strain SLV pEKEx3-aspB, whereas alanine formation was further reduced. 
Surprisingly, the deletion of both transaminases did not prevent accumulation of alanine as a residual 
amount of ~6 mM were detected. This is in contrast to the finding, that AlaT and AvtA are the only 
aminotransferases able to synthesize alanine (Marienhagen and Eggeling, 2008). For further 
investigation SL, SLTV, and the single deletions were cultivated aerobically in minimal medium. All 
strains reached similar biomass, but the strain SLTV showed a growth defect with a prolonged lag 
phase, which could be compensated by the addition of 1 mM alanine (data not shown). In summary, 
the by-product alanine can be reduced by the deletion of both transaminases. The strain 
SLV pEKEx3-aspB shows with 1.02 mol/mol glucose the highest aspartate yield, and was therefore 
chosen for further genetic improvements. 
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3.2.7 Regeneration of reduction equivalents  
Considering the overall reactions of the production route, the regeneration of reduction equivalents is 
of major concern. In glycolysis, two moles of NADH per mol glucose are generated by the 
glyceraldehyde-3-phosphate dehydrogenase GapA (cg1791, gapA). The regeneration of NAD
+
 can be 
performed by the malate dehydrogenase Mdh (cg2613, mdh), which reduces oxaloacetate to malate 
and thereby competes with the aspartate aminotransferase AspB for the substrate oxaloacetate. Both, 
gapA and mdh are upregulated on a transcriptional level under anaerobic conditions. Additionally, 
GapA was shown to be regulated by the NAD
+
/NADH ratio and ATP, and thereby controlling the 
glycolytic flux (Inui et al., 2004b; Omumasaba et al., 2004). Therefore, both enzymes were further 
investigated to determine their influence on aspartate synthesis. 
  
3.2.7.1 The enzymes GapA and Mdh are highly active in crude extracts of C. glutamicum  
The specific activity of GapA was tested in crude extracts of the strain SLV harboring the expression 
vectors pEKEx3-gapA or pEKEx3-mdh-gapA (Figure 22). All strains were cultivated in BHI medium 
supplemented with 1 mM IPTG. Basal expression of gapA was tested with the empty vector and 
resulted in a specific activity of 0.345 U/mg. Plasmid borne gapA expression increased the activity to 
0.513 U/mg. In strain carrying pEKEx3-mdh-gapA the GapA activity was similar to the control strain 
carrying pEKEx3.   
 
Figure 22: Specific activity of GapA in crude extracts of SLV.  
Cultures were grown aerobically in BHI medium and the plasmids were induced with 1 mM IPTG.  
 
The Mdh is encoded on pEKEx3-mdh and was first tested in the strain SL. As the empty vector already 
showed a specific activity of 1.37 ± 0.25 U/mg, the plasmid was transformed into the strain 
ΔsdhCAB ΔldhA Δmdh (SLM, see section 3.2.7.3). The plasmid borne expression of the gene led to an 
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activity of 1.63 ± 0.22 U/mg, which is exceeding the basal activity by 18 %. In the empty vector control 
(SLM pEKEx3) no residual Mdh specific activity was detected. 
 
3.2.7.2 Overxpression of gapA increases velocity of aspartate formation 
To determine the influence of gapA and mdh overexpression on aspartate formation, the strain SLV 
pVWEx1-aspB was transformed with pEKEx3-gapA, pEKEx3-mdh, pEKEx3-mdh-gapA and the empty 
vector as a control. Cultures were supplemented with 50 mM glucose and 100 mM NaHCO3 and 
supernatants were analyzed by HPLC after 24, 48, 72, and 144 hours of incubation.  
The effect of overexpression of gapA or mdh either alone or in combination on the total aspartate 
yield was rather low. The titers of aspartate and the by-products vary only insignificantly after 
complete consumption of glucose. But the overexpression clearly influenced the velocity of the 
process (Figure 23). After 48 hours, an accumulation of 23.5 mM of aspartate was detected in the 
supernatants of the control strain SLV pVWEx1-aspB pEKEx3. At the same time point, the strains 
overexpressing mdh had formed 26.2 mM aspartate, while strains expressing gapA had formed 
30.9 mM. Glucose consumption was improved in this strain, while similar amounts of by-products are 
formed. The combined overexpression of mdh and gapA did not improve the process further. The 
supernatants showed comparable results to cultures overexpressing mdh. Expression of the gene 
combinations was also tested in the SL strain as well as in SLTV. A similar pattern was observed in all 
strains.  
 
Figure 23: Influence of gapA and mdh overexpression in the strain SLV on aspartate production.  
Cultures were inoculated in CGXII medium supplemented with 50 mM glucose and 100 mM NaHCO3. 
Accumulation of amino acids and residual glucose in supernatants of cultures after 48 h is depicted. Red: 
aspartate, white: glutamate; black: alanine; blue: glucose.  
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3.2.7.3 Deletion of malate dehydrogenase impairs glucose consumption  
Mdh is a competitor of AspB, drawing off oxaloacetate to malate on the reductive branch of the TCA 
cycle, thereby regenerating NAD
+
. To further investigate the role of the enzyme for aspartate 
production an in-frame deletion was introduced into the SL strain with the vector pK19mobsacB-mdh. 
The strain ΔsdhCAB ΔldhA Δmdh (SLM) was transformed with pEKEx3-aspB and tested under aspartate 
production conditions. Deletion of the dehydrogenase severely effects consumption of the carbon 
source. More than 40 % of the glucose was left after 72 hours and synthesis of aspartate was 
completely blocked. This clearly indicates the importance of the enzyme for the regeneration of NAD
+
 
and for aspartate production.  
 
3.2.7.4 NAD-dependent GdhPa restores glucose consumption in the strain SLM but is not suitable 
for aspartate production 
 
To find a substitute for NAD
+
 regeneration in the strain SLM, the glutamate dehydrogenase (GdhPa) of 
Peptostreptococcus asaccharolyticus was tested under aspartate production conditions. This enzyme 
catalyzes the reductive amination of 2-oxoglutarate in a NAD-dependent manner, while the 
endogenous enzyme is NADP-dependent. As glutamate is the amino donor for the transamination of 
oxaloacetate to aspartate, the enzyme is also advantageous for precursor supply. 
The expression of gdhPa was tested in SL and SLM carrying pVWEx1-aspB. SL pVWEx1-aspB pEKEx3 
serves as control strain, as SLM expressing aspB is not able to utilize glucose properly (3.2.7.3). The 
expression of gdhPa disturbed the production of aspartate in the SL strain (Figure 24). It was reduced 
by almost 50 % to 20.1 mM and this was accompanied by a significant increase in alanine excretion. In 
the SLM background, expression of gdhPa only partially compensated the mdh deletion. Glucose 
consumption is restored in this strain, but as in SL, aspartate formation was reduced and alanine 
formation increased. Consequently, restoring glucose consumption of an mdh deletion mutant by 
expression of gdhPa is possible, but not applicable for aspartate overproduction. 
Next to GdhPa, also the aspartate dehydrogenases of R. eutropha and P. aeruginosa were tested in the 
SLM background. These enzymes catalyze the NAD-dependent amination of oxaloacetate to aspartate, 
and can therefore couple NAD
+
 regeneration and product formation. However, in accordance with no 
detectable enzymatic activity, their expression did not promote the formation of aspartate.  
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Figure 24: Expression of GdhPa from Peptostreptococcus asaccharolyticus in SL and SLM.  
Cultures were inoculated in CGXII medium supplemented with 50 mM glucose and 100 mM NaHCO3. 
Accumulation of amino acids and residual glucose in supernatants of cultures after 72 h is depicted. Red: 
aspartate, white: glutamate; black: alanine; blue: glucose. 
 
3.2.7.5 Expression of the transhydrogenases genes udhA and pntAB does not improve aspartate 
formation 
Another approach to improve NAD
+
-regeneration was the expression of transhydrogenase genes. 
These enzymes catalyze the transfer of electrons between different reduction equivalents. NADP
+
 can 
be reduced to NADPH with the electrons from NADH and used in the cell for reductive amination of 
2-oxoglutarate to glutamate via the endogenous glutamate dehydrogenase. The aminotransferase 
AspB requires glutamate as amino donor, and therefore the transhydrogenase activity can improve 
aspartate synthesis. Two enzymes of E. coli were tested. PntABEc is a membrane-integral enzyme and 
reduces NADP
+
 with NADH. This reaction is driven by the proton-motive force and one proton is 
transported into the cell for each NADPH formed. UdhAEc is a soluble enzyme and transfers electrons 
between NAD
+
 and NADP
+
 depending on their concentrations. The expression of the enzymes was 
performed in SL pEKEx3-aspB during aspartate synthesis. Both enzymes reduced the accumulation of 
aspartate and promoted alanine formation. The expression of pntABEc reduced the aspartate 
concentration by more than 60 % and glucose is consumed incompletely. The effect of udhAEc 
expression was not that distinct, but still reduced the aspartate excretion significantly by 38 %.  
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3.2.8 Utilization of maltose improves aspartate formation 
As industrial fermentations are not only performed with glucose, but molasses and other mixed 
sugars, additional carbon sources were tested for the production of aspartate. Next to glucose, the 
utilization of fructose and maltose was tested. To balance the molar ratio of carbon, the concentration 
of the disaccharide maltose was reduced to 25 mM. Supernatants from SL pEKEx3-aspB cultures 
incubated for 72 hours with 100 mM NaHCO3 were sampled and analyzed by HPLC. The utilization of 
fructose was diminished in the strain SL pEKEx3-aspB under anaerobic conditions (Figure 25). After 
72 h, less than 50 % of the sugar was consumed, along with reduced excretion of aspartate. However, 
the utilization of maltose was beneficial for the production of aspartate and led to a 13 % increase.  
 
 
Figure 25: Production of aspartate in SL pEKEx3-aspB from alternative carbon sources.  
Cultures were inoculated in CGXII medium supplemented with 100 mM NaHCO3 and 50 mM glucose, 50 mM 
fructose or 25 mM maltose. Accumulation of amino acids and residual carbon source in supernatants of cultures 
after 72 h is depicted. Red: aspartate, white: glutamate; black: alanine; blue: carbon source.  
 
Next to these food carbon sources, also non-food carbon sources were tested. The hemicellulosic 
sugars arabinose and xylose are waste products derived from lignocellulosic biomass. Utilization of 
arabinose is enabled in C. glutamicum by plasmid borne expression of the araBAD operon of E. coli. 
For xylose utilization, the plasmid encoding the xylose isomerase from Xanthomonas campestris 
(xylAXc) and the endogous xylulose kinase (xylB, cg0147) were used. Glycerol is a waste product of 
biodiesel synthesis and utilization was enabled by the glpFKD operon of E. coli. The strain SL was 
transformed with the plasmids and tested with 60 mM of the pentose sugars and 100 mM of the C3 
compound, to balance the ratios of molar carbon. Nevertheless, the tested carbon sources were not 
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consumed properly. After 72 hours, the glycerol concentration was unchanged. Furthermore, only 
35 % of the arabinose and 50 % of the xylose were consumed. None of these alternative carbon 
sources promoted aspartate synthesis. 
 
3.2.9 Velocity of aspartate production is increased by GapA and utilization of maltose 
The production rate of aspartate synthesis was determined depending on the carbon source and the 
genetic background of the strain. The strains SL and SLV overexpressing either aspB or aspB plus gapA 
were supplemented with 100 mM NaHCO3 and 50 mM glucose or 25 mM maltose. Sampling of 
supernatants was performed thrice a day in four hour steps for 72 hours. During the experiment, a 
clear production phase appears between 20 and 52 h. The production rate is calculated only for this 
phase and covers a time of 24 h for each strain (Table 7).  
Table 7: Aspartate production rate, carbon utilization and product yield of SL and SLV expressing aspB or aspB 
plus gapA.  
Strains were cultivated in CGXII medium supplemented with 100 mM NaHCO3 and 50 mM glucose or 25 mM 
maltose. Rates were calculated for the production phase between 20 and 52 h and cover a range of 24 h for each 
strain. In order to compare the carbon consumption of the mono- and disaccharide, values are depicted in 
molC/h*gCDW. Product yield was determined after complete consumption of the carbon source. Abbreviations: 
x: pVWEx1-aspB pEKEx3; xG: pVWEx1-aspB pEKEx3-gapA. 
 
  Aspartate  
production rate 
[mM/h*gCDW] 
Carbon 
consumption rate  
[molC/h*gCDW] 
Aspartate  
yield YP/S  
[g/g] 
Alanine 
yield YP/S  
[g/g] 
Glucose SLx 0.091 ± 0.002 0.679 ± 0.012 0.51 ± 0.02 0.18 ± 0.00 
 SLxG 0.156 ± 0.008 0.959 ± 0.034 0.49 ± 0.05 0.20 ± 0.00 
Glucose  SLVx 0.100 ± 0.007 0.553 ± 0.017 0.59 ± 0.07 0.11 ± 0.00 
 SLVxG 0.154 ± 0.006 0.763 ± 0.025 0.59 ± 0.02 0.12 ± 0.00 
Maltose SLVx 0.153 ± 0.012 0.631 ± 0.040 0.80 ± 0.07 0.10 ± 0.01 
 SLVxG 0.176 ± 0.018  0.664 ± 0.023 0.80 ± 0.02 0.10 ± 0.00 
 
The effects of the deletion of avtA, the overexpression of gapA and the used carbon source were 
determined for the aspartate production rate, the carbon utilization and the yields of aspartate and 
alanine. The deletion of avtA affects the carbon utilization and the formation of the by-product 
alanine. The strains SLxG and SLVxG had similar aspartate production rates, but SLxG showed a by 20 % 
increased carbon consumption. Compared to SLxG, the additional deletion of avtA increased the 
aspartate yield and decreased the alanine formation in SLVxG. In all tested strains, the expression of 
gapA had positive effects on aspartate production and carbon consumption, but did not affect the 
total aspartate yields. On glucose, the overexpression of gapA in SL and SLV increased carbon 
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consumption by i.e. 40 %, which also positively affects the aspartate production rate. On maltose, the 
highest aspartate production rate and the highest yields were achieved. However, the gapA 
overexpression promoted the aspartate production rate and the carbon utilization to a lesser extent 
than on glucose. However, the utilization of the disaccharide raised the yield by 35 % compared to 
glucose. 
 
3.2.10 Aspartate is constantly produced from glucose and maltose 
To show the stability of the process, SLV pVWEx1-aspB pEKEx3-gapA was incubated with the standard 
(Figure 26 A) and the doubled (Figure 26 B) amounts of glucose and maltose. Samples were taken after 
72 and 144 hours and analyzed by HPLC. In all cultures, the same pattern can be observed, a doubling 
of carbon source and time results in a doubled amount of the product. Cells supplemented with 
100 mM glucose synthesize 69.8 mM aspartate, but a residual amount of almost 20 mM of the carbon 
source is still present in supernatants. From 25 mM maltose, 46.3 mM aspartate is synthesized, which 
is almost doubled up to 90.4 mM from 50 mM maltose within 144 hours. 
 
 
Figure 26: Constant production of aspartate in SLV pVWEx1-aspB pEKEx3-gapA with (A) standard and (B) 
doubled amounts of glucose and maltose.  
Cultures were inoculated in CGXII medium supplemented with the indicated amounts of carbon sources and 
NaHCO3 (100 mM NaHCO3 for 50 mM glucose and 25 mM maltose or 200 mM NaHCO3 for cultures supplemented 
with 100 mM glucose and 50 mM maltose). A: 72 h; B: 144 h. Abbreviations: G: glucose; M: maltose. Numbers 
indicate carbon source concentrations in mM. Red: aspartate; white: glutamate; black: alanine; blue: carbon 
source.  
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3.3 Conclusion of aspartate production 
In order to develop a strain for the production of aspartate, two general strategies were followed. 
Under aerobic conditions, growth and production phase are coupled. As aspartate is metabolized 
during growth, it was of major concern to reduce aspartate consuming reactions. However, a deletion 
of the aspartokinase, the main aspartate catabolizing enzyme, was not possible. Furthermore, the 
expression of the aspartate aminotransferase and the aspartase in the C. glutamicum wild type or 
Δfum was not sufficient to enable aspartate overproduction. However, the decoupling of growth and 
production phase enabled overproduction of aspartate. Under anaerobic conditions, the strain SL 
excreted aspartate with a yield of 0.55 mol/mol glucose in minimal medium and formed the 
by-products alanine and succinate. The initial aspartate titer was increased by adaptations of the 
medium and improvements of the production strain. The addition of bicarbonate was beneficial for 
product formation and increased the yield to 0.83 mol/mol glucose. As a side effect, the content of 
alanine was reduced in the supernatants. Nitrate as terminal electron acceptor improved glucose 
consumption but inhibited the production of aspartate. Furthermore, the utilization of maltose as 
carbon source was beneficial for aspartate production. In the strain SL, the transamination of 
oxaloacetate by the aspartate aminotransferase proved to be more efficient than the amination of 
fumarate to aspartate. A reduction of the by-product succinate by the deletion of the cat gene was 
coupled to reduced aspartate production, while the reduction of alanine by the deletion of the alanine 
valine transaminase avtA promoted aspartate formation to 1.02 mol/mol glucose. The velocity of the 
production with glucose was enhanced 1.5-fold by the overexpression the glyceraldehyde 
dehydrogenase and led to the production of 0.154 mM/h*gCDW in the production phase. The highest 
yield was achieved with maltose (0.80 g/g) and the velocity of aspartate production was further 
enhanced to 0.176 mM/h*gCDW. Overall, an efficient growth decoupled production scheme was 
developed that enables aspartate synthesis based on glucose and maltose.   
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3.4 Anaerobic production of β-alanine 
Under physiological conditions, β-alanine is crucial for the synthesis of pantothenate. The 
non-proteinogenic β-amino acid is derived from aspartate by decarboxylation by the 
aspartate-α-decarboxylase PanD (panD, cg0172). Overexpression of panD in an aspartate producing 
strain of C. glutamicum was used to enable the overproduction of β-alanine. 
3.4.1 The aspartate-α-decarboxylase PanD of C. glutamicum shows the highest specific activity  
To define the best suited enzyme for β-alanine production heterologous enzymes were tested for their 
activity. Next to the endogenous PanD protein, the enzymes of E. coli (panD, b0131) and B. subtilis 
(panD, BSU22410) were investigated. The corresponding genes were cloned in the expression vector 
pEKEx3, and specific activity was determined in the SL background with an HPLC based assay. For the 
empty vector control, no aspartate specific decarboxylase activity was detected, while PanDCg 
demonstrated the highest specific activity with 55.4 ± 6.7 mU/mg. For PanDBs, an activity of 
15.4 ± 3.9 mU/mg was measured, but the decarboxylase of E. coli was inactive in crude extracts of the 
strain SL. Therefore, the aspartate-α-decarboxylase of C. glutamicum represents the best suited 
enzyme for β-alanine production.   
 
3.4.2 Production of β-alanine by PanDCg is possible but inefficient 
Synthesis of β-alanine was performed in the aspartate producing strain SL expressing the plasmid 
encoded panD genes of B. subtilis, E. coli, and the endogenous gene. Cultures were inoculated 
anaerobically in medium optimized for aspartate synthesis and supplemented with 50 mM glucose and 
100 mM NaHCO3. Sampling was performed after 72 hours, and the amino acid composition of the 
supernatants was analyzed by HPLC. 
In general, the decarboxylation of aspartate is inefficient, as more than 50 % of total aspartate is not 
converted to β-alanine (Figure 27). The determined specific activities of the decarbocxylases in crude 
extracts correlated with the results obtained for synthesis of β-alanine. The maximal titer of 15.3 mM 
was obtained with the strain that overexpressed the endogenous enzyme. Expression of panDBs led to 
an excretion of 2.7 mM, while no β-alanine was detected in the supernatant of the strain expressing 
panDEc. The main by-products of the cultivation are aspartate and α-alanine. Consequently, the 
endogenous enzyme (referred as panD in the following) was chosen for all further experiments. 
Despite this inefficient conversion of aspartate to β-alanine, the activity of the enzymes was not 
improved in this work. 
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Figure 27: Production of β-alanine in the strain SL expressing the plasmid encoded panD genes of B. subtilis, 
C. glutamicum, and E. coli.  
Cultures were inoculated in CGXII medium supplemented with 50 mM glucose and 100 mM NaHCO3. 
Accumulation of amino acids in supernatants of cultures after 72 h is depicted. Red: aspartate; black: alanine; 
green: β-alanine. N.d.: not detected; Bs: B. subtilis; Cg: C. glutamicum; Ec: E. coli. 
 
 
3.4.3 The overexpression of aspB improves synthesis of β-alanine 
Next to improving the decarboxylation reaction, improvements in the metabolism of the production 
strain can be performed. Physiologically, β-alanine is the precursor for the synthesis of the B-vitamin 
pantothenate. To prevent flux in this pathway, a deletion of the panBC genes was introduced into the 
strain SL that led to ΔsdhCAB ΔldhA ΔpanBC (SLBC). Furthermore, the synthesis of β-alanine was tested 
in the strains SLV and SLTV carrying deletions in the genes avtA and alaT, encoding the two known 
α-alanine synthesizing transaminases of C. glutamicum. Moreover, the expression of panD was 
combined with the expression of the aspartate aminotransferase aspB. 
In general, the production of β-alanine is dependent on the overexpression of panD (Figure 28). The 
control strain SL pEKEx3 excretes only aspartate (35.7 mM) and α-alanine (Figure 28 A). The 
overexpression of panD led to the excretion of 15.8 mM β-alanine into the supernatant. Deletion of 
the α-alanine transaminases did not decrease the amount of the by-product α-alanine. Instead 
deletion of the aminotransferase avtA decreases β-alanine synthesis, and its production was 
completely prevented in the avtA-alaT double mutant SLTV. Furthermore, the deletion of the panBC 
genes was not beneficial for β-alanine production, since the titer was lower compared to 
SL pEKEx3-panD (Figure 28 B). 
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Although high amounts of residual aspartate were detected in all supernatants, the expression of panD 
with aspB was tested (Figure 28 C). This strategy improved the production of β-alanine from 13.2 mM 
to 20.8 mM, which corresponds a yield of 0.24 g/g glucose. 
In summary, the introduced deletions in the transaminases as well as the deletion of panBC did not 
further promote the synthesis of β-alanine and only the overexpression of aspB proved to be 
beneficial. 
 
 
Figure 28: Production of β-alanine in the strains SL, SLV, SLTV and SLBC overexpressing panD.  
A: Deletion of the α-alanine transaminases alaT and avtA (SLV and SLTV). B: Deletion of the genes coding for the 
pantothenate synthetic pathway (panBC); C: Combined overexpression of aspB and panD. Cultures were 
inoculated in CGXII medium supplemented with 50 mM glucose and 100 mM NaHCO3. Accumulation of amino 
acids in supernatants of cultures after 72 h is depicted. Red: aspartate; black: α-alanine, green: β-alanine. 
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3.5.1 C. salexigens EctA and EctB are active in C. glutamicum DM1729 
To test the specific activities of the enzymes, the ectABC operon of C. salexigens was cloned into 
pEKEx3. The resulting plasmid was transferred into the lysine producing strain DM1729. EctB catalyzes 
the reversible transfer of the γ-amino group from diaminobutyrate to 2-oxoglutarate and the resulting 
glutamate was measured discontinuously via HPLC. The specific activity of EctB was 
54.3 ± 17.1 mU/mg, while the control strain carrying pEKEx3 shows no diaminobutyrate transaminase 
activity. The acetyl-CoA transferase EctA catalyzes the addition of an acetyl group to diaminobutyrate, 
thereby releasing CoA, which can be detected spectrophotometrically with Ellmann´s reagent at 
412 nm. A specific activity of 26.0 ± 5.6 mU/mg was detected in crude extracts of DM1729 carrying 
pEKEx3-ectABC, whereas no activity was found in the control strain DM1729 pEKEx3.  
 
3.5.2 Expression of C. salexigens ectABC enables efficient ectoine synthesis in the wild type and 
DM1729 
To enable salt-independent production of ectoine, the C. salexigens ectABC operon is expressed from 
the IPTG inducible promoter Ptac. The aerobic production of ectoine was performed in the wild type 
and in DM1729, which has three point mutations (pyc
P458S
, hom
V59A
, lysC
T311I
) that enable lysine 
production and potentially enhance ectoine synthesis, too (Figure 30). Cells were cultivated in CGXII 
minimal medium supplemented with 200 mM glucose in the presence of IPTG. 
 
 
Figure 30: Aerobic production of ectoine in C. glutamicum wild type and DM1729 by expression of 
C. salexigens ectABC.  
Cells were cultivated in CGXII medium supplemented with 200 mM glucose for 24 h. Red: ectoine [mM]; black: 
lysine [mM]; n. d.: not detected.  
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Production of ectoine is clearly dependent on the expression of the C. salexigens ectABC operon. In the 
wild type, a titer of 18.1 mM ectoine was achieved after 24 hours, while no ectoine was detectable in 
the control strains (Figure 30, red bars). In DM1729 expressing ectABC, lysine production was reduced 
by 76 % to 8.6 mM compared to the reference strain carrying pEKEx3, which accumulated 35.7 mM 
lysine in the supernatant. The expression of ectABC in DM1729 led to an accumulation of 36.9 mM 
ectoine. In summary, expression of ectABC in the genetic background of DM1729 enabled efficient 
production of ectoine with yields comparable to lysine overproduction with this strain. 
 
3.5.3 Production of ectoine is promoted in fed-batch cultivation  
Fed-batch cultivation was performed with DM1729 pEKEx3-ectABC to determine the stability of the 
process. Cells were inoculated with 200 mM glucose and fed with the same amount of substrate after 
24 hours. The production of lysine and ectoine is similar within the first 24 hours, but a notable higher 
OD600 is achieved in the control strain carrying pEKEx3 (Figure 31). The additional feeding of glucose is 
used differently in both strains. The control culture increased the amount of lysine in the supernatant 
to 76.3 mM, and the OD600 was increased only by 16 %. In contrast, the feeding of glucose to cultures 
expressing the ectABC operon increased the ectoine titer only by 26 % to 44.1 mM, but caused a 
doubling of biomass. Taken together, the additional feeding of glucose doubled the optical density of 
the ectoine production strain, but not the concentration of the product.  
 
 
Figure 31: Production of ectoine and lysine of the strains DM1729 pEKEx3 and DM1729 pEKEx3-ectABC after 24 
and 48 hours.  
Cells were fed batch cultivated with additional 200 mM glucose after 24 hours. Red: ectoine, black: lysine; n. d.: 
not detected. The dots indicate the OD600.  
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3.5.4 Use of alternative carbon sources 
3.5.4.1 Growth in glycerol is faster than in arabinose and xylose 
The use of waste products and non-food carbon sources is of major interest for the synthesis of 
compounds of biotechnological relevance. Therefore, DM1729 pEKEx3-ectABC was combined with 
pVWEx1-araBAD or pVWEx1-glpFKD, encoding the biosynthetic genes of E. coli for the utilization of 
arabinose or glycerol, respectively. The genes for the utilization of xylose are encoded on 
pEKEx3-xylAXcBCg, which was transferred into DM1729 pVWEx1-ectABC. The respective plasmid 
combinations without the ectoine biosynthetic genes served as controls in the experiments.  
 
 
Figure 32: Growth of DM1729 in CgXII medium with alternative carbon sources.  
A: Growth with 120 mM arabinose, DM1729 pVWEx1-araBAD combined with: open circles: pEKEx3, filled circles: 
pEKEx3-ectABC; B: Growth with 120 mM xylose, DM1729 pEKEx3-xylAXcBCg combined with: open circles: pVWEx1, 
filled circles: pVWEx1-ectABC; C: Growth with 200 mM glycerol, DM1729 pVWEx1-glpFKD combined with: open 
circles: pEKEx3, filled circles: pEKEx3-ectABC. 
 
Cultures grown with arabinose and xylose enter the stationary phase after 40 and 44 hours, 
respectively (Figure 32 A and B). In contrast, growth on glycerol is significantly faster. Cells enter the 
stationary phase after 25 hours (Figure 32 C). Additionally, only minimal differences in the growth 
rates on arabinose and xylose can be detected between the control strains and the strains expressing 
the ectABC genes. On glycerol, expression of the operon reduced the growth rate from 0.20 to 0.14 h
-1
. 
Nevertheless, all carbon sources are consumed properly.   
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3.5.4.2 Production of ectoine is enabled by arabinose, xylose, and glycerol 
To test the utilization of the non-food carbon sources for ectoine synthesis, the appropriate strains 
were cultivated in CGXII media supplemented with arabinose, xylose or glycerol. The pentoses were 
used in a concentration of 240 mM while glycerol were fed stepwise, as it shows an inhibitory effect in 
higher concentrations (Rittmann et al., 2008). The cultures were inoculated with 200 mM glycerol and 
fed with the same amount of substrate after 24 hours. The different concentrations of the pentoses 
arabinose and xylose and the C-3 compound glycerol were chosen to balance the amount of molar 
carbon used in the experiments. 
 
 
Figure 33: Production of ectoine from arabinose, xylose and glycerol.  
Supernatants of arabinose and xylose grown cultures were analyzed after 72 h, while glycerol grown cultures 
were analyzed after 48 h. Strains carry vectors necessary for the utilization of the respective carbon source and 
the ectoine operon encoded on pEKEx3 (arabinose, glycerol) or pVWEx1 (xylose). Black bars: lysine, red bars: 
ectoine.  
 
Ectoine was efficiently synthesized from all three carbon sources (Figure 33, red bars). After 72 hours, 
strains cultivated with the pentoses arabinose and xylose showed an formation of ectoine of 28.3 mM 
and 20.1 mM, respectively. In glycerol grown cultures, 23.8 mM ectoine were detected within 
48 hours. Lysine was excreted during ectoine overproduction especially in xylose grown cultures, and 
therefore, it is important to minimize the excretion the by-product. 
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3.5.5 Yields of ectoine production 
The yields for ectoine production were calculated after complete consumption of the carbon source. 
The production rates of the process were not determined, as the synthesis was only followed in 24 h 
steps.  
Table 8: Yields for ectoine synthesis from all tested carbon sources.  
Yields were calculated after complete consumption of carbon source. N. d.: not detected. 
 
Strain WT DM1729 
Carbon source Glucose Glucose Arabinose Xylose Glycerol 
Yield lysine [g/g] n. d. 0.145 ± 0.011 0.128 ± 0.012 0.133 ± 0.003 0.113 ± 0.023 
Yield ectoine [g/g] 0.074 ± 0.006 0.146 ± 0.000 0.113 ± 0.002 0.080 ± 0.002 0.100 ± 0.007 
 
The expression of the ectoine operon in the wild type led already to a significant formation of the 
compatible solute. This yield was further enhanced by the introduction of the biosynthetic genes into 
the strain DM1729, in which the utilization of the carbon source glucose led the excretion of 0.145 g/g. 
For the alternative carbon sources, higher yields are achieved for lysine than for ectoine synthesis, 
while there are no differences on glucose (Table 8). With arabinose and with glycerol the ectoine yields 
were 12 % lower than the lysine yields from these carbon sources. On xylose, an increased formation 
of the by-product lysine further reduced the ectoine yield. However, it was shown that efficient 
synthesis of ectoine is possible by heterologous expression of the ectoine biosynthetic genes, and 
furthermore, that this production is possible from sustainable carbon sources. 
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4 Discussion  
4.1 Production of aspartate 
The amino acid aspartate is a chemical building block with broad applications as food additive or as a 
biodegradable specialty polymer and holds potential to be synthesized independently from 
petrochemical resources. In cells, aspartate is not an end-product of a single pathway, but it is a 
central precursor for the synthesis of amino acids, for the cell wall component diaminopimelic acid, 
and for the B-vitamin pantothenate. Several subsequent pathways are dependent on its availability, 
and promoting the synthesis of aspartate does not necessarily mean that the amino acid is 
accumulating in the culture medium. Therefore, strategies were developed to enhance its synthesis 
and to minimalize the utilization of aspartate by the production host Corynebacterium glutamicum.  
Aspartate excretion as a by-product in C. glutamicum was first described during glutamate production 
triggered by biotin limitation (Shiio et al., 1962). Later on, aspartate excreting mutants were derived 
from C. glutamicum ATCC 14067 in several rounds of random mutagenesis with N-methyl-N’-nitro-
N-nitrosoguanidine, which introduces point mutations by transition from GCAT (Mori and Shiio, 
1984; Shiio et al., 1982). These mutants are characterized by reduced activities of citrate synthase and 
the pyruvate kinase and excreted aspartate under biotin limitation. However, aspartate excretion in 
these mutants was not stable and also restricted by other nutritional requirements not necessary 
related to the biosynthesis of the amino acid. Furthermore, the biochemical characterization of these 
strains was focused on measurements of citrate synthase and pyruvate kinase and other enzymes 
possibly influencing aspartate excretion, e.g. malate synthase, were not further investigated. Although 
these mutants overproduce aspartate, the obtained results were not integrated in this work, due to 
the undefined genetic background of these strains.  
 
4.1.1 Synthesis of aspartate under aerobic conditions 
Under aerobic conditions, the overproduction of aspartate was not enabled successfully with the 
implemented genetic modifications of C. glutamicum. The main focus was the expression of the E. coli 
aspartase (AspA) and the endogenous aspartate aminotransferase (AspB), but the expression of the 
genes alone did not promote aspartate synthesis. Therefore, deletions of the fum and panD gene were 
introduced into the genome of C. glutamicum, presumably improving the synthesis of fumarate or 
oxaloacetate, respectively. In both genetic backgrounds no aspartate was excreted, but the expression 
of aspA and aspB promoted growth of these strains, hinting on an indeed improved supply with the 
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respective precursor. With the deletion of the panD gene, cells are impaired in the synthesis of CoA, 
which is a cofactor of the pyruvate dehydrogenase complex (PDHC) marking the entry point of the 
oxidative branch of the TCA cycle. This inhibition was thought to promote the flux into the reductive 
branch, caused by the increased availability of pyruvate for anaplerotic reactions. Instead, the 
supernatants of the ΔpanD strains showed a significant accumulation of pyruvate overflow 
metabolites (valine and alanine), but aspartate overproduction was not detected. In contrast to that, 
the excretion of 2 g/l aspartate as a by-product of glutamate overproduction (32 g/l from 100 g/l 
glucose) was detected in a defined pyruvate kinase (pyk, cg2291) mutant (Sawada et al., 2010). In 
Δpyk, a stoichiometric production of one molecule of PEP and one molecule pyruvate per molecule 
glucose is achieved by the PTS mediated sugar uptake and subsequent glycolysis. This was exploited 
during biotin-limited and thereby growth-arrested glutamate overproduction. Under these conditions, 
only PEP and not pyruvate serves as anaplerotic precursor, caused by the biotin dependence of 
pyruvate carboxylase. Thus, enhanced supply with PEP promoted aspartate excretion in growth 
arrested cells. 
The growth of the panD mutants constructed in this work differed to recent findings for panD mutants 
in E. coli and C. glutamicum (Dusch et al., 1999a; Kennedy and Kealey, 2004). The defined panD mutant 
generated here grew without the addition of β-alanine (Figure 7, p. 52), while the C. glutamicum 
insertion mutant ND2, and the E. coli mutant carrying a point mutation inactivating the decarboxylase, 
grew only with supplementation of the β-amino acid. The latter two mutants were supplemented in 
minimal medium with 5 µM or 1 mM β-alanine, respectively, without determining the minimal amount 
necessary to complement the deletion. However, only small amounts of β-alanine enabled growth of 
the mutants. Prior to growth experiments in minimal medium performed here, cells were 
precultivated in complex medium and it is not known, if cells are fully depleted of β-alanine. A residual 
intracellular pool accumulated during precultivation eventually causes the observed growth of the 
panD mutant. Nonetheless, after a passage on CgXII minimal medium plates supplemented with 
glucose for 24 h, the panD mutant generated here resumed growth on fresh minimal medium plates. 
In the above mentioned Δpyk strains, the excretion of aspartate was linked to a growth arrest, and 
therefore, the panD gene was also deleted in the genetic background of ΔsdhCAB ΔldhA. But also 
under anaerobic and thereby growth arrested conditions, the deletion of panD did not further 
promote aspartate excretion (3.2.5, p. 65). Another pathway for the synthesis of β-alanine is not 
known for C. glutamicum. In eukaryotes, β-alanine is synthesized in three steps from uracil with the 
dihydropyrimidine dehydrogenase, the dihydropyrimidinase and the β-alanine synthase. This pathway 
is present only in some eukaryotes, and enables the use of pyrimidines as sole nitrogen source 
(Campbell, 1957a, b). Recently, a dihydropyrimidine dehydrogenase was discovered in E. coli, but, like 
in C. glutamicum, the complete pyrimidine catabolic pathway is not present (Hidese et al., 2011).  
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The deletion of the gene for the aspartokinase gene (lysC) was another strategy to diminish aspartate 
drain off and enable accumulation of the amino acid. The aspartokinase LysC catalyzes the 
phosphorylation of aspartate and is the entry-point for the synthesis of threonine, lysine and 
diaminopimelic acid. The lysC gene contains an additional promoter mediating the transcription of the 
β-subunit of LysC and forms an operon with the aspartate semialdehyde dehydrogenase gene asd 
(Kalinowski et al., 1990). However, a deletion of the aspartokinase gene by homologous recombination 
was not possible (3.1.6.1, p. 52). Apparently, the viability of cells is strictly dependent on the 
availability of aspartylphosphate. All steps of the recombination were performed on complex medium, 
supplying the cells with all amino acids. Not provided, however, is the cell wall precursor 
diaminopimelic acid, which can only be synthesized in the course of lysine synthesis (Yeh et al., 1988). 
Also the supply with threonine does not enable the synthesis of the cell wall component. Threonine is 
synthesized in four enzymatic steps from aspartylphosphate and might serve as substrate for 
diaminopimelate, however, the dephosphorylation of homoserine phosphate to threonine by 
threonine synthase ThrC is irreversible (Malumbres et al., 1994).  
A disruption mutant of lysC was reported in the lysine producing strain C. glutamicum ATCC 21799, 
formerly known as Corynebacterium lactofermentum or Brevibacterium lactofermentum (Jetten et al., 
1995). This strain is devoid of homoserine dehydrogenase, which causes threonine auxotrophy, and 
carries a feedback-resistant aspartokinase with a three times higher activity compared to 
C. glutamicum ATCC 13032, used in this work. The disruption of lysC was performed by introducing a 
chloramphenicol acetyltransferase into the gene. However, this strain grows in minimal medium with a 
four times higher doubling time compared to the parental strain, and the addition of lysine or 
diaminopimelate has no influence on the growth behavior. The synthesis of lysine showed a strong 
reduction but was not diminished completely. The authors proposed that lysine is synthesized either 
by an unknown path from threonine or by isoenzymes of the aspartokinase, similar to E. coli and 
B. subtilis. These organisms possess three aspartokinases (ask) with different functions and regulations 
(Cohen et al., 1969; Patte et al., 1967; Zhang et al., 1990). In E. coli, Ask I and Ask II, encoded by thrA 
and metL, respectively, are bifunctional enzymes with aspartokinase and homoserine dehydrogenase 
activity. ThrA is allosterically inhibited by threonine, and its synthesis is repressed on the 
transcriptional level by threonine and isoleucine. MetL is involved in the synthesis of methionine and is 
repressed by this amino acid. In contrast, Ask III (LysC) is a monofunctional enzyme, whose activity and 
transcription is regulated by lysine. In B. subtilis, Ask I (DapG) is involved in the synthesis of the cell 
wall precursor diaminopimelate, while Ask II (LysC) is involved in lysine synthesis and Ask III (YclM) in 
threonine and methionine synthesis. Deletion of Ask II and Ask III alone does not affect growth in 
minimal medium, but a combined deletion leads to lysine, threonine and methionine auxotrophy 
(Zhang et al., 1990). The deletion of Ask I in B. subtilis can be compensated by Ask II and III, if no 
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inhibition by accumulation of amino acids (lysine or threonine and lysine, respectively) occurs (Roten 
et al., 1991). For C. glutamicum ATCC 13032, only the monofunctional aspartokinase LysC is known, 
which is allosterically inhibited by a combination of threonine and lysine. This might explain the 
disability to disrupt the gene and the essentiality of LysC for C. glutamicum. 
 
4.1.2 Overproduction of aspartate under anaerobic conditions 
In this work, a fermentative process for the overproduction of aspartate with C. glutamicum was 
developed. The strain C. glutamicum ΔsdhCAB ΔldhA (SL) with deleted succinate dehydrogenase and 
lactate dehydrogenase genes was used as basis for aspartate production. Further adaptations of the 
strain are depicted in Figure 34 and targeted improvements in product formation (e.g. expression of 
aspA and aspB), of the precursor supply (e.g. expression of ppc and pyc), the reduction of by-products 
(deletion of cat, alaT and avtA), or cofactor recycling (e.g. expression of mdh and gapA), and are 
discussed in the following sections. 
 
 Figure 34: Modifications in the central carbon metabolism 
overproduction.  
Red boxes: deletions; green boxes: overexpress
glucose; Hpr, PtsI: unspecific PTS components; MusEFGK
4-α-glucanotransferase; MalP: maltodextrin phosphorylase; Pgm: α
GapA: glyceraldehyde-3-phosphate dehydrog
dependent); IlvBN: acetohydroxyacid
alanine transaminase; AvtA: alanine valine transaminase; Ppc: PEP
Succinyl-CoA:Acetate CoA transferase; SucCD: succinyl
aspartase; Fum: fumarase; Mqo: malate quinone oxidoreductase; Mdh: malate dehydrogenase; AspB: aspartate 
aminotransferase. 
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4.1.2.1 Anaerobic fermentation of aspartate in the strain SL 
One basic requirement for aspartate production is to prevent the metabolization of the amino acid. 
This task was accomplished under anaerobic conditions. In C. glutamicum, the change from oxic to 
anoxic conditions induces a growth arrest and the switch to a fermentative metabolism that is 
characterized by the excretion of succinate, lactate, and acetate (Dominguez and et al., 1993; Inui et 
al., 2004b). The overproduction of aspartate under anaerobic conditions without growth requires 
elimination of the main fermentation products by the deletion of the genes for succinate 
dehydrogenase and lactate dehydrogenase. The strain C. glutamicum ΔsdhCAB ΔldhA pEKEx3 excretes 
aspartate anaerobically with a yield of 0.55 mol/mol glucose and forms alanine as main by-product 
(Figure 10, p. 55).  
In general, anaerobic consumption of carbon sources is coupled to the reduction of a terminal electron 
acceptor other than oxygen or the excretion of reduced fermentation products. Based on this, 
anaerobic fermentations for the production of organic acids like succinate, lactate and ethanol were 
developed (Inui et al., 2004a; Litsanov et al., 2012a; Okino et al., 2008a). Anaerobic processes for 
amino acid synthesis with C. glutamicum were developed recently for alanine and valine (Hasegawa et 
al., 2013; Hasegawa et al., 2012; Jojima et al., 2010). The processes are based on sufficient supply with 
the precursor pyruvate and a decreased flux into the reductive branch of the TCA cycle. However, the 
main difference to the aspartate production described here is that both amino acids are produced with 
amino acid dehydrogenases and that alanine and valine are excreted as reduced fermentation 
products. This strategy was not applicable for aspartate, as the aspartate dehydrogenases analyzed 
here were not active under the tested conditions (3.2.3.5, p. 64). Therefore, aspartate is not excreted 
as a reduced product in the process described here. Other fermentation products besides succinate, 
lactate, and acetate were not detected in supernatants of the strain SL (Figure 18, p. 64; Figure 20, p. 
67). Possible candidates in this strain reside from the glycolysis and reductive branch of the TCA cycle, 
while the production of organic acids from the oxidative branch seems unlikely, as the gltA gene for 
citrate synthase and aceA, coding for the E1p subunit of the pyruvate dehydrogenase complex, are 
downregulated (Inui et al., 2007).  
The addition of nitrate as terminal electron acceptor to anaerobic cultures of the strain SL improved 
the slow glucose utilization caused by the deletion of sdhCAB and ldhA, but came along with a high 
excretion of alanine and a concomitant reduction of aspartate in the supernatants (Figure 13, p. 58 
and Figure 14, p. 59). Nitrate promotes biomass formation in C. glutamicum which is tenfold lower 
than under aerobic conditions (Nishimura et al., 2007; Takeno et al., 2007). The organism possesses 
the narKGHJI gene cluster encoding orthologous proteins of E. coli for nitrate/nitrite antiport, the 
nitrate reductase and an assembly subunit (Bott and Niebisch, 2003). C. glutamicum lacks pathways for 
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ammonification and denitrification and the reduction of nitrate leads to an equimolar formation of 
toxic nitrite. Nitrate respiration induces many genes of the SOS response which is crucial for long term 
survival, to protect cells from reactive nitrogen species (Nishimura et al., 2011). This toxic effect might 
cause the concentration-dependent, bi-phasic metabolization of glucose that was observed for 
cultures supplemented with nitrate (Figure 13, p. 58), consisting of an initial phase of accelerated, and 
a second phase of decelerated glucose consumption. On the other hand, two mol NADH per mol 
glucose are generated during glycolysis, which need to be regenerated by two molecules of nitrate. 
The bi-phasic glucose consumption might therefore be caused by a depletion of nitrate, as the second 
phase with decelerated glucose consumption started, when strains supplemented with 30 mM nitrate 
had consumed around 10-15 mM glucose. However, neither nitrate nor nitrite was measured in this 
experiment. During nitrate respiration alanine was detected as the main fermentation product (Figure 
14, p. 59). The amino acid is synthesized in C. glutamicum from pyruvate by the aminotransferases 
AlaT and AvtA, which use glutamate, aspartate and valine as amino group donors (Marienhagen and 
Eggeling, 2008; Marienhagen et al., 2005). During the aerobic production of lysine, valine and 
pyruvate, an increased accumulation of alanine was detected in the production phase, caused by the 
insufficient conversion of pyruvate into desired products (Blombach et al., 2007; Krömer et al., 2004; 
Wieschalka et al., 2012). Alanine is therefore considered as a product of overflow metabolism, which 
might also occur in the strain SL under anaerobic nitrate respiration. This overflow is supported by 
transcriptomic data for the anaplerotic node (Nishimura et al., 2011). The analysis revealed besides a 
minor increase in the expression of the anaplerotic PEP carboxylase gene ppc, a reduced expression of 
the citrate synthase gene gltA and increased expression of the gluconeogenetic phosphoenolpyruvate 
carboxykinase gene pck and malic enzyme gene malE. This indicates only a minor role of the TCA cycle 
under nitrate respiration. Nonetheless, a reduced expression of TCA cycle genes does not necessarily 
imply a reduced flux through the cycle, which also depends on the activity of the respective enzymes. 
 
4.1.2.2 Enhancing the aspartate overproduction by the overexpression of the aspartate 
aminotransferase gene aspB 
The overproduction of aspartate in C. glutamicum was enhanced by 18 % by the expression of the 
aspartate aminotransferase AspB (Figure 18, p. 64). Neither the expression of aspartases (AspA) nor of 
aspartate dehydrogenases (AspDH) improved aspartate overproduction. Moreover, the expression of 
the aspartase of E. coli AspAEc reduced the aspartate yield to 26 % compared to the control strains 
(Figure 16, p. 62). This result is in line with the results obtained for the enzymatic assays that showed a 
preference of the aspartases for the degradation of aspartate (Table 6, p. 60). In a previous study, it 
was shown that the expression of the AspAEc in a lysine producing strain of C. glutamicum and the 
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feeding of a glucose/fumarate mixture improves lysine yields and leads to a concomitant excretion of 
aspartate (Menkel et al., 1989). Aspartate overproduction with aspartases under aerobic conditions is 
therefore enabled in C. glutamicum, when sufficient amounts of fumarate are provided. Apparently, 
the deletion of the succinate dehydrogenase genes does not enable an accumulation of fumarate in 
the strain SL. Another possibility is a futile cycle between fumarate, aspartate and oxaloacetate 
mediated by the reactions of AspA and AspB. Aspartate formed from fumarate by the aspartase would 
then be converted to oxaloacetate by aspartate aminotransferase (compare to scheme shown in 
Figure 34, p. 90). To test this hypothesis, a strain with a deleted aspB gene (ΔsdhCAB ΔldhA ΔaspB, 
SLB) was constructed. In this strain, aspartate synthesized by aspartases cannot be transaminated to 
oxaloacetate. But neither the expression of the endogenous aspartase nor the expression of 
homologous enzymes from B. subtilis or E. coli was able to compensate the deletion (Figure 17, p. 63), 
indicating that no fumarate is accumulating by the deletion of the sdhCAB genes.  
In another study, a similar strategy was used to establish fumarate production under oxygen-deprived 
conditions. In a strain optimized for pyruvate production, the additional deletion of the sdhCAB gene 
did not enable fumarate accumulation intracellulary or in culture supernatants (Wieschalka, 2012). In a 
succinate-producing derivative of E. coli, the deletion of the fumarate reductase, that catalyzes the 
reduction of fumarate to succinate, does not lead to an excretion of fumarate but malate in anaerobic 
fermentations (Zhang et al., 2011). Explanations for these results are scarce, but are related to a 
possible toxicity of fumarate to the cells. Another possible explanation that prevents the accumulation 
of fumarate, might be a cycle between the malate dehydrogenase (Mdh) and the malate:quinone 
oxidoreductase (Mqo). The enzymes catalyze the opposite reactions from oxaloacetate to malate 
(Mdh) and back to oxaloacetate (Mqo) leading to a net transfer of electrons from NAD to quinone 
(Molenaar et al., 2000; Molenaar et al., 1998). This cycle would prevent aspartate formation with AspA 
as fumarate synthesis is blocked, but does not interfere with the transamination of oxaloacetate by 
AspB.  
Under aerobic conditions, it was shown that AspB is essential, as the growth of mutants was inhibited 
in minimal medium (Figure 6, p. 50). In a previous study, a disruption mutant of the aspB gene was 
created in a restriction-deficient mutant of C. glutamicum ATCC13032 (McHardy et al., 2003). This 
mutant showed no growth defect, which is in contrast to the defined mutants (ΔaspB and 
ΔsdhCAB ΔldhA ΔaspB) analyzed here. However, the aspB mutants obtained here indicate a highly 
specific reaction of AspB, as no other transaminase was apparently able to take over its function. This 
is in contrast to other aminotransferases like IlvE, which has a broad substrate spectrum and is 
involved in the synthesis of leucine, isoleucine and valine. The function of IlvE can at least partially be 
replaced by AvtA (Marienhagen et al., 2005). In E. coli, the aspartate aminotransferase AspC is involved 
in the synthesis not only of aspartate, but also of tyrosine and of phenylalanine. These functions can 
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be taken over by either IlvE, which synthesizes phenylalanine, or TyrB that can replace AspC in 
tyrosine, phenylalanine and aspartate synthesis (Gelfand and Steinberg, 1977; Jensen and Calhoun, 
1981; McHardy et al., 2003; Powell and Morrison, 1978). 
The overexpression of the aspB gene proved to be beneficial for the anaerobic aspartate production 
process and increased the aspartate overproduction to 0.83 mol/mol glucose (Figure 18, p. 64). In 
contrast to AspA, AspB depends on glutamate as amino donor. Therefore, the synthesis of one mol of 
aspartate consumes one mol of NADPH, which is needed by glutamate dehydrogenase for the 
amination of 2-oxoglutarate. In C. glutamicum, the NADP
+
 is reduced in the pentose phosphate 
pathway by glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase or in the 
TCA cycle by isocitrate dehydrogenase. Although information about the activities of these enzymes 
under anaerobic conditions is scarce, a limitation of NADPH-, and therefore, of glutamate-supply is 
unlikely, as the overexpression of the aspB gene improved aspartate production, indicating a high 
intracellular amount of glutamate. Moreover, the expression of the transhydrogenase PntAB, reducing 
NADP
+
 to NADPH, had a negative effect on aspartate overproduction (3.2.7.5, p. 72). Taken together, 
the production of aspartate is presumably not limited by the synthesis or the availability of glutamate. 
Besides the endogenous AspB, also the enzymes of E. coli (AspCEc) and B. subtilis (AspBBs) were tested. 
AspCEc is one of the best characterized PLP-dependent enzymes that belongs to the aminotransferase 
subgroup Iα, in which the binding of the substrate induces a conformational change (Okamoto et al., 
1994). The alignment of the AspCEc sequence and the AspBCg sequence shows only weak sequence 
identity between the enzymes. Five structural amino acids were determined in the crystal structure of 
AspCEc, mediating the binding of the PLP cofactor and the substrate (Jäger et al., 1994; Jeffery et al., 
2000). AspBCg does not share Lys258, necessary for PLP binding in AspC. However, AspBBs also differs 
from the AspCEc sequence and it is devoid of Arg280, necessary in E. coli for the binding and the 
recognition of aspartate. Nevertheless, the aminotransferases AspBBs and AspCEc mediated the 
overproduction of aspartate, but did not exceed aspartate formation of the endogenous enzyme.  
Under anaerobic conditions, processes were developed by Jojima et al. and Hasegawa et al. that 
enable efficient overproduction of alanine and valine with amino acid dehydrogenases (Hasegawa et 
al., 2012; Jojima et al., 2010). Recently, the aspartate dehydrogenases of the thermophilic organisms 
Archaeoglobus fulgidus (AspDHAf, AF1838) and Thermotoga maritima (AspDHTm, TM1643) were 
crystallized and analyzed in detail (Yang et al., 2003; Yoneda et al., 2006). Their structures were used 
as basis for alignments with the mesophilic enzymes of Pseudomonas aeruginosa PAO1 (AspDHPa) and 
Ralstonia eutropha (AspDHRe) used here. All amino acids necessary for substrate binding are highly 
conserved, except AspDHAf L161, which is altered to isoleucine in T. maritima and to alanine in all 
mesophilic enzymes.  
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For the tested AspDHs, no activity was found in enzymatic assays and the expression of these enzymes 
had no influence on aspartate excretion in C. glutamicum (3.2.3.5, p. 64). In E. coli, a production 
scheme for aspartate was developed with AspDHPa. Efficient overproduction of aspartate was achieved 
in an enzymatic process with permeabilized cells that convert fumarate via malate and oxaloacetate to 
aspartate. This three step fed-batch process led to overproduction of 625 mM aspartate in six hours. 
However, an effective fermentative production scheme with living cells was not developed. The 
synthesis of aspartate with AspDHPa leads to an accumulation of around 10 mM aspartate from 
400 mM glucose. A higher titer was achieved from glucose plus succinate, where cells are inoculated 
with 80 mM glucose and succinate was added to the broth every two hours. Within 50 hours, 33 mM 
aspartate were produced from the glucose plus 500 mM succinate (Li et al., 2011). However, this 
scheme was not applicable in C. glutamicum, as the tested AspDHs were inactive and additionally, the 
overall yield obtained in the fermentative process is rather low. 
 
4.1.2.3 The deletion of the alanine valine aminotransferase increases aspartate overproduction 
Alanine was detected as the main by-product during the fermentative production of aspartate. The 
general information about alanine transaminases is rather scarce, but for C. glutamicum, the two 
alanine synthesizing aminotransferases AlaT and AvtA were identified (Marienhagen et al., 2005). AlaT 
uses glutamate or aspartate as amino donor while AvtA is part of the branched-chain amino acid 
(BCAA) pathway and accepts valine or alanine as amino donor, but not glutamate. Under aerobic 
conditions, AlaT was identified as the principal alanine-supplying aminotransferase in C. glutamicum, 
as a deletion of alaT decreased the intracellular content of alanine to a greater extent than did a 
deletion of the avtA gene (Marienhagen and Eggeling, 2008; Marienhagen et al., 2005). A deletion of 
both genes prevented growth on minimal medium plates, which could be restored by the addition of 
alanine. The results obtained with the SL strains harboring the single and the double deletions of alaT 
and avtA, the strains SLT (ΔsdhCAB ΔldhA ΔalaT), SLV (ΔsdhCAB ΔldhA ΔavtA), and SLTV 
(ΔsdhCAB ΔldhA ΔalaT ΔavtA), respectively, are different from these observations. Neither the 
deletion of alaT nor the deletion of avtA alone reduced the alanine content in the supernatants of 
anaerobically incubated cultures. Instead, the strains SLT and SLV excreted higher amounts of alanine 
than the control strain SL and only the deletion of both transaminases decreased alanine in the 
supernatants from 16.2 mM to 5.2 mM (Figure 21 A, p. 68). This residual amount of alanine in SLTV is 
presumably synthesized by unspecific side reactions of other aminotransferases. A similar effect was 
observed in a pyruvate-excreting strain of C. glutamicum that is devoid of alaT and avtA, but still 
excretes alanine as a by-product during the production phase (Wieschalka et al., 2012). Furthermore, 
 the deletion of the alanine transaminases affected aspartate formation. The strains SLT and SLV 
formed less aspartate without overexpression of 
the control strain. With the additional expression of 
strains. The highest aspartate excretion of 1.02
The benefit of the avtA deletion might be found in the synthesis of the branched chain amino acids 
(BCAA). Pyruvate is the precursor for the BCAAs valine
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preference for the synthesis or the degradation of valine by IlvE and AvtA is not known, but it was 
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alanine as a by-product (Hasegawa
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pathway by inhibiting the activity of IlvBN
 
 
Figure 35: Inhibition of IlvBN by valine by deletion of 
Abbreviations: IlvBN: acetohydroxy acid synthase; IlvE: branched
Alanine-valine aminotransferase. 
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formation of aspartate. However, valine or other BCAA were not detected as by-product during 
aspartate overproduction. 
The role of AlaT during anaerobic aspartate production is elusive. The enzyme is proposed as the 
principal alanine supplying enzyme under aerobic growth conditions, but a deletion of alaT during 
aspartate overproduction led to the highest alanine excretion. This underlines the proposed model for 
AvtA and the flux through the BCAA pathway, but does not match the observations for AlaT under 
aerobic conditions. Furthermore, the reduction of the by-product alanine is not completely transferred 
into the product aspartate, as it can be seen from the results obtained for the strain SLTV. Although 
the strain excretes less alanine than the other tested strains, the aspartate content does not exceed 
the content in SLV.  
Taken together, with the deletion of the alanine aminotransferases a reduction of the alanine content 
can be achieved. Additionally, the valine-alanine aminotransferase AvtA occupies a special role, as it 
positively influences aspartate overproduction by a yet not completely understood mechanism.  
 
4.1.2.4 Regeneration of reduction equivalents 
The regeneration of reduction equivalents is of major concern, as it influences glucose consumption 
and therefore the velocity of the process. A maximum of two mol NADH per mol glucose is formed in 
the strain SL by the glyceraldehyde-3-phosphate dehydrogenase (GapA), which can be regenerated to 
NAD
+
 by the malate dehydrogenase (Mdh). Limiting factors in this scheme are the phosphorylation of 
glycerol-3-phosphate by GapA and the carboxylation at the anaplerotic node. GapA is inhibited by high 
NADH levels and is therefore the rate-limiting enzyme in glycolysis controlling sugar consumption 
(Dominguez et al., 1998; Omumasaba et al., 2004). The Mdh synthesizes malate from oxaloacetate and 
fuels the reductive branch of the TCA cycle. Furthermore, the Mdh can contribute to the transfer of 
electrons to the quinone pool under aerobic conditions, when malate is reoxidized to oxaloacetate by 
the malate:quninone oxidoreductase (Mqo) (Molenaar et al., 2000; Molenaar et al., 1998).  
To improve the velocity of aspartate formation, the overexpression of the glycolytic gapA and the 
reductive mdh was tested separately and in combination (3.2.7.2, p. 70). Both, GapA and Mdh had 
positive effects on aspartate overproduction (Figure 23, p. 70). For GapA, the effect was further 
evaluated and was shown to enhance the aspartate production rate 1.5-fold to 0.154 mM/h*gCDW 
and the glucose consumption rate 1.4-fold to 0.763 molC/h*gCDW, but not the total yield (Table 7, 
p. 74). The combined expression of gapA with mdh negatively influenced the velocity of the 
production compared to the single gapA overexpression. This might contribute to the reduced activity 
of GapA during combined expression with mdh, which was at the level of the control strain (Figure 22, 
p. 69.)  
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Besides its function in NAD
+
-regeneration, Mdh is competitive to AspB for the substrate oxaloacetate. 
The initial strategy was to replace the Mdh with aspartate dehydrogenases (AspDH), which would 
serve both, NAD
+
-regeneration and product formation. But this proved to be futile, as no activity was 
detected for the tested AspDHs, when they are expressed in C. glutamicum. The expression of the 
NAD-dependent glutamate dehydrogenase GdhPa of Peptostreptococcus asaccharolyticus was another 
strategy to regenerate NAD
+
 in an mdh deficient strain. The enzyme catalyzes the reductive amination 
of 2-oxoglutarate to glutamate, the precursor for AspB, and would serve precursor supply and NAD
+ 
regeneration (Marx et al., 1999). The expression of the gdhPa gene could restore the impaired glucose 
consumption of the mdh mutant, but not the aspartate production that was achieved in a strain with 
intact Mdh (Figure 24, p. 72). The strategy of combining an increased expression of glycolytic genes 
with NAD-regenerating, product-forming enzymes was followed for the anaerobic production of 
alanine and valine, too (Hasegawa et al., 2013; Hasegawa et al., 2012; Jojima et al., 2010). For alanine 
synthesis, the expression of gapA was combined with the expression of an alanine dehydrogenase, 
which increased the productivity 2.7-fold. In an anaerobic production scheme for valine, several genes 
of the glycolytic pathway (phosphofructokinase, phosphoglucose isomerase, triosephosphate 
isomerase, pyruvate kinase, and gapA) were overexpressed and combined with the heterologous 
expression of a leucine dehydrogenase, which improved glucose consumption 7.6-fold and the valine 
production 9.0-fold. The velocity of aspartate overproduction might therefore be further enhanced, if 
NAD
+
-regeneration can be coupled to product formation. 
 
4.1.2.5 Anaplerosis and carbon sources 
The synthesis of aspartate is draining off oxaloacetate from the TCA cycle, which is replenished at the 
anaplerotic node by the carbon-fixing reactions of the PEP carboxylase (Ppc) and the pyruvate 
carboxylase (Pyc). The formation of the initial aspartate concentration of 0.55 mol/mol glucose 
obtained in standard medium is presumably promoted by the hydrolysis of urea. Under conditions of 
surplus nitrogen, urea enters the cell by passive diffusion, while an active uptake is induced under 
nitrogen starvation (Nolden et al., 2000; Siewe et al., 1998). The urease is a multisubunit complex 
encoded by the ureABCEFGD gene cluster that hydrolyzes urea into two molecules of ammonium and 
one molecule of CO2, which can be fixed by Pyc and Ppc. Furthermore, aspartate overproduction was 
greatly enhanced by the addition of NaHCO3 to the medium, which delivers bicarbonate ions (HCO3
-
) 
for these carboxylations (Figure 12, p. 57). Nevertheless, the overexpression of ppc and pyc
P458S
 did not 
further enhance aspartate excretion, when NaHCO3 was added to the medium (Figure 19, p. 65). 
Similar effects were observed during anaerobic succinate synthesis with bicarbonate, where the 
expression of pyc
P458S
 led to decreased production rates or yields (Okino et al., 2008a; Wieschalka, 
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2012). In contrast, the expression of pyc
P458S
 from the strong constitutive tuf promoter (Ptuf) greatly 
enhanced succinate production (Litsanov et al., 2012a). In the latter production scheme, formate 
instead of bicarbonate was added to the medium, which was reduced to two molecules of CO2 by the 
NADH-forming formate dehydrogenase (Fdh) of Mycobacterium vaccae. A side effect of this reduction 
is the import of CO2 into the cells.  
These results hint on a limitation in the interconversion of HCO3
-
 and CO2, if NaHCO3 is supplemented. 
NaHCO3 dissociates into Na
+
 and HCO3
-
 ions, and a proportion of the bicarbonate ions are dehydrated 
to CO2 in the medium. Only the uncharged CO2 can enter the cells by diffusion, but must be hydrated 
to HCO3
-
 by the anhydrase CynT (cynT, cg2954) to serve as a substrate for the carboxylation reaction. 
Recently, CynT proved to be indispensable for growth, but overexpression of the gene did not result in 
improved growth or yields during lysine synthesis (Mitsuhashi et al., 2004). Taken together, rather the 
diffusion of CO2 in the cells than the hydration is the limiting factor in this scheme, and therefore, the 
selection of the carbon source for anaplerosis might be a valuable target to improve the aspartate 
production process.  
Inui et al. postulated that Ppc is the main anaplerotic enzyme under anaerobic conditions (Inui et al., 
2004b). It was found that a deletion of the ppc gene inhibited glucose consumption and succinate 
formation, while a strain with a deleted pyc gene consumed and produced as the wild type. The 
biochemical analysis of Ppc revealed a synergistic inhibition of the enzyme by aspartate and 
2-oxoglutarate and non-synergistic inhibition by succinate and malate (Mori and Shiio, 1985b). The 
inhibition of Ppc by aspartate is competitive to PEP and bicarbonate, and can additionally be overcome 
by acetyl-CoA or fructose-1,6-bisphosphate (Eikmanns et al., 1989; Mori and Shiio, 1985a). The 
intracellular amounts of the respective compounds were not determined, but a high concentration of 
bicarbonate is expected, as it is a medium component. Furthermore, aspartate is accumulating in the 
medium which might circumvent an inhibition of Ppc by the amino acid. Nevertheless, an inhibition of 
Ppc by aspartate during the production process cannot be excluded. 
The importance of Ppc under anaerobic conditions finds support within the observation made for the 
utilization of maltose. Maltose as carbon source led to the highest aspartate production rate 
(0.176 mM/h*gCDW) and yield (0.80 g/g maltose) (Table 7, p. 74). One main difference between the 
carbon sources glucose and maltose is the uptake. The disaccharide is taken up by the recently 
identified ATP-binding cassette transporter (ABC) MusEFGK2I and converted to either glucose-6-
phosphate or added to the storage polymer maltodextrin (Henrich et al., 2013). In total, the uptake of 
one mol maltose and the conversion to two mol glucose-6-phosphate consumes two mol of ATP and 
one mol inorganic phosphate (Seibold et al., 2009). On glucose, two mol of PEP are consumed for the 
import and the phosphorylation to obtain the same amount of glucose-6-phosphate (Yokota and 
Lindley, 2005). Taken together, the utilization of maltose consumes ATP, while glucose uptake is 
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associated to PEP consumption. The connection between anaplerosis and carbon source is, in this 
case, the role of Ppc. Ppc competes with the PTS for the substrate PEP, and if all synthesized succinate 
is formed by the anaplerotic reaction of Ppc, as postulated by Inui (2004), only fifty percent of the 
available carbon can be channeled into the reductive branch of the TCA. The positive effect of maltose 
on aspartate formation might therefore be the increased availability of PEP for the carboxylation at the 
anaplerotic node. 
 
4.1.2.6 Comparison to other aspartate production processes 
In this work, an anaerobic process with resting cells was developed that led to aspartate 
overproduction with yields of 0.59 g/g glucose or 0.80 g/g maltose. Other fermentative productions 
are described for C. glutamicum by Shiio et al., Mori et al., Sawada et al., and Menkel et al., as well as 
the already discussed production of aspartate in E. coli with the aspartate dehydrogenases of 
P. aeruginosa. The use of the dehydrogenase is effective during enzymatic conversion of fumarate with 
permeabilized cells similar to existing aspartase-based productions on the industrial scale, while the 
expression of the aspDHPa gene in growing cells leads to a low substrate specific yield of 0.02 g/g 
glucose. The excretion of aspartate in C. glutamicum was first observed as a by-product during 
glutamate overproduction. Based on this, Shiio et al. and Mori et al. developed aspartate producing 
strains by random mutagenesis that overproduce aspartate with yields of 0.29 g/g glucose or 0.23 g/g 
glucose, respectively (Mori and Shiio, 1984; Shiio et al., 1982). These mutants are cultivated aerobically 
under biotin-limiting conditions and aspartate excretion is detected in the transition to the stationary 
phase. This demonstrates that arresting cells in growth is a prerequisite to enable aspartate 
overproduction from glucose, similar to the results obtained in this work. Besides this, aspartate 
occurs as a by-product (2 g/l) of biotin-limited glutamate production (32 g/l) in a defined pyruvate 
kinase deficient mutant (Sawada et al., 2010). However, several biotransformations are described with 
immobilized cells that overproduce aspartate in bioreactors (Eggeling and Sahm, 2009; Zajkoska et al., 
2013). In these bioreactors, cells that express aspartases are cross-linked to a polymer and fed with a 
fumarate/ammonium solution. For recombinant E. coli, a process is described where cells are 
embedded in a chitosan matrix and are able to convert 99.8 % of the fed fumarate and produce 
6 g/gCDW/h aspartate (Szymanska et al., 2011). The fermentative process described here, cannot 
compete with these biotransformations in terms of productivity and yield, but it is not dependent on 
petrochemical resources and shows that alternative processes exist if the availability of the substrate 
fumarate is limited. 
 
101 
 
4.2 Anaerobic overproduction of β-alanine 
Next to its function as vitamin precursor, the non-proteinogenic amino acid β-alanine has large scale 
application in the synthesis of hydroxypropionic acid and as supplement in the diet of athletes. In this 
work, overproduction of β-alanine was achieved with aspartate-producing strains of C. glutamicum. 
However, significant amounts of the available substrate aspartate were not converted into the 
product, but excreted to the culture supernatant (Figure 27, p. 78). In advance, the enzymatic activity 
of three different aspartate-α-decarboxylases (PanD) was tested. Compared to the homologous 
enzymes of E. coli and B. subtilis, the endogenous enzyme (PanDCg) showed the highest specific activity 
in crude extracts of C. glutamicum, which is with 55.4 mU/mg in the range of the previously reported 
specific activity of 34.5 mU/mg by Dusch, et al. (Dusch et al., 1999b).  
The aspartate-α-decarboxylase is a pyruvate-dependent multimer consisting of four PanD peptide 
chains, of which three undergo a self-induced auto-proteolysis between the residues Gly24 and Ser25. 
In C. glutamicum it was recently found, that one additional arginine residue in the N-terminal region of 
the pro-protein is needed to initiate the maturation of the protein (Cui et al., 2013). However, the 
proteolysis generates a pyruvoyl-residue representing the prosthetic group of the enzyme 
(Schmitzberger et al., 2003). A major disadvantage of the aspartate-α-decarboxylase is the inactivation 
of this prosthetic group by the substrate aspartate. During the decarboxylation, the pyruvoyl-residue is 
transaminated to alanine depending on time and concentration of aspartate. The effect was detected 
with E. coli PanD, which was tested for enzymatic preparation of β-alanine in matrices similar to the 
enzymatic preparation of aspartate with immobilized E. coli cells (Konst et al., 2009; Webb et al., 
2004). The embedded proteins were mixed with fresh substrate every thirty minutes, but lost 30 % of 
the initial activity within two hours.  
Besides the inactivation, also self-proteolysis of the enzyme might be rate limiting for β-alanine 
overproduction with aspartate-producing strains expressing the panD gene. For 
Mycobacterium tuberculosis, a complete self-proteolysis of purified aspartate-α-decarboxylase was 
observed after 24 hours at 37 °C (Chopra et al., 2002). A similar pattern was observed in vitro with 
E. coli PanD, were self-proteolysis was incomplete after 24 hours at 37 °C but promoted by elevated 
temperatures (Ramjee et al., 1997). How these conditions reflect the self-proteolysis under 
physiological conditions is not known, but it gives an indication of a possible limitation.  
However, the utilization of an aspartate-producing derivative of C. glutamicum expressing the panD 
gene (ΔsdhCAB ΔldhA pVWEx1-aspB pEKEx3-panDCg) leads to the overproduction of β-alanine with a 
yield of 0.24 g/g glucose. As the supply with the precursor molecule aspartate seems unlikely to limit 
the decarboxylation, further improvements need to address stability and activity of the aspartate-α-
decarboxylase.  
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4.3 Aerobic overproduction of ectoine 
The compatible solute ectoine has gained attention due to its chemical properties and the broad range 
of applications as protecting agent of DNA, proteins and the human skin. In this work, 
salt-independent overproduction of ectoine was established by the expression of the ectoine 
biosynthetic genes of Chromohalobacter salexigens in C. glutamicum. The ectABC gene cluster was 
transferred into derivatives of C. glutamicum and allowed efficient production of ectoine from glucose 
and the non-food carbon sources glycerol, arabinose, and xylose (Figure 33, p. 84). Ectoine 
biosynthesis is catalyzed by five enzymatic reactions and shares the initial steps of the synthesis of 
amino acids of the aspartate family that lead to aspartate semialdehyde. The major pathway 
controlling enzyme is the aspartokinase LysC due to its feedback inhibition by lysine and threonine. 
Ectoine is not a natural product of C. glutamicum, and the high amount that was obtained by the 
expression of ectABC in the wild type (0.074 g/g glucose) indicates that LysC is not, or only at a low 
level, influenced by the compatible solute (Figure 30, p. 81). Feedback inhibition of the aspartokinase 
of C. salexigens is only poorly studied, but as the organism possesses only one enzyme, an inhibition by 
ectoine seems unlikely (Pastor et al., 2010). However, expression of the ectoine biosynthetic genes in 
the lysine-producing strain with deregulated aspartokinase DM1729 (pyc
P458S
, hom
V59A
, lysC
T311I
) 
doubled the ectoine yield to 0.145 g/g glucose (Figure 31, p. 82). 
Ectoine is synthesized on an industrial scale with the natural, Gram-negative producers 
Halomonas elongata or C. salexigens in a cell-recycling process called bacterial milking. Thereby, the 
biosynthesis and excretion of the compatible solute are separated in two phases. The biosynthesis is 
performed under high salt conditions with 2.57 M NaCl, and the excretion is induced by an osmotic 
downshock. This scheme has some drawbacks concerning the medium conditions, and is limited in the 
application for Gram-positive organisms. For instance, the halophilic Marinococcus sp. 52 synthesizes 
hydroxyectoine naturally, but does not excrete compatible solutes upon osmotic downshock (Frings et 
al., 1995). However, a high yield of 540 mg/gCDW and a productivity of 32.5 g/l*d
-1
 are obtained in this 
process with C. salexigens (Fallet et al., 2010). For H. elongata, yields of 155 mg/gCDW per cycle are 
obtained, conferring to a productivity of 5.3 g/l*d
-1
 (Sauer and Galinski, 1998). In the batch process 
performed in this work with C. glutamicum DM1729, 36.9 mM ectoine were produced within 24 h, 
corresponding 514 mg/gCDW and a productivity of 5.2 g/l*d
-1
, which is well in the range of the natural 
producers. The higher productivity obtained with C. salexigens can be explained by the six times higher 
biomass (61 g/l compared to 10.2 g/l) used in the process. Additionally, controlled culture conditions in 
a fermenter might further improve ectoine production of C. glutamicum. One major advantage is the 
salt-independent production of the compatible solute, as, besides the cost, the high salt concentration 
negatively influences the work life of fermenters and other equipment.  
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Heterologous production of ectoine was recently shown for C. glutamicum and for E. coli, too. The 
ectoine biosynthetic genes of C. salexigens were used for production in a fed-batch culture of E. coli 
(Schubert et al., 2007). Continuous excretion of ectoine was enabled and led to a final titer of 6 g/l 
ectoine after 160 hours. The final titer was rather low, caused by a high carbon loss of more than 
eighty percent during the production phase. Additionally, the specific activity of EctA in crude extracts 
of E. coli was reduced to one third compared to C. glutamicum, contributing to the obtained results. 
In C. glutamicum, the ectABCD genes of Pseudomonas stutzeri A1501 were integrated in the genome 
under the control of the strong constitutive promoter Ptuf (Becker et al., 2013). Further improvements 
of the strain were a deregulated aspartokinase and the deletion of the gene for the lysine exporter 
LysE. This strain excreted ectoine and small amounts hydroxyectoine simultaneously with an ectoine 
yield of 32 mmol/mol glucose in batch fermentation, which is 18 % of the yield obtained with 
C. glutamicum DM1729 under similar conditions. In fed-batch fermentation at high optical density 
(around OD660=100), a yield of 6.7 g/l*d
-1 
was obtained (Becker et al., 2013). However, a direct 
comparison between this production and the process shown in this work is difficult, as different 
genetic backgrounds and different ectoine biosynthetic genes were used. 
C. glutamicum is a well investigated amino acid-producing strain, and several improvements for the 
overproduction of lysine can be transferred to improve ectoine synthesis. Nevertheless, as lysine is a 
by-product of ectoine synthesis, one important target is to prevent its excretion, similar to the strategy 
in the ectoine-producing C. glutamicum strain of Becker et al. Further improvements are useful at the 
level of aspartate semialdehyde, which is the last common precursor of lysine, threonine, isoleucine, 
and ectoine synthesis. Studies on the homoserine dehydrogenase Hom and the dihydropicolinate 
synthase DapA showed that the regulation of these enzymes influence lysine, threonine, and 
branched-chain amino acid production, respectively (Cremer et al., 1988; Morbach et al., 1996; Sahm 
et al., 1996). Therefore, the additional downregulation of dapA in the strain DM1729 might further 
enhance ectoine overproduction.   
Taken together, a constant, salt-independent production of ectoine competitive to existing 
productions with native producers can be achieved not only from glucose, but also from the non-food 
carbon sources arabinose and xylose. Moreover, efficient production is possible from glycerol, which is 
a stoichiometric waste product of biodiesel synthesis, and therefore, available in large amounts.  
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